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Abstract 
Escherichia coli (E. coli) Kl is one of the commonest Gram negative bacteria 
causing neonatal bacterial meningitis in both developed and developing countries. 
Haematogenous spread is a key step in E. coli Kl meningitis; however, it is not clear how 
bacteria cross the brain endothelium to gain entry into the central nervous system. Previous 
studies have focussed mainly on the identification of bacterial virulence factors, as well as 
the signalling pathways that are activated for the recruitment of actin cytoskeleton to the 
bacterial adhesion site on the apical surface of human brain microvascular endothelial cells 
(HBMEC) and finally lead to bacterial uptake. However, the cellular requirements and 
mechanisms of post-invasion events are poorly understood. 
This study aims to further characterize E. coli KI entry, intracellular trafficking and 
the associated molecular mechanisms. To achieve this, a virulent fluorescent protein-
expressing E. coli K I strain was constructed. In a previous study, caveolin-l, a lipid raft 
marker associated with clathrin-independent endocytosis, was found associated with 
invading and intracellular bacteria in HBMEC. To further study the effect of caveolin-l on 
the bacterial entry, different caveolin-l mutants were applied here. Overexpression of 
caveolin-l Y 14A mutant and caveolin-l~, which is non-phosphorylatable, did not block E. 
coli Kl invasion of HBMEC. Furthermore, E. coli Kl invasion of caveolin-l knockout 
mouse lung endothelial cells (MLEC) was not blocked, which suggested that caveolin-l 
was not required for E. coli K 1 invasion of endothelial cells. The role of dynamin, a large 
GTPase that has been implicated in the membrane fission of caveolae buds, was also 
investigated. Based on quantitative microscopy scoring, no evidence of any inhibitory 
effect on the bacterial invasion was observed in cells overexpressing green fluorescent 
protein- (GFP) tagged dominant negative dynamin 2 [Dyn2(aa)K44A] and dominant 
negative dynamin 1 (DynlK44A). The experimental evidence from this study therefore 
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suggests that E. coli Kl might invade HBMEC via a caveolae- and dynamin-independent 
endocytic pathway. 
To further explore the endocytosis pathway that the bacteria use to invade 
HBMEC, immunofluorescence staining of E. coli Kl infected HBMEC revealed co-
localization of the bacteria with flotillin 1, another lipid raft marker associated with 
clathrin-independent endocytosis. However, E. coli K1 infection of flotillin 1 knockout 
MLEC demonstrated a significantly increased bacterial uptake. This observation suggests 
that E. coli K 1 uptake does not require flotillin 1. In parallel, the number of intracellular 
non-pathogenic E. coli K-12 recovered from the lysates of flotillin 1 knockout MLEC was 
also significantly higher than that recovered from the lysates of wild type MLEC. Further, 
overexpression of GFP-tagged flotillin 1 and flotillin 2 in HBMEC inhibited E. coli Kl 
invasion, which suggest flotillin might have a role as a regulatory cell barrier in host 
defence. 
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1. Introduction 
1.1 Neonatal bacterial meningitis (NBM) 
Neonatal bacterial meningitis (NBM) is caused by inflammation of the meninges, a 
result of bacterial infection during the first month of life. In developing countries, of 
125000 diagnosed cases about 50000 newborns die of meningitis annually (mortality rate 
of 400/0) (Mulholland, 1998). Comparatively, in developed countries, the NBM mortality 
rate has declined from about 50% in the 1970s to about 10% in the late 1990s, although the 
morbidity (0.22 per 1000 births) remains very similar in the past two decades (Holt et a!., 
2001; Oaschignard et a!., 2011). A better understanding of the disease pathogenesis and 
pathophysiology would improve the morbidity and mortality of the disease, despite the 
advances in chemotherapy and supportive care (Polin and Harris, 2001; Bonacorsi and 
Bingen, 2005). 
The clinical presentation of NBM is non-specific, including apnea, temperature 
instability, hypotension, bradycardia, tachycardia, lethargy or irritability, and abdominal 
distention or feeding intolerance (de Louvois, 1994; Wynn and Levy, 2010). The 
prevalence of the causative organisms isolated from early- (occurring between day 0 and 
day 4 of life) and late-onset (occurring between day 5 and day 28 of life) NBM is different, 
and it varies in different countries (Osrin et a!., 2004; Wu et a!., 2009; Zaidi et a!., 2009; 
Talbert et a!., 2010; Oaschignard et a!., 2011). E. coli and group B Streptococci (OBS) are 
the commonest bacteria isolated from NBM cases; however, the mortality rate of E. coli 
associated cases is relatively higher than OBS infection in some countries (Holt et a!.. 
2001; Stoll et a!., 2002; May et a!., 2005; Wu et a!., 2009), and about half of the E. coli-
associated NBM survivors develop neurological disability (Unhanand et a!., 1993: Harvey 
et a!., 1999; Dellagrammaticas et a!., 2000). 
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Following the implementation of intrapartum antibiotic prophylaxis (lAP) 
treatment in mothers who carry GBS from screening at 35 to 37 weeks of gestation since 
the mid-1990s in developed countries, the number of GBS-associated NBM cases have 
declined significantly, while non-GBS NBM cases are either stable (Baltimore et aI., 2001) 
or on the increase (Levine et aI., 1999). Notably, increased ampicillin resistance has been 
found in E. coli strains isolated from E. coli-NBM in the current lAP era (Levine et al .. 
1999; Baltimore et aI., 2001; Stoll et aI., 2002; Alarcon et aI., 2004; Cordero et aI., 200.f; 
Bizzarro et aI., 2008). 
1.2 Escherichia coli (E. coil) 
E. coli is a member of Enterobacteriaceae. It is a facultative anaerobic Gram 
negative bacillus, which colonizes the human neonatal gastrointestinal tract within hours of 
birth, remains as a commensal and provides a lifetime of benefits to the host from intruding 
pathogens, including competition for space or binding sites, competition for nutrients, and 
regulate immune homeostasis (Kaper et aI., 2004; Willing et aI., 2011). However, some E. 
coli strains have acquired specific virulence factors, and are major community and 
hospital-acquired pathogens, and veterinary pathogens. The resultant diseases can be 
categorized into enteric/diarrhoeal disease, urinary tract infections (UTI), and sepsis/ 
meningitis (Kaper et aI., 2004; Bonacorsi and Bingen, 2005). There are eight main 
pathogenic E. coli pathovars, with six diarrhoeagenic: enteropathogenic E. coli (EPEC), 
enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroaggregatiYe E. 
coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC): two 
extraintestinal infections: uropathogenic E. coli (UPEC) and neonatal meningitis E. coli 
(NMEC). In addition to the major pathovars, other pathovars have also been identified 
(Kaper et aI., 2004; Croxen and Finlay, 2010). 
Jl 
The E. coli species has 170 0 lipopolysaccharides antigens or LPS, 103 capsular or 
K antigens, and 56 flagellar or H antigens, and strains are categorised on the basis of their 
antigen configuration (Robbins et aI., 1974; Kaper et a!., 2004). 
Strains possessing the K1 capsular polysaccharide predominate the majority of 
NBM cases (Robbins et aI., 1974). Interestingly, only a few 0 antigens (e.g. 018, 07, 01, 
016) are associated with most of the Kl strains isolated from the cerebrospinal fluid (CSF) 
(Sarff et aI., 1975; Pluschke et a!., 1983). 
1.3 Pathogenesis of E. coli Kl neonatal meningitis 
In most cases of E. coli neonatal meningitis, the infants are believed to acquire the 
pathogen from the mother's delivery canal or from the environment, leading to 
colonization of the infant's intestinal tract (Robbins et aI., 1974; Sarff et aI., 1975; 
Headings and Overall, 1977; Raymond et aI., 2008). The bacteria are normally confined to 
the intestinal tract by the gut mucosal barrier, where they form part of the normal 
commensal flora. The gut barrier is formed of epithelial cells held closely together by tight 
junctions, and has major roles in regulating the movement of ions and molecules between 
cellular spaces, as well as in protecting the host from invading pathogens (Daneman and 
Rescigno, 2009). In E. coli K1 meningitis, the bacteria are able to traverse the gut barrier 
and enter the bloodstream. The interaction of E. coli Kl with gut barrier has not been 
studied extensively; however, an in vitro study with human intestinal epithelial cell lines, 
Caco-2 and T84, showed that E. coli K1 breached the epithelial barrier by disrupting tight 
junctions, evidenced by a decrease in the transendothelial electrical resistance (TEER) 
value and the increased passage of non-invasive E. coli strain through the monolayer on 
Transwell® insert in co-infection experiments (Burns et aI., 2001). 
Once the bacteria have crossed gut mucosal barrier, the bacteria gain access to the 
bloodstream and must overcome the host defense mechanisms to survive intravascularly. 
The bacterial polysaccharide Kl capsule has been shown to possess anti-phagocytic 
properties (Bortolussi et aI., 1979; Mushtaq et aI., 2005) and provides resistance to classic 
complement-mediated bactericidal activity (Cross et aI., 1986; Mushtaq et aI., 2004). In 
addition, the neonatal host defense mechanism is less able to deal with an intravascular 
infection when compared to an adult's immune system. Neonatal macrophages and 
neutrophils have been found to be inefficient in phagocytosis (Filias et aI., 2011), as well 
as in the production and secretion of reactive oxygen species (ROS) (Levy, 2007; Wynn 
and Levy, 2010). Neonatal leukocytes also expresses low levels of surface CR3, which 
functions as a pathogen sensor and recruits complement (Wynn and Levy, 2010). 
Moreover, neonates are found to express low levels of C9 and other components of the 
complement system (C 1, C3, C4, C5) (Wilfert, 1978; Lassiter et aI., 1992). Bacterial 
intravascular survival might be further aided by the deficiency of pro-inflammatory and 
T HI-polarizing cytokines production by neonatal antigen-presenting cells, which aim to 
avoid triggering excessive inflammation during colonization of gut commensal flora 
(Wynn and Levy, 2010). As a consequence of the deficiencies in neonatal immunity, the 
bacterial bloodstream survival is promoted; hence, the bacteria are able to multiply to a 
high level of bacteraemia, and finally invade into the cerebraspinal fluid (CSF) (Glode et 
aI., 1977; Pluschke et aI., 1983; Kim et aI., 1992; Zelmer et aI., 2008). It has been 
documented that patients with bacteraemia of> 1 03 colony forming units per ml of blood 
are highly likely to develop meningitis (Dietzman et aI., 1974). 
The precise sites and mechanisms that E. coli K1 and other meningitis-causing 
extracellular bacterial pathogens, such as Streptococcus pneumonia, Haemophilus 
influenza, and Neisseria meningitidis, enter into CSF are still unclear and in many cases 
controversial. Haemophilus influenza and Neisseria meningitidis are believed to -invade 
CSF via the blood-cerebrospinal fluid barrier (BCSFB) at choroid plexus based on 
histological examinations of brain tissue, which found the presence of the bacteria in the 
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endothelium of choroid plexus and meninges (Smith, 1987; Pron et al.. 1997). However. if 
BCSFB is the bacterial portal of entry, meningitis should be theoretically linked to 
ventriculitis, which has never been observed in post-mortem specimens (Join-Lambert et 
al., 2010). The cerebral microvascular endothelial cells, which form the BBB, have been 
proposed as an alternative bacterial entry site (Quagliarello et aI., 1986; Parkkinen et aI., 
1988), but meningitis-causing extracellular bacteria do not cause encephalitis, and there is 
no evidence that these bacteria are able to multiply in the brain parenchyma (Join-Lambert 
et aI., 2010). Nevertheless, at later stages of the infection, the increased permeability of 
BBB, resulting from increased pinocytosis, leads to the disruption of the intercellular 
junctions of the cerebral capillaries in BBB (Quagliarello et aI., 1986). Intriguingly, post-
mortem examination of a patient who died of fulminant meningococcal meningitis 
revealed that the bacteria adhered to cerebral capillary (Mairey et aI., 2006), suggesting 
that meningitis-causing extracellular bacteria do interact with BBB during infection. In the 
case of E. coli Kl, bacteria have been found in the perivascular area of the subarachnoid 
space of histological brain sections of subcutaneously-infected 5--day-old rats (Kim et aI., 
1992). However a decade later, bacteria were observed in the choroid plexus of 
histological brain sections of E. coli K I-infected 2-day-old rats, where the animals were 
infected orally (Zelmer et aI., 2008). Despite the controversies on the bacterial portal of 
entry into CSF, in vitro studies with cerebral microvascular endothelial cells have allowed 
the identification of bacterial virulence factors that are essential for endothelial cell 
adherent and invasion, as reviewed in section 1.8.1. Future studies will hopefully elucidate 
the precise mechanism by which entry into the CSF is achieved by these pathogens. 
Once in the subarachnoid space, the bacteria take advantage of the immune 
privilege of the CNS and replicate and induce inflammatory cytokines production 
(Simberkoff et aI., 1980). In the CSF, the concentrations of immunoglobulin and 
complement components are low, which leads to inefficient removal of the pathogens 
(Tofte et aI., 1979; Simberkoff et aI., 1980). The bacterial cell wall components. but not 
the bacterial capsule, have been shown to be potent inducers for tumor necrosis factor 
(TNF) and interleukin-l (IL-l) production, which promote the adherence of neutrophils to 
endothelium, meningeal inflammation, and BBB breakdown (Dinarello, 1989; Waage et 
aI., 1989; Ramilo et aI., 1990; Quagliarello et aI., 1991). The hallmark of bacterial 
meningitis is the recruitment of neutrophils into CSF; however, the neutrophils are not 
efficient killers in the CSF (Ernst et aI., 1983). Conversely, neutrophils recruitment appears 
to have a negative effect and may contribute to the pathogenesis of the disease. When the 
recruitment of neutrophils was blocked during the infection, brain edema, intracranial 
pressure, and neuronal apoptosis in the hippocampus of infected animals were reduced 
(Tuomanen et aI., 1989; Braun et aI., 1999). 
1.4 Blood-brain barrier and blood-cerebrospinal fluid barrier, and in vitro models 
The BBB separates the circulating blood from the elements of CNS. The capillary 
BBB, which is localized in cerebral cortex, is formed by endothelial cells that are 
connected via a network of junctional complexes, and have very few endocytic vesicles 
(Figure 1.1A) (Rubin and Staddon, 1999). The junctional complexes are composed of 
adheren junctions and tight junctions, which restrict the movement of hydrophilic 
macromolecules and small ions between the blood and the brain, and result in high 
endothelial electric resistance in the brain capillaries (Abbott et aI., 2006). The major 
molecules of the tight junctions present in brain capillary endothelium are occludin, 
claudin-l, claudin-5, ZO-I, and ZO-2 (Rubin and Staddon, 1999; Abbott et aI., 2006). The 
tight junctional complexes are further stabilized by adheren junctions, which are mainly 
composed of cadherin, and the cytoplasmic tail of which is associated with catenins (Rubin 
and Staddon, 1999). The endothelial cells are also in close contact with astrocytes. the 
paracrine factors produced by these astrocytes might also contribute to the endothelial cells 
tight junction complexes formation (Arthur et aI., 1987). Other perivascular cell types. 
including pericytes, microglial cells, and perivascular macrophages, form the CNS 
perivascular immunological barrier to protect the CNS from invading pathogens (Join-
Lambert et aI., 2010). 
In addition to the intracerebral capillaries, the brain post-capillary venules (Figure 
LIB) are also part of the BBB. These venules have very similar properties as intracerebral 
capillaries, but they do not form as tight barrier as that of intracerebral capillaries (Abbott 
et aI., 2006; Nachman and Rafii, 2008). Ultrastructural studies showed that these venules 
have discontinuous and less complex junctional complexes than that of intracerebral 
capillaries (Nagy et aI., 1984; AlIt and Lawrenson, 1997). There is no electrophysiological 
data to demonstrate the resistance of these post-capillary venules, although rat pial venules 
have been shown to have lower resistance than that of pial arterioles (Butt and Jones, 
1992). Furthermore, when the capillaries tum into venules and veins, the contact between 
endothelial' cells and astrocyte processes is gradually reduced as they are separated by the 
increasing Virchow-Robin perivascular spaces (Join-Lambert et ai., 2010). 
Primary brain microvascular endothelium (BMEC) of various origins can be 
isolated and used as a BBB in vitro model; however, the application of the primary cells is 
limited by the costly cell isolation and maintenance, rapid loss of the differentiated cell 
phenotypes at later passages, and failure to form tight junctions (Arthur et al.. 1987; 
Bourdoulous et al.. 2002). Several groups have immortalized the isolated BMEC by 
transfecting the cells with SV 40 large T antigen, and the immortalized BMEC are shown to 
express specific brain endothelial properties, cell surface adhesion molecules, and 
junctional markers (Blasig et ai., 2001; Stins et aI., 2001; Weksler et aI., 2005). 
Importantly, these BMEC lines are able to form integral layer on Transwell® insert with 
high endothelial electrical resistance when they are cultured in the absence of astrocytes 
either in static or in flow-based system (Stins et al.. 2001: Cucullo et ai., 2008). As in vivo 
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studies of E. coli Kl interactions with BBB in newborn rats do not allow high resolution 
imaging at cellular level, thus do not allow studies of the cell biology aspect of the 
infection, the stable properties and indefinite growth potential of these endothelial lines 
provide an alternative approach, and allow experiments to be conducted with same cell 
source. Despite the ambiguity of extracellular bacterial pathogens utilize capillary BBB for 
invading into CSF, the BMEC lines have benefited studies on the interactions of these 
pathogens with the endothelial cells (Stins et aI., 2001; Doran et aI., 2005; Coureuil et al.. 
2009; Orihuela et aI., 2009; Untucht et aI., 2011). 
Mouse brain endothelioma cell line (bEndS) IS another BBB in vitro model. 
However, this endothelial line is not suitable for studying the interactions of meningitis-
causing bacterial pathogens with endothelial cells, as the cells showed defects in tight 
junctional protein expression, and they fail to form intact monolayer on Transwell® insert 
(Steiner et aI., 2011). 
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Figure 1.1. Vascular arrangement in the cerebral cortex. The illustration shows the 
arrangement of intracerebral blood vessels in the brain. The illustration was adapted from 
(Abbott et aI., 1999). (A) The capillary BBB. The intracerebral capillaries are composed of 
endothelial cells that form tight junctions, and they are in contact with foot processes of 
astrocytes, and pericytes. A thin basement provides both mechanical support and a barrier 
function. (B) The brain post-capillary venules. In contrast to the capillary BBB, the brain 
post-capillary venules, which form the venous BBB, do not form as tight barrier as that of 
the capillary BBB, although they have very similar properties. The presence of Virchow-
Robin perivascular space prevents close contact of the endothelial cells with the foot 
processes of astrocytes. 
BCSFB forms the barrier that separates blood components from CSF. CSF is 
actively produced by the ependymal cells of choroid plexus in brain ventricles. From the 
choroid plexus, the CSF is drained into the subarachnoid space over brain and spinal cord, 
and is reabsorbed into blood through arachnoid villi of the dura mater venous sinuses 
(loin-Lambert et aI., 2010). 
In contrast to the blood vessels of BBB, the endothelial cells of BCSFB are 
fenestrated. The ependymal cells that actively produce CSF are linked together by tight 
junctions (Figure 1.2). Primary choroidal epithelium is available as a BCSFB in vitro 
model and has been used for studying Streptococcus suis infection (Tenenbaum et al., 
2009). In addition to the primary choroidal epithelium, several choroid plexus epithelial 
cell lines are available. Z31 0 and TR-CSFB3 are immortalized rat choroid plexus epithelial 
cell lines carrying the simian virus 40 (SV 40) large T antigen gene (Kitazawa et aI., 2001; 
Zheng and Zhao, 2002); while the CPC-2 cell line was derived from a human choroid 
plexus carcinoma (Kumabe et aI., 1996). Although all the cell lines provide lower cost and 
easier maintenance than primary choroidal epithelium, they vary in the expression of 
junctional proteins, and the protein distribution for some of these junctional proteins are 
altered after immortalization (Szmydynger-Chodobska et al., 2007). 
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Figure 1.2. Schematic diagrams of BCSFB. The BCSFB is composed of fene strated 
capillaries in close contact with ependymal epithelial cells. 
Since both BBB and BCSFB are tightly regulated barriers, pathogens need to cross 
the endothelium (for BBB) or epithelium (for BCSFB) via transcellular (Figure 1.3A ), 
paracellular (Figure 1.3B), or trojan-horse mechanism (Figure 1.3C). For the transcellular 
traversal route, a pathogen invades the host cell, survives intracellularly, traverses through 
the cell, and manipulates host cell exocytosis mechanisms for cell egress (Nassif et af. , 
2002; Kim, 2008). Several pathogens, such as E. coli K 1 (Stins e f af. , 2001), UPEC 
(Chassin et af. , 2008), Streptococcus iniae (Eyngor e! at. , 2007), Streptococcus 
pneumomae (Ring et af. , 1998), Streptococcus suis (Tenenbaum et af. , 2009), and 
Neisseria gonorrhoeae (Wang et aI. , 1998), have been demonstrated to traverse 
transcellularly in infected cells. For the paracellular traversal route, the pathogen crosses 
between host cells, with or without disrupting tight junctions (Nassif e! a f. , 2002 : Kim. 
2008). Trypanosoma sp. have been suggested to cross the BBB via paracellular route (Grab 
et af., 2004). Mycobacterium tuberculosis (Jain et af. , 2006), and Listeria monocytogenes 
(Greiffenberg et af., 1998), have been suggested to cross a BBB via troj an-horse 
mechanism, which involves transmigration of an infected phagocyte across the polarized 
HBMEC (Kim, 2008). 
31 
A Pathogen 
! A ical 
c:=t-~---4- Tight ju n ction s 
Polarized cell 
! Basolateral 
B 
c 
Phagocyte 
Figure 1.3. Models of pathogen traversal of polarized epithelia or endothelia. (A) 
Transcellular traversal. (B) Paracellular traversal. (C) Trojan-horse mechanism. 
1.5 Plasma membranes structures 
Plasma membranes are barriers that protect cell components from external 
environment. They are composed of dynamic lipid bilayers, which are spanned by or 
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associated with proteins at either side of the lipid bilayers. and the proteins have role in 
membrane trafficking and signalling (S imons and GerL 20 10: Simons and Sampaio. 2011 ). 
The lipid molecules (sphingolipids, and sterol s) on the plasma membranes have been 
proposed to be able to assemble into specialized microdomains. termed lipid rafts. which 
are usually stabilized by specific proteins (Lingwood and Simons. 20 I 0). They have 
several significant biological functions , including T cell signalling. viral assembly. ER-to-
Golgi trafficking, and endocytosis (Simons and Gerl , 2010). 
1.6 Endocytosis 
The homeostasis between the cytosol and extracellular environment is maintained 
by regulating the entry and exit of fluids , solutes, and particles through the membrane lipid 
bilayer. Small molecules, such as amino acids, sugars, and ions, enter the cell through 
membrane pumps or ion channels; large molecules enter the non-phagocyt ic cell by 
endocytosis (Conner and Schmid, 2003). Various pathogens have also been documented to 
hijack endocytic pathways for invading non-phagocytic cells (Table 1.1). Endocytic 
pathways are generally identified by the coat proteins in endocytosis. The major endocytic 
pathways (Figure 1.4) includes macropinocytosis, c1athrin-mediated endocytosis, caveolae-
mediated endocytosis, and clathrin- and caveolae-independent endocytosis (Conner and 
Schmid, 2003). 
l5 (5 
Figure 1.4. Endocytic routes. The illustration shows variou endoc~ i c route In non-
phagocytic cell and the size of the endocytic vesicles (Conner and SchmId. 2003). 
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These endocytic routes are classified by their dependence on large GTPase. 
dynamin (Figure 1.5), which is recruited to the neck of the budding vesicle on plasma 
membrane for vesicle scission (Iversen et at., 2003), and it is ab le to assemble into spirals 
and form helical structures on lipid nanotubes in vitro (Stowell et al.. 1999). In mammals. 
there are three dynamin isoforms identified. Dynamin 1 is found specifica lly in neuronal 
tissue (Scaife and Margolis, 1990); dynamin 2 is ubiquitously expressed (Nakata et al.. 
1993 ; Cook et al., 1994); and dynamin 3 is found in testis, lung, and neurons (Nakata et 
al., 1993). Despite the GTPase domain, dynamin contains a middle domain , a pleckstrin-
homology domain, a GTPase effector domain, and a C-terminal proline-rich domain. In 
addition to vesicle scission, dynamin also functions in mitochondria and chloroplast 
division and fusion , and cytokinesis, as reviewed in (Praefcke and McMahon, 2004). 
Figure 1.5. Domain structure of a dynamin. Protein domains of a dynamin. 
The catalytic mechanism of dynamin is very similar as other Ras-family GTPases, 
although it has lower affinity for GTP and higher rates of GTP hydrolys is than the other 
Ras superfamily GTPases (Damke et al., 2001). In general, the conversion between GDP-
and GTP-bound forms of Ras GTPase is catalyzed by Ras specific guanine-nucleotide-
exchange factors (GEF) (Figure 1.6A), while the conversion from the GTP- to the GDP-
bound form occurs through GTP hydrolys is catalyzed by GTPase-activating proteins 
(GAP) (Stenmark, 2009). In the GTP-bound (active) form, Ras activates or binds with high 
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affinity to other cytoplasmic targets or effector proteins and lead to activation of ignalling 
cascades. 
To elucidate the functi ons of Ras proteins in ce ll s, dominant negati ve Ras mutants 
have been widely applied (Figure 1.6B). The dominant negati ve Ras mutants function by 
competing with normal Ras for binding to GEF, and form "dead-end" complexes, which 
are unable to interact with downstream effectors (Feig, 1999). The dominant negati ve Ras 
mutants have also been shown to have higher affinities for GDP than for GTP in NIH3T3 
cells overexpressing dominant negative Ras mutant, RasS 17N (Feig and Cooper. 1988). 
A 
GAP 
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Figure 1.6. The Ras-GTPase cycle. (A) The illustration shows the biochemical 
conversion of GDP-bound Ras to GTP-bound . GEF, guanine-nucleotide-exchange factors; 
GAP, GTPase-activating protein; P04-, inorganic phosphate. (B) The illustration shows the 
mechanism that dominant negative Ras mutants (Ras-DN) compete with nonnal Ras for 
GEF in cells expressing the dominant negative Ras . 
35 
Based on the understanding of Ras-family GTPases and by referring to the Ras-
GTPase structure, dominant negative dynamin mutants have been constructed and the 
GTPase activities in vitro have been studied (Herskovits et aI., 1993; Damke et al. '. 1994; 
Marks et aI., 2001). It was found that overexpression of K44A or S45N dynamin mutant, 
which demonstrated weak guanosine triphosphate (GTP) affinity in vitro, inhibits ligand 
uptake via dynamin-dependent endocytic routes (Herskovits et aI., 1993; Damke et aI., 
1994; Marks et aI., 2001; Pelkmans et aI., 2002). 
1.6.1 Clathrin-mediated endocytosis 
Clathrin was the first discovered coat protein, which it forms a triskelion shape, 
composed of three clathrin heavy chains and three light chains (Pearse, 1976). Clathrin role 
in mediating endocytosis has been well-studied, and it is the classical receptor-mediated 
endocytosis pathway (Pearse, 1976). Clathrin-mediated endocytosis has several 
physiological functions, including cholesterol, iron internalization, and synaptic vesicle 
recycling (Anderson et aI., 1977; Pearse, 1982; Sato et al., 2009). 
After the binding of extracellular cargoes on specific receptors on the plasma 
membrane with cargo-specific adaptor proteins, such as AP2, clathrin triskelions are 
recruited to the plasma membrane from the cytosol, which leads to the formation of a 
polyhedral clathrin cage (Henne et al., 2010). In addition to AP2, other adaptor proteins, 
such as epidermal growth factor protein substrate 15 (Eps 15) and Eps 15 interaction protein 
(epsin), are recruited to the clathrin assembly sites to stabilize the structure on 
phosphatidylinositol-4,5-bisphosphate (PtdIns( 4,5)P2)-rich plasma membrane (Gaidarov et 
al., 1996; Gaidarov and Keen, 1999; Benmerah and Lamaze, 2007; McMahon and 
Boucrot, 2011). At the later stage of vesicle formation, dynamin is recruited to the neck of 
the coated pits by BAR domain-containing proteins, such as amphiphysin, endophilin, and 
sorting nexin 9 (SNX9), and eventually releases the vesicle from plasma membrane 
(Wigge et al., 1997; Ferguson et al., 2009; Sundborger et al., 2011). The requirement of 
actin polymerization during vesicle scission from the plasma membrane varies with 
species, and these variations are believed to be due to membrane rigidity, intracellular 
pressure, and cargo size (McMahon and Boucrot, 2011). In instances where actin is 
recruited to clathrin vesicles, the role of actin is to contribute energy for vesicle scission 
and movement (Engqvist-Goldstein and Drubin, 2003; Kaksonen et al., 2005; 
Aghamohammadzadeh and Ayscough, 2009). 
Once the clathrin vesicle is released into the cytosol, clathrin coat is uncoated, and 
the clathrin triskelia recruited in another cycle of clathrin vesicle assembly. Clathrin 
uncoating is facilitated by auxilin that binds to the terminal domain and ankle of clathrin 
triskelia, and then recruits heat shock cognate 70 (HSC70) to uncoat the clathrin coat 
(Schlossman et al., 1984; Ungewickell et al., 1995). 
After the vesicle is released into the cytosol, the endocytosed cargo is sorted in the 
endosome, and it is either recycled back via recycling endosome to the plasma membrane 
or targeted to late endosomal compartment, which is increasingly acidified, and eventually 
degraded in lysosomes. (Figure 1.7) (Idrissi et al., 2008; Kinchen and Ravichandran, 
2008). Both early and late endosomes are distinctly different in their protein and lipid 
composition (Zerial and McBride, 2001; Gruenberg and van der Goot, 2006). The most 
distinctive markers that distinguish early endosome (EE) are the presence of the small 
GTPase Rab5, early endosomal antigen-l (EEAl), and phosphatidylinositol-3-phosphate 
(PtdIns(3)P) (Clague, 1998; Gruenberg and van der Goot, 2006). Rab7, Rab9, lysosomal-
associated membrane protein-l (LampI), lysobisphosphatidic acid (LBP A), 
phosphatidylinositol-3,5-biphosphate (PtdIns(3,5)P2), are present on late endosomes (LE) 
(Clague, 1998; Efe et al., 2005; Michell et al., 2006). The presence of Rab7 has been 
shown to be necessary for trafficking the cargo from late endosome to lysosome 
(Vanlandingham and Ceresa, 2009), while vesicle transportation from late endosome to 
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Golgi complex as well as newly synthesized lysosomal enzyme transportation from Golgi 
to lysosome are mediated by Rab9 (Riederer et af.. 1994: Barbero et af. . 2002). 
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Figure 1.7. Clathrin-mediated endocytic pathway. The illustration shows the clathrin-
mediated endocytosis and the endosome trafficking pathway in the mammalian cell. EE, 
early endosome; LE, late endosome; RE, recycling endosome; Lys, lysosome; TGN, trans 
golgi network. 
1.6.2 Caveolae-mediated endocytosis 
Caveolae are membrane microdomains enriched with caveolins, sphingolipid and 
cholesterol, and act as clathrin-independent sites of endocytosis of a different subset of 
cargo, such as albumin, and cholera toxin B. Caveolae appear as flask-shaped 
invaginations of 50 - 80 nm diameter on plasma membrane, and are present in specific 
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cells types, such as endothelial cell s. fibroblasts . type I pneumocy1es. and adi poc)1es 
(F igure 1.8A) (Pelkmans and Helenius, 2002 ; Frank et al.. 2003 : Parton and Simons. 
2007). 
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Figure 1.8. Caveolae and caveolin structure. (A) The electron micrograph shows 
caveolae on cell surface. (B) and (C) show the insertion of caveolin into caveolar 
membrane and its structural domains (Parton and Simons, 2007). 
Caveolins are abundant in caveolae, and they consist of three subtypes, caveolin-I. 
caveolin-2, and caveolin-3. Caveolin-l and caveolin-2 are expressed in non-skeletal ce ll s. 
whereas caveolin-3 is found in skeletal muscle and cardiac muscle (Parton, 2003 ; Kumari 
et aI., 20 I 0). Both caveolin-l and caveolin-3 have been shown to be essential for the 
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formation of caveolae on the plasma membrane, while loss of caveolin-2 has no effect on 
caveolar formation (Parton and Simons, 2007). Furthermore, in the absence of caveolin-1, 
caveolin-2 forms low molecular weight oligomers and is retained in the Golgi (Parolini et 
al., 1999). 
Caveolin shows an atypical topology in the cell, with the protein N and C termini in 
the cytoplasm and a hydrophobic hairpin transmembrane domain inserted into lipid 
bilayers in a wedge-like manner (Figure 1.8B and C) (Parton and Simons, 2007). The 
protein is palmitoylated at the cysteine residue 133, 143, and 156 at the C terminus 
(Dietzen et aI., 1995). Cysteine palmitoylation is required for cholesterol binding and 
chaperone complex formation for cholesterol transport to caveolae, but it is not required 
for the protein's localization to caveolae (Dietzen et aI., 1995; Uittenbogaard and Smart, 
2000). In addition to palmitoylation, caveolin is also phosphorylated at the tyrosine residue 
14 by Src tyrosine kinases, which is essential for caveolar vesiculation (Li et aI., 1996). 
Caveolae-mediated endocytosis is not very well-characterized. Caveolin-1 IS 
relatively immobile on the plasma membrane in vivo (Thomsen et aI., 2002); however, 
caveolae is able to bud off and is responsible for the uptake of various agents and virus, 
such as albumin (Schnitzer et aI., 1994), cholera toxin B (Shogomori and Futerman, 2001), 
and SV 40 (Pelkmans et al., 2001). As in clathrin-mediated endocytosis, the caveolar 
pathway requires the recruitment of dynamin and actin polymerization to the endocytic site 
(Henley et al., 1998; Oh et aI., 1998; Pelkmans et aI., 2001; Pelkmans and Helenius, 2002; 
Pelkmans et aI., 2002; Yao et al., 2005). The released vesicle either fuses with tubular 
membrane organelles with neutral pH, termed caveosomes (Pelkmans et aI., 2001), or is 
directed to regular trafficking pathways as in clathrin-mediated endocytosis (Mayor and 
Pagano, 2007). Because of the route to caveosomes, caveolae-mediated endocytosis has 
been suggested as a safer cellular route of pathogen entry to avoid lysosomal degradation 
(Pelkmans et at.. 2001; Parton and Simons, 2007). 
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In caveolin-1 knockout mice, caveolae are absent on the plasma membrane. and 
albumin uptake is abrogated, but transferrin (a ligand for clathrin-mediated endocytosis) 
uptake is unaffected (Razani et al., 2001). However, SV 40 infection of primary embryonic 
fibroblasts isolated from caveolin-1 knockout mice is unaffected (Damm et a!.. 2005). 
There is also some evidence that caveolin-1 might negatively regulate cargo uptake, as, for 
example, uptake of Neisseria gonorrhoeae and Staphylococcus aureus into cells 
overexpressing nonphosphorylatable caveolin-1, or in caveolin-1 knockout cells, is 
enhanced (Boettcher et a!., 2010; Hoffmann et al., 2010). Boettcher et a!. (2002) showed 
that inhibition of Neisseria gonorrhoeae uptake in caveolin-1 expressing cells is due to 
activation of Vav2- and RhoA-mediated cytoskeletal rearrangement as a result of caveolin-
1 phosphorylation. It is still unclear which pathway is implicated in caveolin-1 knockout 
cells, as caveolin-1 seems to interact with other signalling molecules. Recently, caveolin-1 
was shown to regulate endothelial permeability and endothelial nitric oxide synthase 
(eNOS) pathway as well as nitric oxide (NO) and peroxynitrite production in cells isolated 
from, caveolin-1 knockout mice (Siddiqui et al., 2011). 
1.6.3 Clathrin- and caveolae-independent endocytosis 
Several endocytic routes that are clathrin- and caveolae-independent have been 
described lately, and the understandings of these pathways are still very superficial. Most 
of these pathways are predominantly dynamin-independent, but it is unclear how vesicle 
scission occurs at the plasma membrane in the absence of dynamin. The following sections 
briefly discussed some of the clathrin- and caveolae-independent endocytosis. 
1.6.3.1 Flotillin-mediated endocytosis 
Flotillins are widely expressed in all tissues (Volonte et aI., 1999). The proteins 
form microdomains distinct from caveolae on the plasma membrane (Glebov et al.. 2006; 
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Frick et af. , 2007) , and have been implicated in a variety of different cellular processe . 
such as cell adhesion, endocytosis, and cell signalling events (Hoehne et al. , 2005 ; Glebov 
et al. , 2006; Langhorst et af. , 2007 ; Ludwig et al. , 2010) . 
There are two flotillin proteins, flotillin 1 and flotillin 2 (also known as reggie 2 
and reggie 1, respectively). Both proteins have an SPFH domain (~tomatins . Qrohibitins, 
flotillins , HflKJC) , also known as prohibitin homology domain (PHB), at the N terminaL 
which has been shown to interact with F-actin (Figure 1.9) (Langhorst et af. , 2007). The C 
terminal of flotillins contains flotillin repeats that are required for the formation of flotillin 
homo- and hetero-tetramers on the plasma membrane (So lis et af. , 2007) . Myristoy lation at 
glycine 2 and palmitoylation at cysteines 4, 19, and 20 are essential for membrane 
association of flotillin 2 (Neumann-Giesen et af., 2004) ; whereas flotillin 1 is localized to 
membrane raft and plasma membrane via the hydrophobic regions at the N terminal (Liu et 
af., 2005). 
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Figure 1.9. Structure of flotillin 1 and flotillin 2. The illustration shows the protein 
domains of flotillin 1 and 2. Both flotillins have SPFH/PHB domain at the N terminus, and 
flotillin repeats are found at the C-terminus . Palmitoylation, myristoylation and t rosine 
res idues are indicated (Babuke and Tikkanen, 2007) . 
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Flotillin budding from the plasma membrane is rare (Frick et aI., 2007). Hence, the 
role of the flotillin domain as endocytic carriers is still not clear, and the lack of flotillin-
specific ligands further hampers the study of this pathway. Cholera toxin B and glycosyl 
phosphatidylinositol (OPI)-linked proteins are endocytosed into COS-7 and NIH3T3 cells 
via a flotillin 1 and 2-mediated, but dynamin-independent, pathway initiated by 
phosphorylation of Fyn kinase (Olebov et al., 2006; Riento et aI., 2009); however, another 
study found that flotillin 2 was not involved in endocytosis of a OPI-anchored protein into 
He La cells (Langhorst et a!., 2008b). Flotillin 2 was also shown to promote clustering of 
amyloid precursor protein (APP) at the cell surface for internalization via a clathrin-
mediated-like endocytosis, which is cholesterol and AP-2 dependent but epsin 1-
independent (Schneider et aI., 2008). Despite being considered an endocytic coat, flotillin 
has also been found on late endosomal membranes, evidenced by co-localization of the 
proteins with LAMPI and Lysotracker (Dermine et a!., 2001; Langhorst et a!., 2008b). 
1.6.3.2 CLIC/GEEC pathway 
Some studies have also found that OPI-linked proteins are endocytosed Via 
clathrin-independent carriers . (CLIC) into specialized endosomes termed OPI-linked 
proteins-enriched early endosomal compartments (OEECs), which have a tubulovesicular 
structure instead of the typical small spherical carriers of clathrin and caveolar pathways 
(Sabharanjak et a!., 2002; Kirkham et a!., 2005). The endocytosis process is regulated by 
the Rho family member Cdc42, as well as Arfl (an ADP-ribosylation factor family 
protein) by recruiting a RhoOAP domain-containing protein, ARHOAP 1 0, to the plasma 
membrane, and it is dynamin-independent (Kumari et a!., 2008; Kumari and Mayor, 2008). 
Recently, it was found that the CLIC/OEEC endocytosis pathway is the key endocytic 
route for cholera toxin B uptake into fibroblasts (Howes et a!., 2010), where previously the 
toxin had always been regarded as internalized via caveolae- and flotillin-mediated 
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pathway (Shogomori and Futerman, 2001; Glebov et aI., 2006). The post-internalization 
route of the cargo via CLIC/GEEC pathway is unclear, but study of Helicobacter pylori 
VacA toxin showed that trafficking of GEECs to early endosomes and late endosomes 
additionally requires polymerized actin (Gauthier et aI., 2007). 
1.6.3.3 Arf6 mediated pathway 
Arf6, a GTPase involved in actin remodelling, has been implicated as a mode of 
clathrin-, caveolae-, and dynamin-independent endocytosis for several cargo proteins, such 
as class I major histocompatibility complex (MHCI), and E-cadherin, into tubular 
endosomes (Mayor and Pagano, 2007; Donaldson et aI., 2009; Kumari et aI., 2010). 
Endosomes in this pathway are enriched with Arf6, P1P2, and cholesterol, and are also 
coated with actin. At later stages, the endosomes are either directed to late endosomes or 
recycled back to plasma membrane (Donaldson et aI., 2009). Overall, it is not clear 
whether Arf6 is involved directly in cargo internalization or if it is required for vesicle 
trafficking to the downstream pathway, since overexpression of GTP-Iocked Arf6 blocked 
at a post-internalisation step (Brown et aI., 2001). 
1.6.4 Macropinocytosis 
Macropinocytosis is a non-specific cellular uptake pathway that involves formation 
of transient membrane protrusions on the plasma membrane for internalization of fluid into 
a large vacuole, termed macropinosome, 0.2 - 10 /-lm in diameter (Mercer and Helenius, 
2009; Kumari et aI., 2010). The formation of the membrane protrusions is driven by small 
GTPases (Rac1, Cdc42, Arf6), and kinases, such as p21-activated kinase 1 (PAK1), protein 
kinase C (PKC), c-Src, which lead to activation of the actin polymerization cascade 
(Ridley et aI., 1992: Dharmawardhane et aI., 2000; Garrett et aI., 2000: Lundmark et al.. 
2008; Mercer and Helenius, 2008). Macropinosomes are formed as a result of the collapse 
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and fusion of the membrane protrusions onto the plasma membrane. The membrane fission 
machinery for a macropinosome formation is unknown, but some studies suggested the 
fission is achieved by either C-terminal binding protein 1 (CtBP-1) or dynamin for some 
instances (Liberali et a!., 2008; Mercer and Helenius, 2009). 
Macropinocytosis uptake overlaps with several other endocytic pathways, and there 
is no specific cellular marker for the pathway. Rab34 was found to co-localize with actin at 
membrane ruffles, and it also facilitated macropinosome formation in platelet-derived 
growth factor- or phorbol ester-induced macropinocytosis in mouse 10T1I2 fibroblasts 
(Sun et a!., 2003), but not in HeLa cells (Goldenberg et al., 2007). Currently, one of the 
main experimental criteria for macropinocytosis of a pathogen is the inhibition of the 
pathogen uptake by amiloride or ethylisopropyl amiloride (EIPA) treatment (Mercer and 
Helenius, 2009). Both chemical inhibitors are not specific to macropinocytosis, and other 
signalling pathways might be altered during the treatment. 
1. 7 Transcytosis 
Transcytosis is a diverse mechanism that plays an important role in the continuous 
exchange of molecules across the cells (Predescu et a!., 2007). To date, the knowledge on 
transcytosis pathways is mainly from studies of immunoglobulins, and macromolecules 
transportation in polarized epithelial cells (Ghitescu and Bendayan, 1992; Apodaca, 2001; 
Tzaban et a!., 2009). However, it is unknown if similar membrane trafficking pathways 
exist in flat endothelial cells. 
After ligands are internalized from apical or basolateral surfaces, the genenc 
trafficking pathways that they follow are to either first enter into apical (AEE) or 
basolateral early endosomes (BEE), respectively (Figure 1.10). Cargoes sorted for 
recycling to the plasma membrane are transported to common recycling endosomes (CRE) 
and sorted into apical and basolateral recycling routes, facilitated by Rab 11 a. Rab25 and 
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their effector myosin Vb (myoVb) (Golachowska et a!., 2010). Some cargo may recycle 
directly from BEE to the basolateral plasma membrane surface (Sheff et a!.. 1999). 
Similarly, apically internalized cargo may be transported to Rabll-positive ARE and 
recycle back to apical plasma membrane (Leung et a!., 2000). Study of the transportation 
of immunoglobulin G (IgG) by Fc receptor (FcRN) revealed that apical to basolateral 
transcytosis of the complex is regulated by Rab25 and myoVb, but not Rablla (Tzaban et 
a!., 2009). While Rab11a, Rab11 family interacting proteins (Rabll-FIPs), Rab25 , and 
myoVb are required for IgG-FcRN and polymeric IgA (PlgA) basolateral to apical 
transcytosis (Ducharme et a!., 2007; Tzaban et a!., 2009). On the other hand, a transcytosis 
route that results from LE fusion with either apical or basolateral plasma membrane 
surface has been proposed (Lakkaraju and Rodriguez-Boulan, 2008), based on the 
observation of the release of exosomes from apical and basolateral surface by different 
epithelial cells, but the molecular details are unknown (Hundorfean et a!., 2007; Mallegol 
et a!., 2007). 
For endothelial cells, albumin and insulin transportation across the cultured 
endothelium monolayer on Transwell® insert has been proposed to be via caveolae 
(Schnitzer et a!., 1994). The in vitro observation has also been demonstrated in vivo by 
employing caveolin-1 knockout mice, where the uptake and transport of radioiodinated 
albumin from the blood to the interstitium is abolished in the knockout animals (Schubert 
et a!., 2001). Beyond caveolae-mediated transcytosis, the roles of microtubules, 
cytoskeleton, motor proteins, and GTPases during transcytosis in endothelium are poorly 
understood. 
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Figure 1.10. Endocytosis and transcytosis pathway in polarized epithelial cells . The 
illustration shows the transcytosis routes in polarized epithelial cells. The light blue arrows 
highlight apical to basolateral transcytosis route based on study of IgG-FcRN 
transportation in Mardin-Darby canine kidney epithelial cell line (MDCK) (Tzaban et 01., 
2009). 
1.8 Endocytosis of pathogens 
The main difference between phagocytic and non-phagocytic cells is that the 
uptake of molecules by phagocytic cells is an active process, and the cells are able to take 
up relatively large cargo; whereas non-phagocytic cells would only endocytose small 
molecules in general, and the uptake process is passive. In the past, endocytos is \Va 
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thought to occur independently of actin, while phagocytosis is an actin-dependent cellular 
uptake pathway (Messick and Rikihisa, 1993). Therefore, bacteria were thought to enter 
non-phagocytic cells via phagocytosis-like pathway, which required actin remodelling 
(Veiga and Cossart, 2006). Generally, invasive bacterial entry of non-phagocytic cells is 
classically categorized into the "zipper" and the "trigger" mechanisms (Finlay and Cossart, 
1997; Cossart and Sansonetti, 2004; Veiga and Cossart, 2006; Haglund and Welch. 2011). 
Listeria monocytogenes and Yersinia pseudotuberculosis are two well-studied bacteria that 
invade host cells by the zipper mechanism. Upon interaction of bacterial surface proteins 
and cellular receptors on the plasma membrane, such as Listeria InlA and InlB interact 
with E-cadherin and Met respectively (Cossart and Sansonetti, 2004), a cascade of 
signalling molecules is activated that results in actin polymerization and minor membrane 
extensions that engulf a bacterium into the epithelial cell line, Vero (Cossart and 
Sansonetti, 2004). For trigger mechanism, bacteria such as Salmonella and Shigella, inject 
bacterial effectors via secretory apparatus, such as the type 3 secretion system (T3SS), into 
eukaryotic cells, triggering massive actin polymerization and membrane ruffling that 
results in bacterial engulfment (Cossart and Sansonetti, 2004). 
The classical dogma of bacterial invasion of non-phagocytic cells was challenged 
when Listeria, whose entry requires actin polymerization and which was at least 10-fold 
larger than a clathrin coat, was found to invade epithelial cells by hijacking clathrin-
mediated endocytic machinery (Veiga and Cossart, 2005). Following this discovery, the 
involvement of an endocytic coat in bacterial invasion of non-phagocytic cells was 
established. It was shown that "zippering" bacteria, but not "triggering" bacteria, hijack 
cellular endocytic machinery for non-phagocytic cell entry. Intriguingly, EPEC, which 
remains extracellular during an infection, injects bacterial factors that recruit clathrin to 
form actin-rich pedestal at the bacterial attachment site (Veiga et al., 2007). Table 1· shows 
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a list of endocytic pathways with pathogens or pathogen-derived toxins that have been 
identified to hijack respective endocytosis pathways for cell entry. 
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Endocytic 
mechanism 
Clathrin-mediated 
endocytosis 
Dynamin-
dependence 
Yes 
Caveolae-mediated Yes 
endocytosis 
Table 1.1. Endocytosis pathways and pathogens or pathogen derived toxins. 
Pathogen or toxin 
Listeria monocytogenes (Veiga and Cossart, 2005 ; Veiga et aI. , 2007) 
Staphylococcus aureus (Veiga et aI. , 2007) 
Chlamydia trachomatis (Hybiske and Stephens, 2007) 
Ebola virus (Bhattacharyya et aI. , 2010) 
Celliinesl cells 
HeLa; lEG3 , Caco-2. 
HeLa, BSCI. 
HeLa 
HEK293T, Vero, HeLa, HOS-
CD4, human microvascular 
endothelial cells. 
Severe acute respiratory syndrome coronavirus (SARS-coV) (Inoue et aI. , Human hepatoma HepG2 
2007) 
Vesicular stomatitis virus (Cureton et aI. , 2009) 
Dengue virus (Mosso et aI. , 2008) 
Cholera toxin (Torgersen et al., 2001) 
SV40 (pelkmans et aI. , 2001) 
FimH-expressing E. coli K-12 strain [ORNI 03(pSH2)] (Shin et al., 2000) 
Mouse polyoma virus (Richterova et aI. , 2001) 
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BSC1. 
C6/36 HT Aedes albopictus ce ll 
lines. 
BHK, Caco-2, HeLa. 
CV-l. 
Mouse bone marrow-derived 
mast cell s. 
NIH 3T6 mouse fibroblasts, 
normal muri ne mammary gland 
(NMuMG) epi thelial ce lls. 
Flotillin-mediated No 
endocytosis 
Cholera toxin B (Shogomori and Futerman, 2001) 
Cholera toxin B (Glebov et al., 2006) 
Macropinocytosis Yes (in some Vaccinia virus (Mercer and Helenius, 2008) 
instances) 
Human rhinovirus type 8 (HRV8) (Khan et aI. , 2011) 
HIV-1 (Liu et aI., 2002) 
Kaposi's sarcoma-associated herpesvirus (KSHV) (Raghu et al., 2009) 
Afipia felis (Schneider et aI. , 2007) 
Hippocampal neuron. 
COS-7. 
HeLa. 
Rhabdomyosarcoma cells. 
Primary human BMEC. 
Human dermal microvascular 
endothelial cells, human 
umbilical vein endothelial cells. 
Murine macrophage-like cell 
lines J774E, RA W264.7. 
CLIC/GEEC 
pathway 
No? Helicobacter pylori VacA toxin (Gauthier et al. , 2005 ; Gauthier et al., 2007) HeLa 
Arf6-dependent 
endocytosis 
No 
Cholera toxin B (Howes et aI. , 2010) Fi broblast 
unknown 
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1.8.1 E. coli K1 virulence factors and invasion of HBMEC 
Although a newborn rat model has long been established for E. coli K 1 infection 
(Glode et aI., 1977; Moxon et aI., 1977), compared to animal models for other bacterial 
infections, this has not led to much understanding of the bacterial pathogenesis. Since the 
availability of purified human brain microvascular endothelial cells (HBMEC) as an in 
vitro BBB model, bacterial invasion mechanisms and bacterial virulence factors (VF) 
contributing to the disease pathophysiology have been studied extensively (Stins et aI., 
1994; Huang et aI., 1995). 
The Kl capsule of E. coli Kl has long been identified as the primary bacterial 
virulence factor responsible for bacterial intravascular survival and replication (Wilfert, 
1978; Kim et aI., 1992; Metkar et aI., 2007). The capsule is a homopolymer of N-
acetylneuraminic acid with poly(a-2,8) linkages, structurally similar to the polysialic acid 
(PolySia) moiety on mammalian neural cell adhesion molecule (NCAM) found in the 
neonatal brain as well as kidney (Finne, 1982; Finne et aI., 1983a; Roth et al., 1987), 
which is important for cell migration and neuronal plasticity (Rutishauser, 2008). The 
capsule is also immunochemically similar to the Meningococcus group B polysaccharides 
(Finne et aI., 1983b). It has also been shown to exist as O-acetylated and non-O-acetylated 
forms in clinical isolates, but the significance of the capsule acetylation in bacterial 
virulence is not clear (Frasa et aI., 1993; Colino and Outschoorn, 1999). Capsule variation 
results from slipped-strand DNA mispairing of a microsatellite domain located at the 5' of 
neuO gene, an acetylase gene (Deszo et aI., 2005; Vimr and Steenbergen, 2006). Zelmer et 
al. (2008) showed that the meningitis-causing K 1 strain expresses the non-O-acetylated 
form of PolySia in the gastrointestinal tract and in the blood compartment, but stops 
expressing PolySia capsule in the meninges, which might suggest that the bacteria regulate 
their capsule expression in response to unknown molecules secreted from the host immune 
cells. It is also believed that structural and immunochemical similarity between E. coli K 1 
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capsule and mammalian PolySia glycan made the K1 capsule a poor immunogen for the 
host, to avoid host autoimmune responses to PolySia glycan (Harvey et a/., 2001). 
Intriguingly, the K1 capsule also demonstrates anti-phagocytic property (Bortolussi 
et a/., 1979) as E. coli K1 with depolymerised capsule (mediated by endosialidase E) show 
enhanced uptake into peritoneal macrophages isolated from 5 - 10 days old rats (Mushtaq 
et a/., 2005). It has also been shown that the K1 capsule prevents binding of C3 cleavage 
products and deposition of C9, which is required for the formation of complement 
membrane attack complex (MAC), on the bacteria (Cross et at., 1986; Mushtaq et at., 
2004). Therefore, the PolySia capsule protects the bacterium from the bactericidal action of 
serum and the host complement system (Cross et at., 1986), which enable the bacteria to 
survive and replicate intravascularly to high levels of bacteraemia. In addition to the 
important role for evading host immunity, the PolySia capsule is also important for the 
bacterial intracellular survival by preventing the bacteria-containing vacuoles from fusing 
with lysosomes (Hoffman et at., 1999; Kim et a/., 2003). 
The ability of E. coli K1 to replicate to high level of bacteraemia is insufficient to 
develop meningitis, but the bacteria must have the ability to bind to the target tissue under 
high blood flow and pressure in the BBB, followed by cell invasion. It is known that 
pathogenic E. coli can form filamentous surface appendages known as pili or fimbriae, 
which function primarily for cell adhesion at the initial stage of infection (Capitani et at., 
2006). E. coli is able to express many types of fimbriae, which can be divided according to 
the structures of specific mammalian cell receptor that they recognise, such as a-D-
mannosides (type 1 fimbriae), a-D-Gal-(1,4)-p-D-Gal (P fimbriae), or NeuAca2,3-
galactose (S fimbriae) (Saukkonen et a/., 1988; Wang et a/., 2004). Fimbrial phase 
variation has been observed both in vitro and in vivo (Nowicki et al., 1985; Saukkonen et 
a/., 1988). E. coli K1 expressing type S-fimbriae bind to choroid plexus epithelium, the 
luminal surface of vascular endothelium, and HBMEC in vitro (Parkkinen et al., 1988; 
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Prasadarao et al., 1993; Stins et al., 1994). It was also found that the S-fimbriae-expressing 
bacteria predominate in all body fluid and CSF after infection, and it is more virulent than 
E. coli Kl expressing type I-fimbriated form in vivo (Saukkonen et al.. 1988). Further 
study with a pilA- (jimA), the gene that codes for the main fimbriae structure, deleted E. 
coli Kl mutant showed no difference in level of bacteraemia and intestinal colonization, 
but the bacterial oropharyngeal colonization was impaired (Bloch and Orndorff, 1990). In 
contrast, by using a different E. coli Kl clinical isolate, RS218, and its S fimbriae-deleted 
mutant, another study found that S fimbriae are not major determinants for bacterial 
binding to HBMEC and for causing meningitis in vivo (Wang et al., 2004). Studies with 
the RS218 strain further found that the bacteria bind to CD48 on HBMEC via FimH of the 
bacterial type 1 fimbriae (Teng et al., 2005; Khan et al., 2007), which is a tip component of 
the fimbriae (Capitani et al., 2006). Interaction of the bacterial FimH with CD48 increases 
cytosolic free calcium levels and activates RhoA (Khan et al., 2007). In addition to having 
a major role in bacterial adhesion, purified E. coli Kl FimH has also been shown to 
activate a murine microglial cell line, which results in production of nitric oxide and 
tumour necrosis factor-a (TNFa) (Lee et al., 2005). 
Outer membrane protein A (OmpA) is a 35 kDa bacterial surface transmembrane 
protein with four extracellular loops. It is highly conserved in many Gram negative 
bacteria, and is important for efficient binding of E. coli Kl to HBMEC (Prasadarao et al., 
1996b). The N-terminal loops of the protein interact with N-acetylglucosamine (GlcNAc) 
epitopes on the gp96 receptor on HBMEC (Prasadarao et al., 1996a; Prasadarao, 2002). 
gp96 receptor is an endoplasmic reticulum chaperone, which is also expressed on the cell 
surface of human colonic carcinoma (Caco-2) cell line (Li et al., 2002), and has also been 
shown to interact with Listeria Vip (Cabanes et al., 2005). OmpA-gp96 interaction induces 
the signal transducer and activator of transcription 3 (stat3) signalling pathway. 
phosphorylation of the focal adhesion kinase (F AK), activation of phosphatidylinositol-3-
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kinase (PI3K), and leads to the phosphorylation of protein kinease Cu (PKCu) (Reddy et 
a!., 2000a; Reddy et a!., 2000b; Prasadarao, 2002; Maruvada et a!., 2008). The actiYation 
of these signalling events results in actin polymerization at the bacterial adhesion site that 
is necessary for bacterial internalization into HBMEC (Prasadarao et a!., 1999). 
Several other bacterial determinants have been identified to be crucially important 
for E. coli K1 invasion of HBMEC, namely IbeA, IbeB, YijP, and cytotoxic necrotizing 
factor I (CNFl) (Huang et a!., 1995; Huang et al., 1999; Wang et aL 1999; Khan et a!., 
2002). A specific HBMEC receptor for CNF1 has been identified as a 37 kDa laminin 
receptor precursor (37LRP) by screening the cDNA library of HBMEC in a yeast two-
hybrid system (Chung et a!., 2003), whereas vimentin was identified as the specific 
HBMEC receptor that interacts with IbeA (Chi et a!., 2010). It was found that both CNF1 
and OmpA use different signalling pathway for recruiting actin to bacterial adhesion site. 
where the interaction of the bacterial CNF 1 with HBMEC leads to RhoA activation, 
without activating PI3K (Khan et a!., 2002; Khan et a!., 2003). 
The data from previous studies might suggest that E. coli K1 invasion of HBMEC 
involved the activation of several signaling pathways by different bacterial VF, with the 
primary goal in inducing actin cytoskeleton rearrangement for bacterial entry via zippering 
mechanism (Prasadarao et a!., 1999). However, the specific endocytic pathway hijacked by 
the bacterial invasion of HBMEC is not well-studied. Clathrin was shown to be absent 
from the bacterial attachment site (Prasadarao et a!., 1999), but the bacteria were reported 
to invade HBMEC via caveolae-mediated endocytosis (Sukumaran et a!., 2002). 
Studies performed with the BBB in vitro model showed that, following bacterial 
invasion, E. coli K 1 do not replicate intracellularly (Prasadarao et a!., 1999). The b.acteria 
are localised in compartments positive for early endosomal markers (Rab5, EEA 1, and 
transferrin receptor) at early time point of infection, and are labelled for late endosomal 
markers (Rab7 and LAMPI) without the presence of cathepsin D. a lysosomal hydrolytic 
55 
enzyme (Kim et aI., 2003). The intracellular E. coli Kl were also reported to co-localize 
with caveolin-1 (Sukumaran et al., 2002). 
The transcytosis route of E. coli K1 across BBB is unclear. The bacteria were 
demonstrated to traverse HBMEC monolayer grown on Transwell insert without affecting 
monolayer integrity, which suggested the bacteria crossed the monolayer via transcellular 
route (Stins et aI., 2001; Zhang et al., 2002). In contrast, another study reported that 
OmpA-expressing E. coli K1 transcytosed HBMEC via a paracellular route by activating 
PKCu, which subsequently disrupted HBMEC tight junctions by dissociating ~-catenins 
from vascular endothelial cadherins (Sukumaran and Prasadarao, 2003). Similar to E. coli 
K1, the transcytosis of Neiserria meningitidis across brain endothelial cells is unclear and 
has been debated for a long time (Nassif et aI., 2002; Coureuil et aI., 2009). Recently, N 
Meningitidis were shown to recruit junctional proteins, such as VE-cadherin, ~-catenin, 
claudin-5, ZO-1, to the attachment site of the bacterial colonies via ~-arrestin-dependent 
pathway, subsequently depleted junctional proteins, and resulted with the opening of 
intercellular junctions, which allowed the bacterial to traverse endothelial cells via 
paracellular route (Coureuil et aI., 2009; Coureuil et aI., 2010). 
Although E. coli K 1 is known to cause meningitis, the gastrointestinal tract has 
been shown as the primary site of colonization in neonatal animal model (Saukkonen et al., 
1988; Bloch and Orndorff, 1990). Therefore, it is likely that the bacteria have to breach 
gastrointestinal epithelium into the bloodstream. The application of Caco-2, and human 
colonic adenocarcinoma (T84) cell lines as in vitro gastrointestinal epithelium model 
showed that E. coli K1 infection of these cell lines is dependent on the cell differentiation 
and the bacterium disrupted the tight junctions during infection for crossing the epithelium 
via paracellular route (Bums et aI., 2001). The difference in the bacterial traversal of 
HBMEC and gastrointestinal epithelium model might implicate that different transcytosis 
routes were manipulated by the bacteria for crossing the cell barriers. 
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1.9 Project aims 
E. coli K1 is able to invade HBMEC in vitro, and the bacterial entry is receptor-
mediated via zippering mechanism. The signalling pathways that lead to actin 
polymerization to enable the bacterial internalization into HBMEC have been very well-
investigated in previous studies, as detailed above. However, the endocytosis pathway that 
is responsible for the bacterial uptake is not clear. Some studies have shown that bacterial 
uptake is clathrin-independent (Prasadarao et at., 1999), but caveolae-dependent 
(Sukumaran et at., 2002). Further, the bacteria have been shown to traverse HBMEC via a 
transcellular route (Stins et al., 2001), but the transcytosis pathway used by the bacterium 
has not been described. 
The major aim of this study was to further investigate the endocytosis pathway that 
is responsible for E. coli K1 invasion of HBMEC, and to describe the transcytosis pathway 
that the bacterium manipulates for traversal of HBMEC transcellularly. The hypothesis 
was that the bacterium invaded HBMEC via caveolae-mediated endocytosis and further 
traversed to the basolateral surface of HBMEC in a caveolin-1-associated compartment. 
The first objective was to make a fluorescent protein-expressing E. coli K1 strain 
that could retain bacterial virulence. The fluorescent E. coli K1 strain would allow 
investigation of bacterium-HBMEC interactions under a confocal microscope. The second 
objective was to optimize HBMEC transfection efficiency with various transfection 
methods. High HBMEC transfection efficiency would allow investigation of comparative 
distributions of cellular markers with intracellular bacteria, and also the effect of a cellular 
marker and its corresponding mutant on E. coli K1 invasion/traversal of HBMEC. The 
third objective was then to utilise the fluorescent E. coli Kl strain and the optimized 
HBMEC transfection protocol to further investigate E. coli K 1 invasion via caveolae-
mediated endocytosis. The final objective of this project was to study the transcytosis 
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pathway that the bacterium manipulated for crossing HBMEC monolayer. This would give 
a much clearer picture of the infective behaviour of this pathogenic bacterium. 
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2. Materials and methods 
2.1 Materials 
Unless otherwise stated, all reagents and biochemicals were purchased from Sigma-
Aldrich, Poole, Dorset, UK. 
2.1.1 Bacterial culture and reagents 
2.1.1.1 Bacterial strains 
Strains 
E44 (E. coli KI) [A kind gift from Dr. 
Naveed Khan (University of 
Nottingham, Sutton Bonington, UK)]. 
HBIOI (E. coli K-I2) (New England 
Biolabs Inc.,Herts, UK) 
DH5a (Invitrogen, Paisley, UK) 
KI-Cherry 
KI-GFP 
2.1.1.2 Bacterial culture media 
Media Contents 
Genotype or characteristic(s) 
OI8:KI:H7. A spontaneous rifampin resistant 
mutant of RS218 strain, isolated from the CSF of 
meningitis patient (Silver et al., 1980; Achtman 
et al., 1983). 
F-, thi-I, hsdS20 (rB-, mB-), supE44, recA13, 
ara-I4, leuB6,proA2, lacYI, ga/K2, rpsL20 
(strr), xyl-5, mtl-I 
F- <D80IacZ~MI5 ~(lacZYA-argF)U169 deaR 
recAI endAI hsdRI7(rk-, mk+) phoA supE44 thi-
1 gyrA96 relAI A-
E44 transformed with pFPV -mCherry. 
E44 transformed with pFPV25 .1. 
E44 transformed with rpsM-
Luria-Bertani (LB) broth 1 % (w/v) tryptone (Merck, Nottingham, UK), 0.5% (w/v) 
yeast extract (DIFCO, Surrey, UK), 0.5% (w/\') NaCl 
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(VWR BDH Prolabo, West Sussex, UK) 
Luria-Bertani (LB) agar 1 % (w/v) tryptone, 0.5% (w/v) yeast extract. 0.5% (w/v) 
NaCI, 1.5% (w/v) bacteriological agar (Oxoid, available 
via Thermo Fisher Scientific, Loughborough, UK) 
MacConkey agar (Code: 
CM0007) (Oxoid) 
Bought as pre-made mix: 2% (w/v) peptone, 1 % (w/v) 
lactose, 0.5% (w/v) bile salts, 0.5% (w/v) NaCI, 0.0075% 
(w/v) neutral red, 1.2% (w/v) agar 
2.1.2 Mammalian cell propagation reagents 
2.1.2.1 Mammalian cell 
Cell Descriptions 
Human brain Isolated from cerebral cortex 
microvascular endothelial specimens obtained from 
cells (HBMEC) patients (4 - 7 -year-old) with 
seizure disorders or from post-
mortem brains. Immortalized 
with SV 40 large T antigen. 
Primary mouse lung Isolated from mouse lung. 
endothelial cells (MLEC) 
Primary flotillin 1 
knockout MLEC 
Primary caveolin 1 
knockout MLEC 
Isolated from flotillin 1 
knockout mouse lung. 
Isolated from caveolin 1 
knockout mouse lung. 
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Source 
Stins et al., 2001. A 
kind gift from Dr. 
Naveed Khan. 
Purified by Dr. Grant 
Otto and was a kind 
gift from Dr. Ben 
Nichols (MRC LMB, 
Cambridge ). 
Purified by Dr. Grant 
Otto and was a kind 
gift from Dr. Ben 
Nichols. 
Purified by Dr. Grant 
Otto and was a kind 
gift from Dr. Ben 
Nichols. 
2.1.2.2 Mammalian cell culture media 
Culture media 
HBMEC 
growth media 
MLEC growth 
media 
Contents 
RPMI-1640 supplemented with 20% (v/v) fetal bovine serum (FBS) 
(Biosera, Ringmer, UK), 2 mM L-glutamine, 1 mM sodium pyruvate, 
1 00 ~g/ml streptomycin, 100 units/ml penicillin, non-essential amino 
acids (Gibco, Invitrogen), and vitamins (Gibco, Invitrogen). 
50 mllow glucose Dulbecco's Modified Eagles Medium (DMEM) 
and 50 ml Ham's F12 supplemented with 20% (v/v) FBS, 0.00125% 
(w/v) heparin, 2 mM L-glutamine, 1 00 ~g/ml streptomycin, and 100 
units/ml penicillin, 0.1 mg/ml endothelial cell growth supplement 
(AbD Serotec, Oxford, UK). 
Experimental RPMI-1640 supplemented with 5% (v/v) FBS, and 2 mM L-
media glutamine. 
Imaging media RPMI-1640 without phenol red supplemented with 5% (v/v) FBS, 2 
mM L-glutamine, 25 mM HEPES (PH 7.4). 
Freezing media Growth media supplemented with 10% (v/v) DMSO, and 200/0 (v/v) 
FCS. 
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2.1.3 Bacterial expression vectors used in this study 
Plasmids 
pCherryl 
pCherry3 
pEnvyl 
pEnvy2 
pFPV25.1 
pRSET -mCherry 
pFPV -mCherry 
Characteristic( s) 
Bacterial expression vector containing Mycobacterium tuberculosis 
codon-optimised mCherry gene, hygromycin resistant. 
Bacterial expression vector containing Mycobacterium tuberculosis 
codon-optimised mCherry gene, hygromycin resistant. 
Bacterial expression vector containing Mycobacterium tuberculosis 
codon-optimised GFP gene, hygromycin resistant. 
Bacterial expression vector containing Mycobacterium tuberculosis 
codon-optimised GFP gene, hygromycin resistant. 
Bacterial expression vector containing gfPmut3a gene downstream 
of a Salmonella typhimurium promoter, rpsM, ampicillin resistant. 
Bacterial expression vector containing mCherry, ampicillin 
resistant. 
Bacterial expression vector containing mCherry gene downstream 
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Reference or source 
Carroll et al. (2010); A kind gift from Dr. Paul 
Carroll (Queen Mary, University of London, UK). 
Carroll et al. (2010); A kind gift from Dr. Paul 
Carroll. 
A kind gift from Dr. Paul Carroll. 
A kind gift from Dr. Paul Carroll. 
Valdivia and Falkow (1996); A kind gift from Dr. 
Olivier Marches (Queen Mary, University of 
London, UK). 
Shaner et al. (2004); A kind gift from Dr. Roger 
Tsien (University of California, San Diego). 
Constructed in this study. 
pEGFP 
rpsM-
of a Salmonella typhimurium promoter, rpsM, ampicillin resistant. 
Bacterial expression vector encodes a red-shifted variant of wild 
type GFP, ampicillin resistant. 
pFPV25.1 with rpsM deleted, ampicillin resistant. 
Clontech, BD Biosciences, Oxford, UK; A kind 
gift from Dr. John Raynes (London School of 
Hygiene and Tropical Medicine). 
Constructed in this study. 
2.1.4 Mammalian expression vectors used in this study 
Plasmids 
pNI-EGFP 
Cavl-GFP 
Cavl-YFP 
Characteristic( s) Reference or source 
Mammalian expression vector encodes a red-shifted variant of wild Clontech, BD Biosciences. 
type GFP, kanamycin resistant. 
pN 1-EGFP vector containing wild type canine caveolin-l gene, Pelkmans et al. (2001); A kind gift from Dr. Ben 
kanamycin resistant. 
Mammalian expression vector carrying EYFP tagged wild type 
canine caveolin-l gene, cloned by replacing EGFP gene in Cav 1-
GFP, kanamycin resistant. 
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Nichols. 
Constructed in this study. 
GFP-Rab7WT 
GFP-Rab7T22N 
GFP-Rab7Q67L 
CFP-Rab7WT 
Dyn2(aa)WT GFP 
Dyn2(aa)K44A GFP 
Dyn1WT GFP 
pCI-EGFP vector containing wild type canine Rab7 gene, 
kanamycin resistant. 
pCI-EGFP vector containing canine Rab7 T22N mutant gene, 
kanamycin resistant. 
pCI-EGFP vector containing canine Rab7 Q67L mutant gene, 
kanamycin resistant. 
Mammalian expression vector carrying ECFP tagged wild type 
canine Rab7 gene, cloned by replacing EGFP gene in GFP-Rab7, 
kanamycin resistant. 
pNI-EGFP vector containing wild type rat dynamin 2 gene, 
kanamycin resistant. 
pN 1-EGFP vector containing rat dynamin 2 K44A mutant gene, 
kanamycin resistant. 
(Bucci et aI., 2000); A kind gift from Professor 
Albert Haas (University of Bonn, Germany) and 
Dr. Bianca Schneider (Research Center Borstel, 
Germany). 
Bucci et al. (2000); A kind gift from Professor 
Albert Haas and Dr. Bianca Schneider. 
Bucci et al. (2000); A kind gift from Professor 
Albert Haas and Dr. Bianca Schneider. 
Constructed in this study. 
Cao et al. (1998); A kind gift from Dr. Mark 
McNiven (Mayo Clinic, Rochester, MN). 
Cao et at. (1998); A kind gift from Dr. Mark 
McNiven. 
Unknown EGFP mammalian expression vector containing dynamin A kind gift from Dr. Emmanuel Boucrot and Dr. 
1 gene, ampicillin resistant. Harvey McMahon (MRC LMB, Cambridge, UK). 
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DynlK44A GFP 
Cavl-palm--GFP 
Cavl-Tyrl4-GFP 
Cav1~-GFP 
Flotillin I-GFP 
Flotillin 2-GFP 
GrP-Rab5WT 
CiFP-Rab5S34N 
Unknown EGFP mammalian expression vector containing dynamin 
1 K44A mutant gene, ampicillin resistant. 
pNI-EGFP vector containing human caveolin-1 palmitoylation 
mutant gene, kanamycin resistant. 
A kind gift from Dr. Emmanuel Boucrot and Dr. 
Harvey McMahon. 
Parat et al. (2003); A kind gift from Dr. Marie-
Odile Parat (University of Queensland, Australia). 
pNI-EGFP vector containing human caveolin-l T14A mutant gene, Parat et al. (2003); A kind gift from Dr. Marie-
kanamycin resistant. 
pNI-EGFP vector containing human caveolin-l ~ gene, kanamycin 
resistant. 
pNI-EGFP vector containing wild type murine flotillin 1 gene, 
kanamycin resistant. 
pN 1-EGFP vector containing wild type rat flotillin 2 gene, 
kanamycin resistant. 
pCI-EGFP vector containing wild type murine Rab5 gene, 
kanamycin resistant. 
pC l-EGFP vector containing murine Rab5 S34N mutant gene, 
kanamycin resistant. 
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Odile Parat. 
Parat et al. (2003); A kind gift from Dr. Marie-
Odile Parat. 
Glebov et al. (2006); A kind gift from Dr. Ben 
Nichols. 
(Neumann-Giesen et al., 2004); A kind gift from 
Dr. Ben Nichols. 
Nichols et al. (2001); A kind gift from Dr. Ben 
Nichols. 
Nichols et al. (2001); A kind gift from Dr. Ben 
Nichols. 
GFP-Rab5Q79L 
GFP-RabllaWT 
GFP-RabllaS25N 
GFP-Rab 11 aQ70L 
LDLR-A 18-GFP 
GFP-Rab9WT 
GFP-Rab9Q66L 
GFP-Rab9S21 N 
pC l-EGFP vector containing murine Rab5 Q79L mutant gene, 
kanamycin resistant. 
pCI-EGFP vector containing wild type human Rablla gene, 
kanamycin resistant. 
pCI-EGFP vector containing human Rablla S25N mutant gene, 
kanamycin resistant. 
pCI-EGFP vector containing human Rablla Q70L mutant gene, 
kanamycin resistant. 
Nichols et at. (2001); A kind gift from Dr. Ben 
Nichols. 
(Knodler et ai., 2010); A kind gift from Dr. Wei 
Guo (University of Pennsylvania, Philadelphia, 
PA). 
Knodler et ai. (2010); A kind gift from Dr. Wei 
Guo. 
Knodler et ai. (2010); A kind gift from Dr. Wei 
Guo. 
pNI-EGFP vector containing recycling-deficient mutant of the low- (Kreitzer et at., 2003); A kind gift from Dr. Geri 
density-lipoprotein receptor gene, kanamycin resistant. 
pC l-EGFP vector containing wild type murine Rab9 gene, 
kanamycin resistant. 
pCI-EGFP vector containing murine Rab9 Q66L mutant gene, 
kanamycin resistant. 
pC 1-EGFP vector containing murine Rab9S21 N mutant gene, 
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Kreitzer (University of Com ell). 
(Seaman, 2004); A kind gift from Dr. Matthew 
Seaman (CIMR, Cambridge). 
A kind gift from Dr. Matthew Seaman. 
A kind gift from Dr. Matthew Seaman. 
kanamycin resistant. 
LAMPI-GFP pNI-EGFP vector containing wild type rat Igp120 gene, kanamycin (Patterson and Lippincott-Schwartz, 2002); A kind 
resistant. gift from Dr. George Patterson. 
2.1.5 Primary antibodies 
Name Species Monoclonal or polyclonal Fixation Concentrations used Source 
Anti-caveolin-l Rabbit Polyclonal Methanol, or 1 :200 (IF) BD Biosciences. A kind gift from 
fonnaldehyde Dr. Ben Nichols. 
Anti-caveolin-l Mouse Monoclonal Methanol 1 :200 (IF) BD Biosciences. A kind gift from 
Dr. Ben Nichols. 
Anti-flotillin 1 Mouse Monoclonal Methanol 1 :200 (IF) BD Biosciences. A kind gift from 
Dr. Ben Nichols. 
Anti-flotillin 2 Mouse Monoclonal Methanol 1 :200 (IF) BD Biosciences. 
Anti-~-Actin Mouse Monoclonal 1 :20000 (WB) Sigma-Aldrich. 
(Clone Ac-15) 
67 
Anti-E. coli 018 Rabbit Polyclonal Methanol, or 1 :500 (IF) Denka-Seiken, Coventry, UK. 
formaldehyde 
Anti-GFP Rabbit Polyclonal 1:1000 (WB) Invitrogen. 
Anti-GFP (Clone Mouse Monoclonal Formaldehyde 1:500 (IF) Invitrogen. 
3E6) 
Anti-EEAI (Clone Mouse Monoclonal Formaldehyde 1 :200 (IF) BD Biosciences. 
14IEEAl) 
Anti-pan cadherin Mouse Monoclonal Methanol, or 1 :200 (IF) Abeam, Cambridge, UK. 
(Clone CH-19) formaldehyde 
Anti-LAMP2 Rat Monoclonal Methanol, or 1 :500 (IF) Abeam. A kind gift from Dr. 
(Clone ABL-93) formaldehyde Sharon Tooze and Dr. Minoo Razi 
(Cancer Research UK, Lincoln's 
Inn Field, London) 
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2.1.6 Secondary antibodies 
Name Species Monoclonal or Concentrations Source 
polyclonal used 
FluoProbes®-546 anti-rabbit Donkey Polyclonal 1:200 Interchim, Cheshire Science Ltd., Chester, 
UK 
FluoProbes®-488 anti-mouse Donkey Polyclonal 1:200 Interchim. 
FluoProbes®-642 anti-mouse Donkey Polyclonal 1:200 Interchim. 
FluoProbes®-642 anti-rabbit Donkey Polyclonal 1:200 Interchim. 
Cy2 anti-rabbit Goat Polyclonal 1 :200 A kind gift from Professor Ulrich Schaible 
(Research Center Borstel, Germany). 
Cy2 anti-rat Goat Polyclonal 1:200 A kind gift from Professor Ulrich Schaible. 
ECL anti-rabbit IgG, HRP-linked whole antibody Donkey Polyclonal 1 :3000 GE Healthcare, Buckinghamshire, UK. 
ECL anti-mouse IgG, HRP-linked whole antibody Sheep Polyclonal 1:3000 GE Healthcare, Buckinghamshire, UK. 
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2.1. 7 Cell imaging reagents 
Reagents 
4' ,6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) 
Source 
Molecular Probes, Invitrogen. 
Endosialidase-GFP fusion protein (PKIA-
GFP) 
Jokilammi et al. (2004): A kind gift 
from Professor Jukka Finne 
(University of Turku, Finland). 
Fluorescein isothiocyanate (FITC) Sigma-Aldrich. 
Phalloidin-TRITC Sigma-Aldrich. 
2.1.8 Reagents used in the transfection of mammalian cells 
Reagents Source 
jetPRIME™ Polyplus-transfection SA, Illkirch, France. 
jetPEI™ Polyplus-transfection SA. 
jetPEI™-HUVEC Polyplus-transfection SA. 
FuGENE®HD Promega, Southampton, UK. 
Lipofectamine ™ 2000 Invitrogen. 
PLUS™ Reagent Invitrogen. 
2.1.9 Primers for constructing pFPV-mCherry 
Oligonucleotides were synthesized by Eurofins MWG Synthesis, Germany. The 
primers were dissolved to 100 pmollJ-tl in sterile MilliQ water and stored at -20°C. 
1. mCherry-FXba TGCTCTAGATTTAAGAAGGAGATATACATATGGTGAGC 
AAGGGCGAGGAG 
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2. mCherry-RSph CATGCATGCTTACTTGTACAGCTCGTCCAT 
2.1.10 Buffers and solutions 
TBE Buffer, SOx 
Agarose Loading Dye, 5x 
Ampicillin (l00 mg/ml) (lOOOx) 
Kanamycin (30 mg/ml) (lOOOx) 
Chloramphenicol (34 mg/ml) (lOOOx) 
10% (w/v) sodium dodecyl sulphate 
(SDS) 
CCMB buffer [10 mM KAc, 100/0 (v/v) 
glycerol, 80 mM CaCb'2H20, 10 mM 
MgCb'6H20, 20 mM MnCbAH20, 
pH6.4] 
lOx Tris-Glycine buffer 
4x resolving buffer [1.5 M Tris, OA% 
(w/v) SDS, pH8.8] 
Dissolve 108 g Tris base (Trizma), 55 g boric 
acid and 40 ml 0.5 M EDTA [pH8.0]. Make up 
to 1000 ml with water. 
0.25% (w/v) bromophenol blue, 0.25% (w/v) 
xylene cyanol FF in 40% (w/v) sucrose solution. 
Dissolve 1 g ampicillin in 5 ml sterile MilliQ 
water, and add 5 ml absolute ethanol to the 
solution. Store at -20°C, protected from light. 
Dissolve 0.3 g kanamycin in 10 ml sterile 
MilliQ water. Store at -20°C. 
Dissolve 0.34 g chloramphenicol in 10 ml 
absolute ethanol. Store at -20°C, protected from 
light. 
Dissolve 109 SDS in 100 ml MilliQ water. 
Dissolve 0.1 g KAc, 10 ml glycerol, 1.18 g 
CaCb'2H20, 0.2g MgCb'6H20, OAg 
MnCb·4H20 in 50 ml MilliQ water. Adjust pH 
to 6A. Top up with MilliQ water to 100 ml, and 
filter the solution with 0.22 11m syringe filter. 
Store at 4°C. 
Dissolve 15 g Tris, and 72 g Glycine in 500 ml 
MilliQ water. Store at 4°C. 
Dissolve 18.17 g Tris and'+ mll0% (w/v) SDS 
in 100 ml MilliQ water. Adjust pH to 8.8. Store 
at 4°C. 
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4x stacking buffer [0.5 M Tris, 0.4% 
(w/v) SDS, pH6.8] 
Ix SDS-PAGE running buffer 
Blotting buffer 
100/0 (w/v) ammonium persulphate 
(APS) 
6x SDS sample buffer 
Ix Dulbecco's phosphate buffered 
saline (PBSA) 
lOx Phosphate buffered saline (PBS) 
0.2 mg/ml hydrocortisone 
Dissolve 6.06 g Tris and 4 ml 10% (w/\') SDS in 
100 ml MilliQ water. Adjust pH to 6.8. Store at 
4°C. 
50 ml lOx Tris-Glycine buffer and 5 ml 10% 
(w/v) SDS. Top up to 500 ml with MilliQ water. 
100 ml lOx Tris-Glycine buffer and 200 ml 
methanol. Top up to 1000 ml with MilliQ water. 
Dissolve 0.05 gAPS in 0.5 ml MilliQ water. 
Made fresh each time. 
Dissolve 1 g SDS, 1.2 mg bromophenol blue, 3 
ml glycerol in 7 ml 4x resolving buffer. Store at 
room temperature. Prior to usage, add 6 III 2-
Mercaptoethanol to 94 III the solution. 
Dissolve 0.2 g KCl, 0.2 g KH2P04, 8 g NaCl, 
and 1.74 g Na2HP04·7H20 in 900 ml MilliQ 
water. Adjust pH to 7.2. Top up to 1000 ml with 
MilliQ water. Sterilize by autoc1aving. 
Dissolve 80 g NaCl, 2 g KCl, 11.5 g 
Na2HP04·7H20, and 2 g KH2P04 in 900 ml 
MilliQ water. Adjust pH to 7.2. Top up with 
MilliQ water to 1000 ml. Sterilize by 
autoc1aving. 
5 mg/ml hydrocortisone: Dissolve 50 mg 
hydrocortisone in 10 ml absolute ethanol. Store 
solution at -20°C protected from light. 
0.2 mg/ml hydrocortisone: Add 0.4 ml 5 mg/ml 
hydrocortisone to 9.6 ml sterile complete growth 
medium. Aliquot into 1 ml aliquots. Store at -
20°C protected from light. 
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2.2 Methods 
2.2.1 PCR amplication ofmCherry gene from pRSET-B mCherry 
50 III PCR reactions were carried out using 1 x Pfu reaction buffer (Roche, West 
Sussex, UK), 0.3 IlM primers (see section 2.10), 0.2 mM dNTPs (an equimolar mixture of 
dATP, dCTP, dGTP, and dTTP to an overall concentration of 0.2 mM), 1 U Pfu DNA 
polymerase (Roche), and 10 ng pRSET-B mCherry plasmid DNA. 
200 III thin-walled reaction tubes were used in a thermal cycler (Ml-Research, 
Hertfordshire, UK). The reactions were heated to 95°C for 5 mins before 25 cycles of: 
94°C for 45 secs (denaturation), 55°C for 1 min (primer-template annealing), and 72°C for 
1 min (polymerisation); followed by 72°C for 10 mins and 4°C indefinitely. The resulting 
products were analysed on a 0.7% (w/v) agarose gel. 
2.2.2 DNA analysis by agarose gel electrophoresis 
Agarose gel electrophoresis was used to check restriction digested plasmid DNA 
products, to visualize PCR products, and to isolate specific DNA fragments for vector and 
insert preparation. 
Typically, 0.7% (w/v) agarose gels were casted by dissolving 0.7 g agarose in 100 
ml Ix TBE buffer. When it had cooled to a temperature of around 55°C, 1 III 10 mg/ml 
ethidium bromide (Invitrogen) was added. The molten agarose was poured into the gel 
frame and allowed to set before adding enough 1 x TBE buffer to cover the gel. 
Prior to loading, 2 III loading dye was added to the DNA sample and carefully 
pipetted into the wells. The gel was run at a 5V /cm until the bromophenol blue front had 
migrated at a sufficient distance. Gels were then visualized using a UV trans-illuminator 
(Syngene Bio imaging, Synoptics Ltd .. UK) and then photographed if required. 
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2.2.3 DNA fragment purification 
For PCR reactions that resulted In a single PCR product on an agarose gel. 
QIAquick PCR Purification kit (Qiagen, West Sussex, UK) was used according to the 
manufacturer's instructions to purify the PCR product from excess primers, nucleotides, 
polymerases, and salts, before the PCR product was used for setting up a restriction 
endonuclease digestion. PCR product was eluted in 30 III buffer EB (10 mM Tris-Cl, 
pH8.S). 
In this study, DNA from post-enzymatic manipulations for vector and insert 
preparation was purified from agarose gel by using QIAEX II gel extraction kit (Qiagen) 
according to manufacturer's instructions. The DNA was eluted by adding 20 III Tris buffer 
to the air-dried pellet and incubated at SO°C for S mins. 
2.2.4 Restriction endonuclease digestion of DNA 
Usually, S Ilg DNA was digested in a volume of SO Ill. To this, S III lOx reaction 
buffer was added, plus enzyme to a concentration of 2 U/llg DNA (typically 1 - 2 Ill) and 
100 Ilg/ml BSA. The mixture was mixed and incubated at 37°C for 2 h, or longer if 
complete digestion was required. At the end of the reaCtion, the enzyme was inactivated by 
heating at 6SoC for 20 mins or higher temperatures as appropriate. 
2.2.5 Ligation of DNA fragments 
The reaction that allows for the insertion of the desired gene into a vector is 
catalyzed by T4 DNA ligase and involves the ATP-dependent formation of a 
phosphodiester bond between the 3 'hydroxyl end of a double-stranded DNA fragment and 
the S'phosphate end of the same or another DNA fragment. The reaction conditions for 
ligation of DNA fragments are shown in Table 2.1. 
7-+ 
Table 2.1. Components and conditions used for a ligation reaction. 
lOx T4 DNA ligase buffer 1.0 III 
Insert DNA 
Vector DNA 
T4 DNA ligase (Fermentas, UK) 
Final Reaction volume 
Ligation condition 
Depending on the ratio of insert DNA to 
vector DNA used. Generally 3: 1 molar 
equivalent insert to vector. 
1.0 III 
10.0 III 
Incubated at 4°C for overnight. 
The ligation reaction was performed in an autoc1aved 0.5 ml centrifuge tube and 
centrifuged briefly to bring all the contents to the bottom of the tube. 
2.2.6 Extraction and purification of plasmid DNA 
Plasmids are generally prepared from bacterial cultures grown between 16 - 18 h in 
the presence of selective agent such as an antibiotic. For routine molecular biology works, 
small scale plasmid DNA purification was performed with Wizard® Plus SV Minipreps 
DNA Purification System (Promega); whereas for mammalian cell transfection, medium 
scale plasmid DNA purification was performed by PureYield™ Plasmid Midiprep System 
(Promega) according to the manufacturer's instructions. 
Both plasmid DNA purification kits uses alkaline conditions to lyse the bacterial 
cells, which denatures chromosomal and plasmid DNA, as well as proteins. Denatured 
chromosomal DNA and proteins are precipitated after the addition of acidic buffer for 
neutralization, while circular plasmid DNA are covalently closed. Plasmid DNA in the 
solution are bound to an anion-exchange column under appropriate low salt and pH 
conditions. RNA, proteins and other contaminants are removed by a medium-salt wash. 
The plasmid DNA was eluted in 10 mM Tris-CI, pH8.5 buffer and stored at -20°C. 
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2.2.7 Determination of DNA concentration and purity definitely in DNA techniques 
Determination of DNA concentration was carried out using a spectrophotometer 
model ND-I000 (NanoDrop®) to measure absorption of DNA solutions at OD26o and 
OD28o • A figure of between 1.8-1.9 indicates pure DNA. 
2.2.8 Bacterial culture conditions 
E. coli were grown at 37°C in Luria-Bertani (LB) broth overnight in a shaker 
incubator. For transformed bacteria, media was supplemented with ampicillin (l00 ~g/ml), 
kanamycin (30 ~g/ml) or hygromycin B (50 ~g/ml) as appropriate. 
2.2.9 Making electroporation competent E. coli Kl and transformation of plasmid 
DNA encoding fluorescent protein into E. coli Kl byelectroporation 
To enable fluorescence visualisation of the bacteria under a confocal microscope, a 
plasmid DNA encoding fluorescent protein was transformed into the bacteria. The 
transformation of plasmid DNA into E. coli Kl was performed using electroporation 
according to Seidman et ai., 2001, since plasmid DNA transformation using heat shock of 
chemically-competent cells was very inefficient for this strain. 
Briefly, a starter culture of E. coli Kl was grown overnight at 37°C in LB broth 
with shaking. The overnight bacterial culture was inoculated into 500 ml LB broth at 50 
times dilution and was grown at 37°C for approximately 1.S h with shaking, or until the 
ODs9snm reached between O.S - 0.7. Bacteria were harvested (4200 rpm in Beckman lS-
13.1, at 4°C for 20 mins), washed twice in pre-chilled sterile distilled water and once in 
100/0 (v/v) glycerol, suspended in 0.5 ml 10% (v/v) glycerol, and stored at -80°C in SO ~l 
aliquots. Plasmid DNA (approximately 1.0 ~g in maximum S ~l volume) was added to 
competent bacteria, pulsed at 2.S kV (Biorad Gene Pulser Xcell electroporation system) 
with an electrode gap of 0.2 cm. 2S0 ~l LB broth was added immediately to the bacteria, 
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and incubated at 37°C for 1.S h with shaking. The culture was plated onto an LB agar plate 
supplemented with the appropriate antibiotic to select for transformed bacteria and was 
incubated at 37°C overnight. Colonies were picked the following day and grown up. 
To screen for transformed bacteria that fluoresced, S III of the overnight bacterial 
culture was spotted onto a glass slide and a cover slip was laid onto the culture carefully to 
avoid air bubble formation. The transformed bacteria were checked for fluorescence using 
a Zeiss Axioplan 2 fluorescence microscope with CCD or a Zeiss LSMSI0 confocal 
mIcroscope. 
2.2.10 Making chemical competent E. coli cells and transformation of plasmid DNA 
into E. coli by heat shock 
To maintain plasmid in bacterial stocks, all plasmid DNA were initially propagated 
in E. coli D HSa strain. This strain, and E. coli K -12 (HB 1 0 1) that was used as a non-
pathogenic E. coli control in all bacterial assays, are compatible with heat-shock 
transformation and were prepared by chemical competency (Seidman et al., 2001). 
To make competent bacteria, a starter culture of E. coli K-12 or DHSa was grown 
overnight at 37°C in LB broth with shaking. The overnight bacterial culture was inoculated 
into SOO ml LB broth at SO times dilution and was grown at 37°C for 3 h with shaking to 
the ODS9Snm reached between O.S - 0.7. Bacteria were harvested (4200 rpm in Beckman lS-
13.1 at 4°C for IS mins), washed once in pre-chilled CCMB buffer, and incubated on ice 
for 1 h. The bacterial suspension was harvested as previously described, the bacterial pellet 
was re-suspended in S ml CCMB buffer, and stored at -80°C in SO III aliquots. Plasmid 
DNA (approximately 1.0 Ilg in maximum 10% bacterial volume) was added to competent 
bacteria, mixed and incubated on ice for 30 mins. Each transformation reaction was heat-
pulsed at 42°C for 30 s and immediately incubated on ice for 2 mins. 2S0 III LB broth was 
added to the bacteria, and incubated at 37°C for 1.S h with shaking. The culture was plated 
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onto an LB agar plate supplemented with the appropriate antibiotic to select for 
transformed bacteria and was incubated at 37°C overnight. Colonies were picked the 
following day and grown up in LB supplemented with the appropriate antibiotic. 
When making fluorescent E. coli K-12, the transformed bacteria were checked for 
fluorescence with a Zeiss Axioplan 2 fluorescence microscope with CCD or a Zeiss 
LSM510 confocal microscope, as described in section 2.2.9. 
2.2.11 Making bacterial frozen stocks 
400 III log phase bacterial culture was added to 600 III sterile 75% (v/v) glycerol in 
a sterile microcentrifuge tube. The bacteria-glycerol mixture was vortexed and stored 
immediately in -80°C. To recover the bacteria, the bacterial stock was retrieved from -80°C 
on dry ice, and the frozen surface of the culture was scraped with a sterile inoculation loop. 
The bacteria on the loop were streaked immediately onto LB agar plate containing 
appropriate antibiotics, if required. The LB agar plate was incubated at 37°C for 16 - 18 h. 
2.2.12 Bacterial growth kinetics 
A starter culture of the bacteria was grown overnight at 37°C in LB broth with 
shaking. The overnight culture was inoculated into fresh LB broth at 50 times dilution. The 
optical density (ODS9S) of the culture was read using a spectrophotometer (WP A 
lightware®, Cambridge, UK). The culture was then incubated at 37°C in a shaker incubator 
with shaking at 200 rpm for 120 mins. At various time points (30, 60, and 120 mins), 1 ml 
of the culture was sampled and the ODS9S was read with the spectrophotometer. 
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2.2.13 HBMEC and primary mouse lung endothelium (MLEC) culture maintenance 
2.2.13.1 HBMEC and MLEC propagation 
HBMEC, and MLEC cultures were maintained in a 75cm2 vented tissue culture 
flasks in growth media at 37°C, 5% CO2 in a CO2 incubator. Cells \vere split at 
approximately a 1: 1 a ratio every 5 days using the following protocol. Medium was 
removed and flasks were rinsed with 2 ml 0.25% trypsin, 0.53 mM EDTA solution. An 
additional 3 ml trypsin-EDT A was added and the cells were incubated at 37°C for 10 mins. 
7 ml growth media was added and re-suspended. 9 ml of the trypsin/cell mixture was 
removed and growth medium was added to the cells. For in vitro infection experiments, 1 x 
105 cells/ml HBMEC or MLEC are plated in 24-well tissue culture dishes 3 days prior to 
experiment; for time-lapse live-cell imaging, 5 x 104 cells/ml HBMEC are plated in 
LabTek 8-well glass cover slip chambers (Nalge Nunc, VWR) 3 days prior to experiment. 
2.2.13.2 Cryopreservation of HBMEC and MLEC 
HBMEC and MLEC were trypsinised as above and centrifuged at 1000 rpm for 10 
mms. The supernatant was removed. The cell pellet was then re-suspended in 
cryopreservation media to cell density of 1 x 106 cells/ml and dispensed as 1 ml aliquots 
into cryotubes. The aliquots were frozen at -80°C in an isopropanol freezing container for 2 
- 3 days and then transferred to liquid nitrogen. For recovery from liquid nitrogen the cells 
were warmed in a water bath for 1 - 2 mins, and then the cells were carefully added 
dropwise to 10 ml pre-warmed growth media in a 50 ml tube. The cells were centrifuged at 
, 1000 rpm for 5 mins. The media was aspirated and 1 ml fresh pre-warmed growth media 
was added to the cell pellet and re-suspended gently. The cell suspension was added to 9 
ml pre-warmed growth media in a 75 cm2 vented flask. The cells were allowed to adhere in 
an incubator at 37°C with 5% C02. 
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2.2.14 HBMEC transfection 
For plasmid DNA transfection into HBMEC cells, 1 x 105 cells/ml HBMEC were 
seeded onto 700/0 ethanol cleaned microscope glass cover slips (No.1 13mm diameter) 
(VWR, Lutterworth, UK) in a 24-well tissue plate 2 days prior to experiment, in order to 
achieve approximately 80% confluency for transfection. Various cationic polymer and 
lipid-based transfection reagents as well as Nuc1eofection kits were tested. 
2.2.14.1 Transfection with jetPRIME™ transfection reagent 
On the day of transfection, cells were replenished with 0.5 ml fresh HBMEC 
growth medium. 1.0 flg plasmid DNA was diluted in 50 fll jetPRIME ™ buffer, mixed the 
tube gently by tapping. 2 fll jetPRIME™ transfection reagent was added to the diluted 
DNA, and mixed by tapping immediately. The DNA-lipid complex mixture was incubated 
at room temperature for 10 mins. The DNA-lipid complex was added dropwise onto the 
cells, and repeatedly pipetted up and down with a P200 micropipette. The cells were 
incubated with the DNA-lipid complex in a tissue culture incubator at 37°C, 5% CO2. 5 - 6 
hours post-incubation, the medium containing DNA-lipid complex was removed, and cells 
were washed once with pre-warmed unsupplemented RPMI-1640. Cells were replenished 
with fresh HBMEC growth medium, were further incubated in a tissue culture incubator 
for 20 - 24 hours. 
2.2.14.2 Transfection with Lipofectamine™ 2000 transfection reagent 
On the day of transfection, cells were replenished with 0.5 ml fresh HBMEC 
growth medium. 0.5 flg of plasmid DNA was diluted in 100 fll Opti-MEM® reduced 
serum medium (Invitrogen), mixed the tube by tapping. 1 fll PLUS™ reagent was added 
directly to the diluted DNA, and was mixed by tapping. The reaction was incubated for 5 
mins at room temperature. 3 fll Lipofectamine ™ 2000 transfection reagent was added to 
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the diluted DNA, and mixed by tapping immediately. The DNA-lipid complex mixture was 
incubated at room temperature for 30 mins. The DNA-lipid complex was added dropwise 
onto the cells, and repeatedly pipetted up and down with a P200 micropipette. The cells 
were incubated with the DNA-lipid complex in a tissue culture incubator at 37°C, 5% CO2. 
5 - 6 hours post-incubation, the medium containing DNA-lipid complex was removed, and 
cells were washed once with pre-warmed unsupplemented RPMI-1640. Cells were 
replenished with fresh HBMEC growth medium, were further incubated in a tissue culture 
incubator for 20 - 24 hours. 
2.2.14.3 Transfection with jetPEI™ transfection reagent 
On the day of transfection, cells were replenished with 1.0 ml fresh HBMEC 
growth medium. 1.0 I-1g plasmid DNA was diluted in 50 1-11 150 mM NaCl buffer, ,mixed 
the tube gently by tapping. 2 or 4 I-1ljetPEI™ transfection reagent was diluted in 50 1-11 150 
mM NaCl buffer in a separate microcentrifuge tube, mixed by tapping. The diluted 
jetPEI™ solution was added to the diluted DNA, and mixed by tapping immediately. The 
DNA-lipid complex mixture was incubated at room temperature for 30 mins. 100 1-11 DNA-
lipid complex was added dropwise onto the cells, and repeatedly pipetted up and down 
with a P200 micropipette. The cells were incubated with the DNA-lipid complex in a tissue 
culture incubator at 37°C, 5% CO2 for 20 - 24 hours. 
2.2.14.4 Transfection with jetPEI™-HUVEC transfection reagent 
On the day of transfection, cells were replenished with 1.0 ml fresh experimental 
medium. 2.0 I-1g plasmid DNA was diluted in 50 1-11 150 mM NaCl buffer, and the tube 
mixed gently by tapping. 4 1-11 jetPEI™-HUVEC transfection reagent was diluted in 50 1-11 
150 mM NaCl buffer in a separate micro centrifuge tube, and mixed by tapping. The diluted 
jetPEI™-HUVEC solution was added to the diluted DNA. and mixed by tapping 
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immediately. The DNA-lipid complex mixture was incubated at room temperature for 30 
mins. 1 00 ~l the DNA-lipid complex was added dropwise onto the cells, and repeatedly 
pipetted up and down with a P200 micropipette. The cells were incubated with the DNA-
lipid complex in a tissue culture incubator at 37°C, 5% CO2 for 4 hours, then the medium 
containing DNA-lipid complex was removed, and cells were washed once with pre-
warmed unsupplemented RPMI-1640. Cells were replenished with fresh HBMEC growth 
medium, were further incubated in a tissue culture incubator for 20 - 24 hours. 
2.2.14.5 Transfection with FuGENE® HD transfection reagent 
On the day of transfection, cells were replenished with 0.5 ml fresh HBMEC 
growth medium. Before transfection, FuGENE® HD was warmed to room temperature, 
and mixed briefly by inverting. 0.5 ~g plasmid DNA was diluted in 25 ~l Opti-MEM® 
reduced serum medium (Invitrogen), the tube mixed gently by tapping. 1.5 ~l FuGENE® 
HD transfection reagent was added to the diluted DNA, and mixed immediately by 
repeatedly pipette up and down ;::::15 times. The DNA-lipid complex mixture was incubated 
at room temperature for 15 mins. The DNA-lipid complex was added dropwise onto the 
cells, and repeatedly pipetted up and down with a P200 micropipette. The cells were 
incubated with the DNA-lipid complex in a tissue culture incubator at 37°C, 5% CO2 for 20 
- 24 hours. 
2.2.14.6 HBMEC Nucleofection with HUVEC Nucleofector Kit-OLD and Amaxa 
HUVEC Nucleofector Kit 
Prior to experiment, Nucleofector solution was thawed to room temperature. 
HBMEC growth medium was pre-incubated at 37°C, 5% CO2. 5 x 105 cells/ml HBMEC 
were prepared and re-suspended in 1 00 ~l Nucleofector solution. 2 ~g plasmid DNA was 
added to the side of the electroporation cuvette and the HBMEC suspension was added 
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carefully into the cuvette. Cells were electroporated according to the manufacturer's 
instructions. SOO ~l BBMEC growth medium was added immediately to the electroporated 
cells and transferred to a tissue culture plate. The cells were incubated in a tissue culture 
incubator at 37°C, S% CO2 for 24 or 48 hours. 
2.2.15 HBMEC and MLEC infection 
On the day of experiment, 9S% confluency or confluent HBMEC or MLEC in 24-
well tissue culture plates were washed three times with pre-warmed plain RPMI-1640 
media, and replenished with pre-warmed experimental medium. HBMEC were incubated 
with E. coli at MOl of 100. After the addition of bacteria, the plate was centrifuged at SOO 
x g, lSoC for S mins. The plate was incubated at 37°C, S% CO2 for 120 mins. The 
mono layers were washed three times with plain RPMI-1640 medium and further incubated 
in experimental medium containing 1 00 ~g/ml gentamicin for 60 mins, or Sand 18 hours 
for 7 and 20 hours time point respectively, to kill off extracellular bacteria. The 
mono layers were washed three times with plain RPMI-1640 medium or PBS and lysed 
with 0.3% (w/v) SDS in PBSA. The serial diluted lysates were plated on LB agar plates, 
and the plates were incubated overnight at 37°C. The number of bacterial colonies were 
counted and calculated as cfulml = (number of counted colonies / volume of culture plated) 
x dilution factor. 
2.2.16 HBMEC transcytosis assay 
S x 104 cells/ml HBMEC were seeded onto the apical chamber of a 4.67cm2 
collagen-coated polytetrafluoroethylene (PTFE) Transwell membrane, pore size 0.4 ~m 
(Coming). Transendothelial electrical resistance (TEER) of the HBMEC monolayer on 
Transwell was measured with a Millicell® ERS volt-ohm meter (Millipore, Watford, UK) 
according to the manufacturer's instructions. Briefly, the probe was sterilized bv 
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immersing in 70% ethanol for 30 mins and air-dried. The probe was rinsed with plain 
RPMI-1640. For measuring TEER, the shorter probe was inserted into the Trans\vell insert 
carefully without touching the cells at 90°; while the longer probe was inserted into the 
medium in the lower chamber. The meter was set to Ohms mode and the resistance was 
recorded. The resistance of the monolayer was calculated by subtracting the resistance 
reading obtained from sample well to the resistance reading obtained from blank well. To 
correct for the area covered by the cell monolayer, the calculated resistance value was 
multiplied by the effective membrane area of the Transwell insert. 
When the cells on the Transwell membrane reached complete confluency, the 
medium was replaced with HBMEC growth media containing 1.0 Ilg/ml hydrocortisone to 
induce intercellular tight junctions formation. The medium was changed on alternate days. 
5 days after hydrocortisone treatment, the cells were used for transcytosis assay. The 
Transwell membranes were washed in plain RPMI-1640 medium and replenished with 
fresh experimental medium. 0.2 ml bacterial suspension, which contained approximately 1 
x 108 cfulml bacteria, was applied to the apical chamber. At each time point (0, 2, S, and 
12 h incubation), 600 III medium in the lower chamber was sampled for quantitation of cfu 
and replaced with 600 III fresh experimental medium. The recovered organisms were 
differentiated by lactose fermentation on MacConkey agar. 
2.2.17 Cell imaging 
2.2.17.1 Fluorescein isothiocyanate (FITC) labelling of E. coli 
Bacteria were grown up as above, then peUeted in a microfuge at 13000 rpm for 2 
mins and re-suspended in PBS. FITC was added to a final concentration of 0.5 mg/ml in 50 
mM Na2C03-1 00 mM NaCI buffer, pHS.O. The bacteria were incubated in the dark at room 
temperature for 10 mins. Free FITC was removed by washing in PBS and centrifugation at 
8000 rpm, and the bacteria were used immediately. 
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2.2.17.2 Cell fixation 
HBMEC cells were grown on glass coverslips in a 24-well tissue culture plate until 
950/0 or complete confluent. The cells were incubated with bacteria and were processed for 
immunofluorescence microscopy. The cells were washed three times with plain RPMI-
1640 to remove unbound bacteria prior to fixation. For formaldehyde fixation. cells were 
fixed with 3% formaldehyde/PBS for 15 mins at room temperature. To quench the 
autofluorescence signal from formaldehyde, the fixed cells were incubated in 50 mM 
NH4CI for 20 mins at room temperature. 
An alternative fixation method to formaldehyde is methanol fixation. Cells on 
coverslips were incubated with absolute methanol for 10 mins at -20°C. Fixed cells were 
rehydrated sequentially in the following solutions for 1 min: absolute ethanol, 95% 
ethanol, 70% ethanol, 50% ethanol, and MilliQ water. After fixation, the cells were washed 
three times for 5 mins in wash solution (5% FCS/PBS), and immunolabelled as described 
in section 2.2.19.3. 
2.2.17.3 Immunofluorescence staining 
For intracellular staining, primary antibody (section 2.1.6) was diluted in wash 
solution containing 0.2% saponin. 15f..l1 antibody mix was aliquoted onto a piece of 
Parafilm within a petri dish. The coverslips were inverted onto the antibody drop and 
incubated for 1 hour at room temperature. The humidity within the petri dish was 
maintained using a small damp tissue. After 1 hour incubation, the covers lips were washed 
three times with wash solution. The binding of primary antibodies was visualised with 
secondary antibodies conjugated to fluorophores (section 2.1.7), by incubating at room 
temperature in the dark for 1 hour. After washing three times with wash solution, the cells 
nuclei were stained with 1 f..lg/ml DAP!. The cells were washed once with wash solution 
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and once with PBS, cells were mounted on the glass slide with Confocal Matrix (Micro-
Tech-Lab, Austria). 
2.2.17.4 Differential antibody staining 
To distinguish intracellular from extracellular bacteria, differential antibody 
staining was performed. For formaldehyde fixed cells, extracellular bacteria were labelled 
without permeabilization using anti-E. coli 018 and FluoProbes®-642 conjugated donkey 
anti-rabbit. In methanol fixation, the plasma membrane is permeabilized during fixation. 
Therefore, for methanol fixation, the above staining procedure was performed on ice prior 
to fixation. 
After staining with secondary antibody, cells were permeabilized with 0.1 % 
TritonX-lOO/PBS for 10 mins, then intracellular bacterial staining using the same primary 
antibodies, followed by FluoProbes®-546 conjugated donkey anti-rabbit. This staining 
procedure yields extracellular bacteria with both 642 and 546 signals, while intracellular 
bacteria only positive for 546 signal only. 
2.2.17.5 Kl capsule staining 
5 J.lI sterile PBS was spotted onto a glass cover slip, and bacterial colonies were 
picked, smeared onto the glass cover slip. The bacterial smear was air-dried, fixed with 2% 
(v/v) formaldehyde and stained with 10 J.lg/ml PKIA-OFP probe in PBS without detergent. 
To differentiate the OFP signal from the probe and intracellular OFP signal from the Kl-
OFP the PKIA-OFP-stained KI-OFP was counterstained with mouse anti-OFP clone 3E6 , 
antibody, and followed by Fluoprobes-642 conjugated donkey anti-mouse antibody in PBS 
without detergent. The anti-OFP antibody only stained the OFP of PKIA-OFP probe, 
which bound the bacterial surface. The cover slip was mounted onto a glass slide with 
Confocal Matrix. 
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2.2.17.6 Confocal microscopy 
Fluorescent images were acquired with an inverted confocal microscope (LSM51 0; 
Carl Zeiss MicroImaging, Inc.). Argon laser (excitation 488 run) and a filter set to detect 
FITC emission (BP505 - 550) for imaging EGFP, FITC, Cy2, and FluoProbes-488; Argon 
laser (excitation 458 run) and a filter set to detect CFP emission (BP470 - 500) for imaging 
ECFP; HeNe 1 laser (excitation 543 run) and a filter set to detect Rhodamine emission 
(LP585) for imaging mCherry and FluoProbes-546; HeNe 1 laser (excitation 514 run) and a 
filter set to detect YFP emission (LP530) for imaging EYFP; HeNe2 laser (excitation 633 
run) and a filter set to detect Cy5 emission (LP630) for imaging FluoProbes-642; Laser 
Diode (excitation 405 run) and a filter set to detect DAPI emission (BP390 - 420) for 
imaging DAPI. Cells were observed using a 63xINA lAO plan-Apochromat oil immersion 
objective with the confocal pinhole set to one Airy unit. Imaging parameters, such as gain 
and offset levels, and line averaging, are optimised to avoid oversaturation of pixels and to 
improve signal:noise ratio. Images were acquired using LSM510 software package (Carl 
Zeiss MicroImaging, Inc.). Image analyses were performed with ImageJ and Adobe 
Photoshop Elements 8.0. 
2.2.17.7 Live cell imaging 
For short-duration imaging experiments, HBMEC cells were grown on glass 
coverslips in a 24-well tissue culture plate, and were infected with E. coli K1 expressing 
fluorescent protein at 37°C with 50/0 C02. Unless otherwise stated, at the end of infection, 
cells were incubated in experimental medium containing 1 00 ~g/ml gentamicin at 37°C for 
1 hour. Coverslips were washed three times with prewarmed unsupplemented RPMI-1640 
medium. Coverslips were lifted from the well and mounted onto a low-tech rubber gasket 
imaging chamber with approximately 35 ~l imaging medium (Ward. 2007). 
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In order to track the intracellular bacterial activity over time, time lapse imaging 
was set up. For time lapse imaging experiments, HBMEC cells were grown in a LabTek 8-
well glass cover slip chamber (Nalge Nunc) and transfected with fluorescent protein-
tagged mammalian expression vector. Infection was performed as described above (section 
2.2.17), infected cells were replenished with imaging medium containing 100 !lg/ml 
gentamicin, and imaged immediately. 
Prior to imaging, the confocal microscope imaging chamber was preheated to 37°C 
to avoid focus problems resulting from expanding metal components of the stage. If CO2 
chamber was used, CO2 control was switched on to zero the C02 in the system from 
previous usage, and CO2 was then supplied to the system approximately 15 mins before 
imaging. For acquisition of tile-z stack images, tile dimensions [n(x), n(y)] was set in 
addition to the z-stack parameters. To avoid focus drift during imaging, autofocus function 
was set up during timelapse imaging. 
2.2.17.8 Tile z-stack imaging 
For quantification of the effect of cells overexpressing mutant proteins on E. coli 
K 1 invasion, tile z-stack imaging was performed. The rationale to acquire tile images was 
to avoid potential experimental bias by acquiring neighbouring fields over large areas of 
the cover slip automatically under software control. Imaging parameters were set up as 
described in section 2.2.19.5, and saved. Z-stack parameters as well as tile dimensions 
[n(x), n(y)] was set. 
2.2.18 Protein gel electrophoresis and Western blotting 
Cells were washed once with PBSA. 50111 6x SDS sample buffer was added to the 
cells and the cells were scraped off from the tissue culture dish with a cell scraper 
(Sarstedt, Leicester, UK). The cell lysates were transferred to a 1.5 ml microcentrifuge 
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tube, and incubated at 98°C for 10 mins, followed by 1 min incubation on ice. The lysates 
were centrifuged at 13000 rpm for 5 mins, room temperature and supernatants remo\'ed to 
clean tubes. 20 1-11 samples were resolved in a 10% SDS gel in a Mini-Protean 3 (BioRad) 
with 2 1-11 PageRuler prestained protein ladder (Fermentas) in Ix running buffer. Gels were 
run for approximately 70 mins at constant current 15mA or until the front dye reached the 
bottom edge of the gel. The separated proteins were then transferred onto PVDF 
membranes (Millipore, Sigma-Aldrich) using the Mini-protean 3 transfer apparatus 
(BioRad). Membranes were immersed in methanol for 15 seconds, followed by soaking in 
distilled water for 2 mins, and then equilibrated in blotting buffer for 5 mins. Proteins were 
transferred overnight at 4°C at 30V, 90mA. Non-specific binding sites were blocked using 
PBS/O.l % Tween-20 containing 5% (w/v) dry skimmed milk for 1 hour with shaking at 
room temperature. To probe for specific proteins, membranes were incubated for 1 hour at 
room temperature with primary antibodies. After washing three times in PBS/O.l % Tween-
20, membranes were incubated with HRP-conjugated secondary antibody at 1 :3000 
dilution. Antibody-protein complexes were detected using Enhanced chemiluminescent 
(ECL) Western blotting substrate (Pierce, Fisher Scientific, Leicestershire, UK) and 
exposure to film (Kodak, Sigma-Aldrich) in the dark for the appropriate amount of time (1 
to 20 minutes) depending on signal strength. Film was developed by automatic x-ray film 
processor (Xograph, Gloucestershire, UK). 
2.2.19 Statistical analysis 
All experiments were repeated three times and performed in duplicate or triplicate. 
Data were analysed with GraphPad Prism Version 4.02. For data from two experimental 
conditions compared with each other, 2-tailed Student's t test was used to test statistical 
significance. In instances where multiple experimental conditions were compared with a 
single control group, statistical significance was tested using one-way ANOV A followed 
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by Newman-Keuls multiple comparison post-comparison test. A p value less than 0.05 was 
considered significant. 
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3. Construction of a fluorescent E. coli Kl strain that retains virulence 
3.1 Introduction 
To date, in published E. coli K1 studies involving fluorescence microscopy, the 
bacteria have either been surface labelled with fluorescent dye or immunolabelled with a 
bacteria-specific antibody or with an endosialidase-GFP fusion probe (Kim et al., 2003: 
Sukumaran et al., 2003; Alsam et al., 2005; Zelmer et al., 2008). Whilst these studies have 
provided great advances in understanding E. coli Kl interactions with host cells, the 
techniques used do have their limitations. 
Surface labelling of bacteria with a fluorescent dye, such as fluorescein 
isothiocyanate (FITC), and NHS Rhodamine, is a rapid and cheap bacterial labelling 
approach (Hazenbos et al., 1994; Schneider et al., 2000; Steele-Mortimer et al., 2000). 
However, as the dye only labels the bacterial extracellular surface, the dye will be diluted 
over each generation during bacterial replication. Furthermore, binding of FITC to the 
bacterial surface has been demonstrated to interfere with adenylate cyclase toxin activity of 
Bordetella pertussis, which affects bacterial uptake by human neutrophils in vitro 
(Weingart et al., 1999). 
Immunolabelling of fixed bacteria with a specific bacterial antibody is another 
common method widely employed for labelling bacteria in fixed samples. As the sample 
requires prior fixation, some fixatives, especially aldehydes, generate autofluorescent 
signal, and some cell structures, such as lipid raft-associated molecules, are not properly 
preserved by the fixative (Drecktrah et al., 2008; Tanaka et al., 2010). Further, certain 
bacterial antigens, such as fimbriae (Saukkonen et al., 1988), and E. coli Kl capsule 
(Zelmer et al., 2008), express different forms of their antigens at different stages of 
infection, therefore selection of antibody requires care. For E. coli K 1, the endosialidase-
GFP probe is an alternative non-antibody probe. It is an engineered noncatalytic E. coli 
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Kl-specific bacteriophage-encoded endosialidase tagged with GFP that binds specifically 
to the Kl capsule in a fixed sample but does not degrade it (Jokilammi et al., 2004). 
An alternative bacterial-labelling strategy is cytoplasmic expression of fluorescent 
proteins in bacterial cells from an introduced plasmid (Weingart et al., 1999; Qazi. et al.. 
2001; Ruthel et al., 2004; Knodler et al., 2005; Drecktrah et al., 2007; Lamberti et al., 
2010; Van Engelenburg and Palmer, 2010). This bacterial labelling approach provides 
stably fluorescent live bacteria for microscopy studies, but some adverse outcomes from 
the burden of fluorescent protein synthesis to Salmonella pathogenicity have been 
observed in bacterial uptake into macrophages and epithelial cell lines in vitro as well as in 
vivo infection (Knodler et al., 2005). In addition to the production of fluorescent proteins, 
the presence of plasmid, and antibiotic resistance markers, such as tetracycline resistance 
gene (tetR), and chloramphenicol resistance gene (CmR), on the plasmid has also been 
shown to affect bacterial virulence traits (Abromaitis et al., 2005; Knodler et al., 2005; 
Clark et al., 2009). However, it has been further demonstrated that by integrating CmR and 
fluorescent reporter genes into the bacterial chromosome, the fluorescent protein-
expressing Salmonella retains its virulence (Clark et al., 2009). 
The aim of this project was to study the interactions of E. coli K1 with various 
cellular and organellar markers in HBMEC by live-cell imaging. Live-cell imaging allows 
the study of the dynamic interactions of the pathogen with host factors over time (Schroder 
et aI., 2006; Drecktrah et aI., 2008). For example, the application of live-cell imaging 
revealed that Salmonella-induced filaments (Sifs) are highly dynamic and bidirectional, 
with microtubule-dependent movement (Drecktrah et al., 2008). Therefore, to enable the 
application of live-cell imaging for studying E. coli Kl interaction with HBMEC. a 
fluorescent E. coli Kl strain that retains virulence is required. The virulence 'of the 
fluorescent protein-expressing E. coli Kl can then be screened with an HBMEC invasion 
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assay, which has been extensively applied to study E. coli Kl pathogenesis. as reyiewed in 
chapter 1. 
3.2 Objectives and aims 
The aim of this chapter was to construct a fluorescent E. coli Kl strain that retained 
virulence. The specific objectives are: 
• To determine the optimal infection conditions for E. coli K1 infection of HBMEC by 
testing different multiplicities of infection (MOl) and varying the incubation time of 
the cells with the bacteria. 
• To transform various bacterial fluorescent reporter constructs into E. coli Kl and to 
screen the virulence of the transformed E. coli K 1 by the optimised HBMEC invasion 
assay in comparison to untransformed E. coli K 1. 
3.3 Results 
3.3.1 Invasion and intracellular survival of E. coli Kl and K-12 in HBMEC 
To determine the kinetics of the bacterial invasion of HBMEC, the cells were 
incubated with the bacteria at MOl of 100 for varying intervals of time (Figure 3.1A). 
Extracellular bacteria were killed by gentamicin, which is poorly permeable to eukaryotic 
cell membranes (Barnhart et aI., 2002). Therefore, bacteria that have invaded into the host 
cells are protected from the bactericidal effect of gentamicin. After gentamicin treatment, 
cells were washed, and the viable intracelluar bacteria were quantified as described in 
chapter 2. 
The percentage of recovered intracellular E. coli Kl from HBMEC increased with 
longer incubation times (Figure 3.1 B). An incubation of 120 minutes resulted in a 
significant increase in the percentage of intracellular E. coli K1 recovered compared to a 
30 and 60 minutes incubation (p < 0.05. using (-test, one-tailed distribution), which might 
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be resulted from intracellular bacterial replication. As expected, when the non-inyasiye E. 
coli K-12 were used, no intracellular bacteria were recoyered after 30 or 60 minutes 
incubation, and only a very low percentage of bacteria (0.000180/0) had invaded HB?\lEC 
after 120 minutes. These results show that more E. coli K1 invade HBMEC with longer 
incubation times; whereas for E. coli K-12, which is a non-invasive laboratory E. coli 
strain, extended incubation time of the bacteria with HBMEC results with no or very low 
number of bacterial invasion. 
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Figure 3.1. Invasion of E. coli Kl and K-12 into HBMEC. (A) Schematic of 
experimental design . To determine the optimal infection time, HBMEC were infected with 
E. coli K 1 or K-12 at MOl of 100 for different time intervals. The infected cells were 
washed and incubated in medium containing 100 /lg/ml gentamicin for 60 minutes to kill 
extracellular bacteria at the end of the infection. Cells were washed and lysed . The cell 
lysates were plated on LB agar to enumerate the number of bacteria. (B) Quantitation of 
the number of bacteria invaded HBMEC at various time intervals of incubation as 
indicated. The result represents the percentage of bacteria invaded into HBMEC. Results 
are from one representative experiment of two independent repeats performed in tri'plicate 
and presented as mean of triplicates ± SD. 
E. coli KI are able to replicate extracellularly in the blood of infected neonates as 
well as the neonatal rat model (Glode et af., 1977; Pluschke et af., 1983 ; Kim et af. , 1992 ; 
Zelmer et al., 2008). However, the ability of the bacteria to survive intracellularly is 
unclear. To investigate the ability of E. coli K 1 to survive intracellularly in HBMEC, the 
cells were incubated with either K 1 or K-1 2 at MOl of 100 for 120 minutes (Figure 3.2 ). 
Following this , the cells were cultured in experimental medium containing g ntamicin to 
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kill extracellular bacteria (Figure 3.2B). The intracellular bacterial load was then assessed 
at increasing time intervals to determine bacterial persistence. A minor decrease in the 
percentages of intracellular E. coli KI was observed at 180 minutes, but the percentage of 
intracellular E. coli Kl increased significantly at the end of the 300 minutes incubation in 
gentamicin (p < 0.05, using (-test, one-tailed distribution). For intracellular survival assays 
involving E. coli K-12, a very low percentage of intracellular bacteria (0.0003%) were 
recovered 60 minutes post-gentamicin treatment, and the percentage of recovered bacteria 
was further decreased to 0.0000635% at 300 minutes post-gentamicin treatment. The 
results clearly indicate that E. coli KI are able to survive and replicate intracellularly in 
HBMEC at least up to 5 hours post infection, as very low number of viable intracellular E. 
coli K 1 was recovered after 18 hours incubation in media containing gentamicin (data not 
shown), which might be due to bacterial killing intracellularly or bacterial egress from the 
infected HBMEC at later time point. Whereas the non-pathogenic E. coli K-12 are not able 
to survive intracellularly in HBMEC. In addition, these results also demonstrated that the 
gentamicin did not affect the survival of intracellular Kl bacteria. 
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Figure 3.2. Intracellular survival of E. coli Kl in HBMEC. (A) Schematic of 
experimental design. To determine the intracellular survival of the bacteria, HBMEC were 
infected with E. coli K 1 or K-12 at Mor of 100 for different time intervals . The infected 
cells were washed and incubated in medium containing 1 00 ~g/ml gentamicin for the time 
periods indicated. Cells were washed and lysed. The cell lysates were plated on LB agar to 
enumerate the number of bacteria. (B) Quantitation of the intracellular survival. The result 
represents the percentage of recovered intracellular bacteria. Results are from one 
representative experiment of three independent repeats performed in triplicate and 
presented as mean of triplicates ± SD. 
3.3.1.1 E. coli Kl bearing M. tuberculosis codon optimized fluorescent reporter 
vectors invasion of HBMEC 
E. coli K 1 transformed with M tuberculosis codon optimized fluorescent reporter 
vectors were initially screened with a cheap Acanthamoeba phagocytosis assay and were 
found to retain virulence when compared to untransformed E. coli K 1 (data not shown). 
The final application of the virulent fluorescent E. coli K 1 strain is for stud ing th 
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interactions of the fluorescent bacterial strain with HBMEC, which is a non-phagoc)1ic 
cell type used as a blood-brain barrier model in vitro. Therefore, the fluorescent E. coli K 1 
strains, which had demonstrated to be virulent in Acanthamoeba had to demonstrate , 
similar virulence trait in HBMEC. 
KlpmCherry3 and KlpEnvyl were selected for further screening with HBMEC. 
Invasion assays were performed at MOl of 100 for 60 minutes (Figure 3.3). The 
percentages of recovered intracellular bacteria for KlpmCherry3, and KlpEnvyl were 
significantly lower than untransformed Kl (p < 0.01, using t-test, one-tailed distribution). 
It was also observed that the doubling time for all Kl and K-12 transformed with the 
Mycobacterium sp. codon-optimised fluorescent reporter constructs were longer than the 
untransformed Kl and K-12, respectively (data not shown). It appears that although the 
bacterial strains were equally able to infect Acanthamoeba, the virulence of the bacteria 
transformed with M tuberculosis codon optimized fluorescent reporter constructs was 
impaired in their ability to invade HBMEC. These transformed bacteria were therefore not 
suitable for use in future experiments. 
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Figure 3.3. Screening of virulence of E. coli Kl expressing fluorescent protein in 
HBMEC. To determine the virulence of the K1 expressing fluorescent protein, invasion 
assays were performed by infecting HBMEC with either native E. coli Kl, K-12 or 
fluorescent protein expressing E. coli K1 strains at MOl of 100 for 60 minutes, followed 
by incubation in media containing gentamicin for 1 hour. The result represents the 
percentage of bacteria invaded into HBMEC. Results are from one representative 
experiment of two independent repeats performed in triplicate and presented as mean of 
triplicates ± SD. 
3.3.1.2 pFPV25.1-transformed E. coli Kl invasion of HBMEC 
pFPV25.1 plasmid contains E. coli codon optimised GFP reporter gene, gfpmut3a, 
fused downstream of a Salmonella typhimurium (s. typhimurium) promoter, rpsM (Figure 
3.4A) (Valdivia and Falkow, 1996). This construct had been extensively used in studies 
involved S. typhimurium (Cheminay et al., 2005; Radtke et al., 2007; Gerlach et aI., 2008), 
and enteropathogenic E. coli (EPEC) (Unsworth et aI., 2007; Marches et aI., .2008); 
therefore, this plasmid was tested for use in E. coli K 1. 
As with other constructs, pFPV25.1 was transformed into K 1 and K -12 as 
previously described, and the fluorescence stability was confirmed using a confocal 
microscope (Figure 3.4B). All pFPV25.1-transformed Kl (KI-GFP) fluoresced. when 
observed with a confocal microscope. The growth profile of the K1-GFP was slightly 
lower when compared to native Kl (Figure 3.4C), with the doubling time ofKl-GFP was 
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approximately 36.3 minutes, and the K1 doubling time was 35 minutes in this specific 
experiment. 
To determine whether the virulence of K1-GFP is retained, HBMEC invasion 
assays were performed (Figure 3.4D). The percentage of recovered intracellular KI-GFP 
was roughly 400/0 lower than that of native K1, however this was shown to be not 
significant (p > 0.05, using (-test, one-tailed distribution). The reduction in the K I-GFP 
invasion efficiency was deemed to be acceptable for further experiments, as the 
transformant bacteria were still invasive when compared to the non-pathogenic E. coli K-
12 (Figure 3.4D) and the previous transformed strains (Figure 3.3). 
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Figure 3.4. Screening of virulence E. coli Kl transformed with pFPV25.1 construct in 
HBMEC. (A) The illustration shows the pFPV25.1 plasmid map. Unique restriction 
enzyme cutting sites are indicated in blue. (B) The confocal micrograph shows fluorescent 
E. coli Kl transformed with pFPV25.1 (KI-GFP). Scale bar: 10 /lm. (C) The growth 
kinetics of KI-GFP and untransformed E. coli KI in LB broth. The results show the 
absorbance at 595 nm of the bacterial cultures at the time intervals indicated. (D) To 
determine the virulence of the transformed K 1, invasion assays were performed by 
incubating HBMEC with either E. coli K 1, K-12 or K I-GFP at MOl of 100 for 120 
minutes, followed by incubation in media containing gentamicin. The result represents the 
percentage of bacteria invaded into HBMEC. Results are from one representative 
experiment of two independent repeats performed in triplicate and presented as mean of 
triplicates ± SD. 
It has been shown previously that the bacterial K 1 polysialic acid capsule is crucial 
for bacterial intracellular survival in HBMEC, no defect was observed in the HBMEC 
invasion by KI capsule deletion mutant (Kim et at. , 2003). Thus. the apparent lower 
invasIOn efficiency of KI-GFP seen in Figure 3.4D may be due to impairment in KI 
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polysialic acid capsule expression, leading to the killing of the intracellular bacteria rather 
than a reduction in bacterial invasion. To examine the presence of Kl polysialic acid 
capsule on KI-GFP, the transformed bacteria were smeared onto a cover slip, fixed with 
formaldehyde, and stained with PKIA-GFP probe, which binds Kl polysialic acid capsule 
specifically (Jokilamrni et al., 2004; Zeimer et al., 2008), in the absent of detergent. As the 
transformed bacteria already expressed GFP, visualization of the bound PKIA probe was 
facilitated by counter-staining with a mouse anti-GFP antibody, followed by Fluoprobes 
642-conjugated anti-mouse antibody. An experimental control which KI-GFP smear was 
not stained with the PKIA-GFP probe, but was stained with the anti-GFP antibody, 
followed by Fluoprobes 642-conjugated anti-mouse antibody, did not detect any signal in 
the far red channel (Figure 3.5B). This result showed that the intracellular GFP of KI-GFP 
was not detected by the anti-GFP antibody when staining was performed without 
permeabilization with detergent. Hence, the staining showed the presence of Kl polysialic 
acid capsule on the untransformed Kl and KI-GFP (Figure 3.5A and C respectively). 
Therefore, the reduction in the KI-GFP invasion efficiency was not caused by intracellular 
bacterial killing as the result of the absence of Kl polysialic acid capsule expression on the 
transformant, but was probably due to a defect in other bacterial determinants that are 
essential for HBMEC invasion. 
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Figure 3.5. The presence of KI polysialic acid capsule on KI-GFP. To examine the 
presence of Kl polysialic acid capsule on Kl and K I-GFP, the bacterial culture was 
smeared on a glass cover slip, air-dried, and fixed with 2% (v/v) formaldehyde. The 
bacterial smear was stained with 10 Ilg/ml of PK 1 A-GFP probe in PBS, then by mouse 
anti -GFP clone 3E6, and followed by Fluoprobes 642 conjugated donkey anti-mouse 
antibody without permeabilizing by detergent. As an experimental control (B), K I-GFP 
was stained with mouse anti-GFP antibody, followed by Fluoprobes 642 conjugated 
donkey anti-mouse antibody only. (A and C) The images show the presence of the 
bacterial Kl capsule on Kl and KI-GFP respective ly. Contrast of all images was 
enhanced. GFP signal from intracellular GFP of K I-GFP and from PK 1 A-GFP probe 
(green); signal resulted from anti-GFP staining (red). Scale bar: 10 11m (A and C) ; 5 11m 
(B). 
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3.3.1.3 Deletion of rpsM promoter from pFPV25.1 and the transformed bacterial 
invasion of HBMEC 
It was previously shown that cytoplasmic fluorescent protein expression affects 
Salmonella virulence (Knodler et aI., 2005; Clark et aI., 2009). To investigate if GFP 
expression was the major factor that affects the transformed bacterial invasion and survival 
in HBMEC, the rpsM gene was deleted from pFPV25.1, to construct a promoterless 
construct that does not expression GFP, as illustrated in Figure 3.6. 
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Figure 3.6. Deletion of rpsM from pFPV25.1. The illustration summarizes steps in vo lved in de leting rpsM gene in pFPV2S . 1 using 
standard cloning techniques. pFPV2S. 1 was digested with Sma l and Xba l, blunted with Klenow fragment, and re- li gated. The resulting 
construct was a promoterless bacterial express ion vector, rpsM. 
The construct was transformed into E. coli K 1 by electroporation. As the promoter 
had been deleted, there was no GFP expression in the transformed bacteria, therefore, to 
additionally confirm the transformed E. coli K 1 that grew on a ampicillin selection LB 
agar plate, the plasmid DNA was extracted and linearised by HindIII digestion for the 
expected 4786 bp band compared to the plasmid with intact promoter of 5390 bp (Figure 
3.7 A). The quality of the plasmid DNA extracted from E. coli Kl was poor compared to E. 
coli DH5a strain, a standard E. coli cloning strain, possibly due to the presence of 
nucleases in the pathogenic strain. The growth kinetics of the transformed bacteria, 
KlrpsM-, was slightly lower than Kl, with the doubling time of 32.43 minutes (Figure 
3.7B), which is similarly observed in other fluorescent protein-expressing Kl. 
In order to demonstrate the invasion efficiency of the KlrpsM-, HBMEC invasion 
assays were performed (Figure 3.9C). Interestingly, the percentage of recovered 
intracellular KlrpsM- was nearly 2-fold and slightly lower than that of Kl and KI-GFP. 
The observation might suggest that the reduction in the invasion efficiency of fluorescent 
protein-expressing K 1 is not caused by the expression of fluorescent protein, but the 
presence of the plasmid DNA alone might be a metabolic burden to the bacteria, hence, the 
bacterial virulence is affected. Alternatively, the presence of certain genetic components on 
the expression vector, such as antibiotic resistance gene, contribute to the loss of the 
bacterial virulence trait (Abromaitis et al., 2005). 
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Figure 3.7. Screening of E. coli Kl transformed with rpsM- plasmid DNA and the 
growth kinetics of the transformed E. coli K1. (A) SmaI and XbaI digestion resulted in 
the deletion of rpsM, the promoter for gfp in pFPV25.1. Therefore, E. coli Kl transformed 
with rpsM- (KlrpsM-) does not express GFP . To screen for KlrpsM-, plasmid DNA was 
extracted from the bacteria, and digested with HindII!. The gel photograph shows the 
products generated from HindIII digestion of the extracted rpsM- plasmid DNA. Lanes: 1, 
1 kb DNA ladder; 2, pFPV25.1 digested with HindIII (5390 bp); 3, undigested rpsM 
extracted from transformed E. coli DH5a (cloning strain); 4, rpsM extracted from E. coli 
DH5a digested with HindIII (4786 bp) ; 5, undigested rpsM extracted from transformed E. 
coli Kl ; 6, rpsM extracted from E. coli Kl digested with HindIII (4786 bp). (B) The 
growth kinetics of the transformant in LB broth were compared to the untransformed E. 
coli Kl. The results show the absorbance at 595 run of the bacterial cultures at the time 
intervals indicated. 
3.3.1.4 Construction of pFPV -mCherry and the mCherry-expressing E. coli Kl 
invasion of HBMEC 
Whilst KI-GFP was shown to fluoresce and to retain the bacterial virulence trait in 
HBMEC infection, the major aim of this study was to apply the fluore scent bacterial strain 
for studying the interaction of the bacteria with cellular markers. which the majorit of th 
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available cellular markers containing mammalian expression vectors are also GFP-tagged. 
Therefore, it was of crucial importance to have an E. coli K 1 strain expressing other 
fluorescent proteins, with excitation and emission spectra that did not overlap with GFP, 
but that still retained virulence. 
We chose mCherry as a candidate to test for its known brightness, photostability, 
and distinct excitation and emission spectra from GFP. The cloning strategy was 
performed as illustrated in Figure 3.8. All the transformed E. coli Kl were found to be 
fluorescent when they were screened with a confocal microscope (Figure 3.9A). The 
variability in the fluorescent intensity of the bacteria in Figure 3.9A was due to different 
focal plane of the bacteria when the image was acquired from live bacteria. The growth 
kinetics of the transformed bacteria, KI-Cherry, was slightly lower than Kl (Figure 3.9B), 
the doubling time of KI-Cherry was approximately 36.47 minutes compared to the 
doubling time of K 1, which was 35 minutes in this experiment. 
As with other constructs, to determine the virulence of KI-Cherry, HBMEC 
invasion assays were performed by infecting HBMEC with either E. coli Kl, K-12, Kl-
GFP, KI-Cherry or KlrpsM- (Figure 3.9C). The results indicate that KlrpsM-, and Kl-
GFP exhibit a decrease in HBMEC invasion efficiency, however, the decrease was not 
statistical significant, and they remain significantly more invasive than the non-pathogenic 
E. coli K-12 laboratory strain. In contrast, the invasion efficiency of KI-Cherry was very 
similar to the native Kl (Figure 3.9C). Therefore, mCherry expression seems to have no 
adverse effect on E. coli K 1 virulence. 
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Figure 3.9. Screening of vi rulence E. coli Kl expressing fluorescent protein in 
HBMEC. (A) A confocal micrograph to show fluorescent K I-Cherry. Scale bar: 5 ~m . (B) 
The growth kinetics of the transformant in LB broth were compared to the untransformed 
E. coli K 1. The results show the absorbance at 595 nm of the bacterial cultures at the time 
intervals indicated. (C) To determine the viru lence of the transformed K 1, invasion assays 
were performed by infecting HBMEC with either E. coli KI or K-12 or KI-GFP or KI-
Cherry or K 1 rpsM- at MOl of 100 for 2 hours, followed by incubation in media containing 
gentamicin for 1 hour. The result represents the percentage of bacteria invaded into 
HBMEC. Results are from one representative experiment of two independent repeats 
performed in triplicate and presented as mean of triplicates ± SD. 
3.3.2 Transcytosis of E. coli Kl across HBMEC 
During an infection, it is thought that E. coli K 1 invade and transcytose from the 
endothelial cells of BBB to the CNS and subsequent ly trigger the infiltration of immune 
cells, which results in inflammation of the meninges (Siegel and McCracken. 1981: Kim ef 
01. , 1992; Ze lmer et 0/.,2008). To model the BBB in vitro, HBMEC. \ hich are polarized 
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endothelial cells, were grown on collagen-coated Transwell inserts as illustrated in Figure 
3.10A. Upon complete confluency, tight junction formation was induced by culturing the 
cells in the presence of hydrocortisone (Franke et aI., 2000).The formation of tight 
junctions and the integrity of the HBMEC monolayer were evidenced by an increase in 
transendothelial electrical resistance (TEER) (Figure 3.l0B). When the TEER reading 
reached approximately 20 ncm2, the monolayer'S permeability to 4 kDa FITC-conjugated 
dextran was assessed (Figure 3.1 OC). A small amount of fluorescent signal could be 
detected in the media collected from the basolateral compartment 90 minutes after the 
introduction of the FITC-conjugated dextran to the apical compartment. Howeyer, when 
the HBMEC containing insert was compared with a cell-free insert (empty insert), the 
amount of fluorescent signal detected in media collected from basolateral compartment of 
empty insert was approximately 10-fold higher than that collected from the HBMEC 
containing insert after 90 minutes of incubation (Figure 3.1 OC). 
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Figure 3.10. in vitro blood-brain barrier (BBB) model. (A) An illustrat ion of how the 
BBB in vitro relates to the Transwe ll insert model. (8 ) To determ ine the perm eabi li ty of 
HBMEC, cells were seeded onto a collagen-coated Transwe ll insert. When the ce ll s on the 
Transwell membrane reached complete confluency, the medium was replaced with 
HBMEC growth media containing 1.0 Ilg/ml hydrocorti sone for stimulating the fo rmat ion 
of barrier properties. The transendothelial electrical resistance (TEER) measurements were 
monitored. The graph shows the TEER measurements (Ocm2) throughout the culture 
duration. Results are one representative experiment of 4 independent repeats performed in 
triplicate and presented as mean of triplicates ± SO. (C) To demonstrate the barrier 
properties of HBMEC cultured on Transwell insert on day 9, 4 kDa FITC-conjugated 
dextran (0 .1 mg/ml) (Sigma-Aldrich) was added to the apical chamber of ce ll s. After 
addition of the reagent, medium was sampled at the indicated time intervals. The 
permeability was quantified as fluorescence intensity of the FITC that passed from the 
apical chamber to the basolateral chamber. 
Although FITC-conjugated dextran transportation through HB MEC monolaye r was 
reduced, the TEER of the HBMEC line used in this study was lower than the reported 
TEER for other immortalized HBMEC, HCMECID3, which ranged fro m 60 to 80 Oem 2 
(Weksler et aI. , 2005 ; Cucullo ef ai. , 2008). To confirm that the HB MEC used in this tudy 
were able to form intercellular junctions, confluent HBMEC were stained for eadherin. a 
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transmembrane protein associated with intercellular junctions. The distribution of the 
staining suggests that the cells are able to form intercellular junctions (Figure 3.11). In 
addition, F -actin staining also revealed cell periphery localization indicative of intercellular 
junction formation (Figure 3.11). 
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Figure 3.11 Immunostaining of cadherin and F-actin of HBMEC. Confluent 
monolayers of HBMEC cells (passage 15) were fixed with either 2% (v/v) formaldehyde 
(F-actin) or methanol (cadherin), immunostained for cadherin with mouse anti -pan 
cad herin, and followed by Fluoprobes 488 conjugated donkey anti-mouse antibody. or 
stained with 30 ~g/ml phalloidin-TRITe. F-actin and cadherin (green) nuclei (blue). Scale 
bar: 20 ~m. 
After confirming the successful production of an integral monolayer of HBMEC on 
the Transwell inserts, a transcytosis assay was performed to study the kinetics of the 
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bacterial traversal of HBMEC. After the TEER reading of HBMEC on Transwell insert 
reached at least 20 Ocm2, cells were infec ted with approximately 1 x 108 cfulml of either 
K 1 or K-12 . Samples of media were taken fro m the basolateral compartment at the 
indicated times, and these were serially diluted before being plated on LB agar plates to 
enable bacterial growth and quantification. K1 were detected in the basolateral 
compartment at 8 hours post-infection (Figure 3.12), while K-1 2 were absent at all the time 
intervals studied. These results clearly demonstrate that the non-pathogenic E. coli K -12 
are unable to traverse HBMEC, while E. coli K 1 are able to invade and subsequently 
traverse HBMEC. 
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Figure 3.12. Transcytosis of E. coli Kl and K-12 through HBMEC. To study the 
bacterial transcytosis kinetics, HBMEC on Transwell membranes were incubated with 
approximately 1 x 108 cfu/ml of either E. coli K 1 or K-12. Media were sampled from the 
basolateral chamber at the indicated time intervals. The result represents the percentages of 
bacteria traversed through HBMEC. Results are from one representati ve experiment of 
three independent repeats performed in triplicate and presented as mean of triplicates ± SD. 
3.3.2.1 KI-Cherry transcytosis of HBMEC 
Although K I-Cherry had been shown to retain the ability to invade HBMEC at the 
similar efficiency as the native KI (Figure 3.9), the transformed bacteri a further had to 
retain the ability to traverse an HBMEC monolayer grown on Transwell fi lter inserts . To 
determine whether the mCherry expression affected the abili ty of K 1 to traverse HBMEC. 
a transcytosis assay was perfoffi1ed by co-infecting HBMEC cultured on Transvvell filter 
1 15 
inserts with either E. coli K1 and K-12, or K1-Cherry and K-12 (Figure 3.13). As shown in 
Figure 3.12, K -12 did not traverse HBMEC monolayer on Transwell insert, therefore, K -12 
were used as an indicator of the monolayer's integrity, and K-12 could be differe!1tiated 
from K1 or K1-Cherry by the distinct small dark pink colony on MacConkey agar. while 
K1 and K1-Cherry appear as big white or light pink colony on MacConkey agar. 
HBMEC mono layers on Transwell filter inserts were incubated with approximately 
1 x 108 cfulml of each bacterial strain. Media from the basolateral compartment was 
collected at various time intervals, and the serially diluted specimens were plated on 
MacConkey agar. At 8 hours, E. coli K1 was detected in the basolateral compartment, and 
the percentages of the bacteria that traversed the HBMEC monolayer increased 
significantly from 0.250/0 at 8 hours to 77.42% at 12 hours post-infection (Figure 3.13A). 
The absence of E. coli K-12 at both intervals indicated that the HBMEC monolayer 
remained intact during the infection. In contrast, during K1-Cherry co-infection with K-I2, 
K-12 were detected in the basolateral compartment after 12 hours (Figure 3.13B). The 
percentages of K1-Cherry traversed HBMEC were 0.54% at 8 hours and increased to 40% 
after 12 hours infection. 
In conclusion, although K I-Cherry was able to invade HBMEC as efficiently as 
native K1, K1-Cherry affects HBMEC monolayer integrity, possibly by deforming the 
intercellular tight junctions. Therefore, K1-Cherry was suitable for further imaging 
experiments but not as appropriate for bacterial transcytosis studies. 
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Figure 3.13. Transcytosis of E. coli K1 expressing mCherry through HBMEC. To 
determine the virulence of the K I-Cherry, transcytosis assays were performed by 
incubating HBMEC with either KI and K-I2 (A) or KI-Cherry and K-12 (8) with 
approximately 1 x 108 cfulml of each bacterial strain. At the time intervals indicated, media 
were sampled, and plated on MacConkey agar. The results represent the percentages of 
bacteria traversed through HBMEC. Results are from one representative experiment of two 
independent repeats performed in triplicate and presented as mean of triplicates ± SD . 
3.4 Discussion 
The major objective of this study was to construct a fluorescent E. coli K 1 strain 
that retains the bacterial virulence trait. To assess the virulence of the fluorescent bacterial 
strains, an Acanthamoeba phagocytosis assay and HBMEC invasion assay were initiall 
employed (data not shown). After various attempts, one of the constructs. pFP 25 .1. 
which contains E. coli codon-optimised gfp gene fused downstream of a S. T}phimuriulJI 
promoter, rpsM, retained bacterial invasiveness. Interesti ngly. the replac m nt of gfp g n 
11 7 
with a mammalian codon optimised mCherry gene in pFPV25.1 seemed to ha\'e no 
detrimental effect on the bacterial invasiveness, although the intracellular gro\\1h of Kl-
Cherry in comparison to untransformed K 1 is not known. 
To enable the application of confocal microscopy imaging for studying E. coli Kl 
interactions with various cellular markers, particularly as the majority of the available 
mammalian expression constructs encode GFP chimaeric proteins, an E. coli Kl strain 
expressing mCherry was constructed. mCherry was chosen for the fluorescent protein's 
photostability and brightness (Shaner et aI., 2005). Further, mCherry is expressed as a 
monomer, which avoids the potential formation of toxic aggregates in the bacteria as 
observed in some dimeric or tetrameric fluorescent proteins, such as DsRed, and tdTomato 
(Shaner et aI., 2004; Shaner et aI., 2005). mCherry also offers a potential advantage over 
other fluorescent proteins, as mCherry expression and fluorescence in M tuberculosis was 
not affected by hypoxic conditions (Carroll et al., 2010). The long excitation wavelength of 
mCherry also reduces the phototoxicity effect on live cells, and allows live-cell imaging of 
the infection (Tsien, 1998). Furthermore, mCherry-expressing E. coli Kl also provide a 
tool for future deep tissue in vivo imaging experiments, as the long excitation wavelength 
is able to penetrate tissue efficiently (Carroll et al., 2010). 
Previously, an E. coli Kl strain expressing GFP was used to study bacterial 
interaction with vimentin in HBMEC, but the authors did not demonstrate the virulence of 
the transformed strain (Chi et al., 2010). Several studies have shown that the production of 
fluorescent protein and/or the presence of plasmid DNA in Salmonella enterica abrogates 
bacterial virulence in both epithelial and macrophage cell lines as well as in vivo (Knodler 
et aI., 2005; Clark et aI., 2009). In this study, although the growth kinetics of the 
fluorescent protein-expressing bacteria are slightly lower than the growth kinetics of the 
nati ve E. coli K 1, we found no evidence of correlation in the abrogation of the bacterial 
virulence and fluorescent protein expression. as bacteria harbouring a promoterless 
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plasmid DNA, which did not express fluorescent protein, also demonstrated a marginally 
decreased efficiency in HBMEC invasion. The reduction in the bacterial HBMEC invasion 
efficiency could be due to the metabolic burden caused by harbouring extra copies of 
plasmid in the bacteria. Interestingly, we found that expression of a mammalian codon 
optimised mCherry under the control of a Salmonella promoter, rpsM, did not affect the 
bacterial invasiveness. In fact, the bacteria invaded HBMEC as efficiently as the native 
bacteria; whereas a decrease in invasion efficiency was observed for E. coli Kl expressing 
an E. coli-codon optimised GFP under the control of rpsM (pFPV25.1). 
Although we showed that mammalian codon-optimised mCherry did not affect the 
reporter's expression as well as virulence trait in E. coli K 1, one of our preliminary data 
additionally observed that expression of Mycobacterium sp. (GC-rich organism) codon-
optimised fluorescent proteins in both E. coli Kl and non-pathogenic E. coli K-12 affected 
the bacterial growth kinetics (data not shown). These fluorescent E. coli K 1 strains further 
demonstrated distinct levels of virulence in two different cell types, in which the bacteria 
were able to infect and to survive in Acanthamoeba, which is an active phagocytic cell 
(data not shown); while they failed to invade non-phagocytic HBMEC. This observation 
suggests that expression of the Mycobacterium sp. codon-optimised fluorescent proteins in 
E. coli Kl might have affected the expression of a set of bacterial virulence factors, main 
factors essential for HBMEC invasion, but probably not the factors that are required for the 
bacterial intracellular survival. In order to further understand the effects of the expression 
of Mycobacterium sp. codon-optimised fluorescent proteins on the bacterial virulence 
factors expression, it would be important to study the expression and the form variations of 
the bacterial polysialic Kl capsule in both native and transformed bacterial strains, as well 
as the expression of some of the known bacterial virulence factors that are required for the 
bacteria adhesion and invasion of HBMEC, such as Type 1 fimbriae, OmpA, and Cnfl. 
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Additionally, several lines of evidence have demonstrated that the presence of a 
tetracycline resistance gene (tet), or chloramphenicol resistance gene (CmR), on a cloning 
vector might have an adverse effect on Salmonella survival in macrophages, and could 
impair the bacterial invasiveness of epithelial cells (Abromaitis et ai., 2005; Clark ef at.. 
2009). However, Clark et al. (2009) further demonstrated that the DNA copy number 
determined the outcome of fluorescent reporter expression in Salmonella virulence by 
showing that chromosomally-encoded GFP, also carrying a CmR gene, did not affect 
Salmonella invasion. In this study, there was no direct evidence on the correlation of gene 
copy number and the transformed bacterial virulence. but plasmid copy number might 
contribute to the loss of virulent traits in transformed E. coli K 1 which would need to be 
tested against chromosomal integration. However, the major hindrance for stably 
integrating fluorescent protein gene into the E. coli K1 genome is the lack of access to the 
bacterial genome data in public databases, although the findings from the sequencing 
projects have been published (Xie et ai., 2006). 
Another risk of having a bacterial strain harbouring a fluorescent reporter construct 
is the stability of the construct in the bacteria. It was shown that plasmids expressing 
fluorescent proteins from the Mycobacterium bovis hsp60 promoter were unstable in 
Mycobacterium smegmatis (Carroll et al., 2010). In this study, it was observed that all K1-
Cherry expressed mCherry when the bacteria were cultured for 2 hours without antibiotic 
selection (data not shown) and upon cell infection (see Chapter 6), bacteria maintained 
fluorescence for 20 hours or more without antibiotic selection, which suggested that the 
pFPV-mCherry construct was stably maintained in K1-Cherry. 
In this study, the HBMEC demonstrated lower TEER than the TEER reported by 
Stins et al. (2001), as well as the TEER measurement for other immortalized HBMEC, 
HCMEC/D3, which ranged from 60 to 80 ncm2 (Weksler et at.. 2005; Cucullo et ai., 
2008). The low TEER detected in our system might indicate an inability of these cells to 
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form a tight monolayer on the Transwell® membrane. Alternatively, the low TEER might 
be caused by the presence of FBS in the medium during TEER measurement. It has been 
previously reported that primary brain endothelial cells (PBEC) were less permeable to 
sucrose under FBS-free condition, and it was also evidenced by an increase in the TEER 
reading in that experimental condition (Franke et aI., 2000). It was also speculated that the 
content of growth factors in the growth medium used for cell maintainence might also 
affect the tight junctional proteins expression of these cells, hence, different TEER was 
observed from Stins et al. (2001). The reduction in FITC-dextran and the non-invasive E. 
coli K -12 translocation in transwells with hydrocortisone-stimulated HBM~C, in 
combination with the distribution of cadherin and actin suggest that the cells are capable of 
forming intercellular interactions. However, the expression of several other major tight 
junctional proteins, such as claudin-5, occludin, ZO-1, and JAM-A, need to be studied, to 
further characterize the tight junction phenotype of the HBMEC. 
Despite the low TEER of the HBMEC on Transwell, it was demonstrated that E. 
coli K1, but not non-pathogenic E. coli K-12, could traverse HBMEC monolayer cultured 
on Transwell insert (Figure 3.12). The result from this study also confirmed the published 
result by Stins et al. 2001, whereby we demonstrated that the HBMEC monolayer on 
Transwell insert remained intact during the bacterial infection, as E. coli K-12 was absent 
in the basolateral compartment of the Transwell filter insert when co-infection of both E. 
coli K1 and K-12 was performed. Although E. coli K1 expressing mCherry (K1-Cherry) 
were shown to retain the ability to invade HBMEC, the presence of non-pathogenic E. coli 
K-12 in the basolateral compartment at late time point of KI-Cherry and K-12 co-infection 
of the HBMEC monolayer on Transwell filter insert might suggest the leakage of the 
monolayer. Immunofluorescent staining of the K1-Cherry infected HBMEC on Transwell 
membrane with either fluorophore conjugated-phalloidin (for F-actin) or specific tight 
junction antibodies, such as occludin, and claudin 5, might be able to confirm the obseryed 
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results. F-actin co-localizes with tight junction proteins in intact polarized epithelium and 
endothelium, and the staining also allows detection of the presence of an intercellular gap, 
which is an indicator of permeable tissue monolayer (Martins-Green et al.. 2008). It might 
also be interesting to study the bacterial factors that are affected by the fluorescent protein 
expression, which led to the change in bacterial virulence and disruption of HBMEC 
monolayer integrity during infection. 
The negative effect of the KI-Cherry on the HBMEC monolayer in the Transwell 
insert was a disappointing discovery. Despite this effect, the fluorescent bacteria were still 
considered to be a useful tool for studying HBMEC invasion in this study. Alternative 
approaches include the application ofPKIA-GFP and E. coli Kl specific antibody to label 
the bacteria along with antibodies to cellular markers; however, these methods come with 
their own caveats. Essentially, access to E. coli K I-specific and certain cell marker 
antibodies was limited; as such GFP-tagged cellular markers were the primary tool for 
studying intracellular markers that E. coli Kl may interact with. Although an alternative 
non-antibody E. coli Kl probe, the endosialidase-GFP probe (PKIA-GFP), was available. 
the application of this probe in studying the bacteria interaction with various GFP-tagged 
cellular markers would require changing the GFP tag of the cellular proteins to red 
fluorescent protein (RFP), which frequently changes the conformation of cytosolic protein 
(Ward, T., personal communication), and the functionality of each construct would thus 
need to be validated before use. Also, the application of PKIA-GFP and E. coli Kl-
specific antibody for the bacterial staining only works in fixed tissue, but fixation (as well 
as the application of detergent for cell permeabilization) of GFP-tagged cytosolic and 
membrane proteins often results with redistribution of the proteins (Tanaka et al.. 2010; 
Schnell et al., 2012). On the other hand, labelling of the bacteria with fluorescent dye was 
not considered, as one of the preliminary data showed that FITC-labelled, and the labelling 
buffer-exposed E. coli K 1 demonstrated lower invasion of HBMEC than that of untreated 
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E. coli Kl (data not shown). Similar observation was made in Mycobacterium tuberculosis 
study (Schaible, U., personal communication). Therefore, the availability of KI-Cherry 
allows live-cell imaging of infected HBMEC overexpressing GFP-tagged cellular markers. 
Although some caution is needed with the results obtained from this system, important 
results could be further verified with the use of untransformed bacteria in a fixed tissue 
system if time and antibody availability allowed. 
In conclusion, the level of bacterial virulence can be affected by the presence of 
plasmids, and cytoplasmic production of fluorescent proteins. An mCherry-expressing E. 
coli Kl strain that retains bacterial invasiveness was successfully constructed in this study 
and this can therefore be used in future live-cell imaging experiments for studying the 
bacterial invasion of HBMEC. 
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4. Optimization of HBMEC transfection efficiency 
4.1 Introduction 
Genetic materials (such as DNA, RNA, and siRNA) can be delivered into 
eukaryotic cell via chemical, lipid, physical, or viral vector-mediated methods (Kingston, 
2001). The availability of these gene delivery technologies allows the study of a gene 
function and expression in a cell (Hawley-Nelson et aI., 2008). The technology also allows 
production of correctly folded protein, especially for proteins that require special post-
translational modification, such as glycoprotein, for structural studies or as a therapeutic or 
diagnostic agent (Chan et aI., 2002; Bowden et a/., 2008). 
Viral vectors, such as retroviral, adenoviral, and baculoviral systems, usually give 
promising cell transduction efficiency (Kingston, 2001). However, for infection study, the 
major concern with this transfection approach is the potential cellular changes resulting 
from viral vector-uptake on bacterial infection of the transduced cells. 
Several common non-viral vector transfection approaches, such as calcium 
phosphate transfection, liposome-mediated transfection, and electroporation, offer 
alternative approaches for introducing genetic material into mammalian cells. For calcium 
phosphate-, and liposome-mediated transfection, negatively charged DNA is bound to the 
positively charged surface of calcium, or cationic lipid. Following the attachment of 
calcium-DNA or lipid-DNA complexes on the cell surface, uptake of the complex is 
triggered via uncharacterized pathways (Kingston, 2001; Kingston et aI., 2003; Hawley-
Nelson et aI., 2008). 
Electroporation uses an electric field to open up micro-sized pores transiently in the 
plasma membrane to allow diffusion of macromolecules, such as DNA, into the cells. This 
approach is applicable to all cell types under optimized experimental settings (Potter, 
2003). In the past decade, eukaryotic cell electroporation (particularly specific 'difficult' or 
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pnmary cell types) has been further improved by the introduction of Nucleofection 
technology (Lonza, Germany), which involves electroporating cells under optimized 
electroporation conditions in special proprietary buffers. The technology offers greatly 
improved transfection efficiency and cell viability to various generic cell lines and primary 
cells. Endothelial cells, which are notoriously difficult to transfect, have also benefited 
from this technology (Doulet et aI., 2006; Lui-Roberts et aI., 2008; Kang et aI., 2009). 
In previous studies, Lipofectamine™ 2000 was used for transfecting plasmid DNA 
into HBMEC, and transfected cells were treated with antibiotic for stable clone selection 
(Khan et al., 2002; Sukumaran and Prasadarao, 2002; Sukumaran et aI., 2002; Rudrabhatla 
et aI., 2006). Although stable transfection offers 100% of the selected cells expressing the 
exogenous protein of interest, the efficiency of the gene incorporation into the genome is 
low, and typically require 2 - 3 months to generate a stable cell line. One part of this study 
involved the application of a collection of GFP tagged cellular markers and their mutant 
forms to screen for their effects on E. coli Kl invasion and intracellular survival in 
HBMEC. Hence, it is practically unfeasible to generate stable cell lines for all constructs 
used within the limited time of this study. Further, the majority of constructs used code for 
peripheral membrane proteins (for example Rab GTPases), which are poorly expressed in 
stable cells (Ward, personal communication). Therefore, a transient transfection protocol 
that provides high transfection efficiency is required for this study. 
4.2 Objectives and aims 
The aim of this chapter was to optimise HBMEC transfection efficiency, with the 
specific objectives being: 
• To optimise nucleofection parameters with Amaxa® Nucleofector® Kit. 
• To optimise HBMEC transfection efficiency with different liposomal and non-
liposomal based transfection reagents. 
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4.3 Results 
4.3.1 Plasmid DNA transfection with Amaxa Nucleofection kit 
Using human umbilical vein endothelial cells (HUVEC) specific Am ax a 
Nucleofection kit, plasmid DNA transfection rate up to 70% and siRNA transfection rate 
of 90% have been achieved for HUVEC (Cutler, personal communication; Lui-Roberts et 
aI., 2008). As recommended by the Cutler lab (MRC Laboratory for Molecular Cell 
Biology, UCL, London), two Amaxa Nucleofection kits, namely HUVEC Nucleofector® 
Kit-OLD (Old) and Amaxa® HUVEC Nucleofector® Kit (New), were tested for plasmid 
DNA nucleofection into HBMEC. For pmaxGFP nucleofection performed with New, two 
alternative nucleofection programs, U-OOI and A-034, were applied as suggested by the 
manufacturer. GFP expression was screened with a confocal microscope at 24 and 48 
hours post-nucleofection. The number of GFP-expressing cells and total number of cells in 
phase images were counted manually, and transfection efficiency was expressed as the 
percentage of GFP-expressing cells (Figure 4.1). At 24 and 48 hours post-nucleofection, 
the transfection efficiency was less than 20% for nucleofection performed with both kits 
(Figure 4.1A). Although nucleofection performed with New by applying program A-034 
(New/A-034) gave lower transfection efficiency than the transfection efficiency for 
nucleofection performed with either Old, or with New by applying program U-OOI 
(New/U-001), more cells were attached to coverslips, and fewer rounded cells were 
observed (data not shown). Therefore, nucleofection with New/ A-034 was chosen for 
further optimizing nucleofection conditions by altering concentration of pmaxGFP (Figure 
4.1 B). HBMEC nucleofection with 5/lg plasmid DNA successfully brought up the 
transfection efficiency to approximately a fold higher than the transfection efficiency for 
nucleofection with 2/lg of plasmid DNA, although no difference was observed in the 
transfection efficiency at both time points. 
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Figure 4.1. Optimization of HBMEC transfection with Amaxa Nucleofector kit. (A) 
To optimize plasmid DNA nucleofection of HBMEC, HBMEC were nucleofected with 2 
!J.g pmaxGFP by either HUVEC Nucleofector® Kit-OLD (program U-OOl) (Old) or 
Amaxa® HUVEC Nucleofector® Kit [program U-OOI (NewlU-OOl) or A-034 (New/A-
034)]. pmaxGFP expression was assessed and imaged with a confocal microscope 24 and 
48 hours after nucleofection. Transfection efficiency is expressed as a percentage of 
maxGFP-expressing cells over total number of cells. Results are from one experiment. (B) 
Optimization of New/ A-034 was performed by nucleofecting HBMEC with either 2 !J.g or 
5 !J.g pmaxGFP, and transfection efficiency was assessed after 24 and 48 hours. 
Transfection efficiency is expressed as a percentage of maxGFP-expressing cells over total 
number of cells. Results are from one experiment. 
Nucleofection with PBS was tried as described by Kang et al. (2009), which 
claimed high transfection efficiency in arterial and venous endothelial cells, but resulted 
with no transfected cells. The cost of a nucleofection kit is high, but the transfection 
efficiency of HBMEC was generally unsatisfactory with no more than 800/0 efficiency 
which would be very difficult for screening purposes, hence alternative transfection 
reagents were tried. 
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4.3.2 Plasmid DNA transfection with liposomal- and non-liposomal-based transfection 
reagents 
In the majority of previous studies, Lipofectamine™ has been widely used for 
transfecting plasmid DNA into HBMEC (Reddy et al., 2000a; Sukumaran et al., 2002; 
Prasadarao et al., 2003; Sissons et al., 2005). Therefore, different transfection conditions 
with Lipofectamine ™ L TX was applied to HBMEC with different concentrations of pN 1-
EGFP with or without PLUS reagent in Opti-MEM® reduced serum medium. To avoid 
experimental bias, tiled images were acquired with a confocal microscope 24 and 48 hours 
post-transfection. The number of GFP-expressing cells and total number of cells in phase 
images were counted manually, and transfection efficiency was expressed as the 
percentage of GFP-expressing cells (Figure 4.2). There was no difference observed in the 
transfection efficiency between 500 ng and 1000 ng of plasmid DNA used at both time 
points. However, the application of PLUS reagent in transfection reactions improved the 
transfection efficiency by at least a fold for both plasmid DNA concentration at both time 
points. The results show that plasmid DNA can be transfected into HBMEC by 
Lipofectamine™ LTX, and the transfection efficiency is improved by PLUS reagent to 
approximately 30%, although this level of transfection efficiency was still unsatisfactory 
for screening purposes. 
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Figure 4.2. The effect of PLUS reagent on HBMEC transfection efficiency. To 
optimize plasmid DNA transfection of HBMEC with Lipofectamine™ L TX, HBMEC 
were incubated with either 500 ng or 1000 ng ofpN1-EGFP-lipid complex in the presence 
or absence of PLUS reagent. EGFP expression was assessed and tile images were taken 
with a confocal microscope 24 and 48 hours after transfection. Transfection efficiency is 
expressed as a percentage of EGFP-expressing cells over total number of cells. The results 
represent the percentage of EGFP-positive HBMEC. Results are from one experiment. 
In the attempt to optimize HBMEC transfection efficiency, various lipid-based and 
cationic polymers proprietary transfection reagents were applied for transfecting pN 1-
EGFP into HBMEC (Figure 4.3A). 24 hours post-transfection, the general transfection 
efficiency for all transfection reagents was below 30%, and the lowest transfection 
efficiency, below 10%, was obtained for transfection performed with FuGENE® HD. 
However, for transfection performed with jetPRIME™, HBMEC transfection efficiency 
was increased significantly to approximately 50% when 1 Ilg of plasmid DNA and 2 III of 
jetPRIME™ were employed (Figure 4.3A). Western blotting confirmed an increase in the 
GFP protein levels for transfection performed with 1 Ilg of plasmid DNA and 2 III of 
jetPRIME ™ compared to the other transfection methods (Figure 4.3B). Some rounded 
cells, presumably dead cells, were frequently observed (data not shown). In conclusion, 
HBMEC transient transfection efficiency was significantly improved by increasing 
plasmid DNA concentration and volume ofjetPRIME™ in the transfection mixture. 
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Figure 4.3. Optimization of HBMEC transfection using different transfection 
reagents. (A) HBMEC cells were transfected with pN l-EGFP using different 
transfectants . LPF, Li?ofectamine ™ L TX and PLUS ™ reagent with 0.5 Il g ~lasmid DNA; 
jPrl , 1 III jetPRIME M with 0.5 Ilg plasmid DNA; jPr2, 2 III jetPRIME M with 1 Ilg 
plasmid DNA; jPEI, jetPEI™ with 1 Ilg plasmid DNA; jPEI-H, jetPEI™-HUVEC with 2 
Ilg plasmid DNA; FG, FuGENE® HD with 0.5 Ilg plasmid DNA. 24 hours post-
transfection, GFP expression was assessed by acquiring tiled images with a confocal 
microscope. Transfection efficiency is expressed as a percentage of EGFP-expressing cells 
over total number of cells. Results are representative of two independent experiments 
performed in duplicate and presented as mean ± standard deviation. Statistical significance 
was evaluated with analysis of variance and Newman-Keuls post hoc analysis . (8) Total 
GFP protein in the transfected cell lysate was determined by Westen blotting analysis , 
lanes equivalent to chart above. 
4.4 Discussion 
This study showed that HBMEC can be transfected with plasmid DNA using a 
Nucleofection kit, although the transfection efficiency was unsatisfactory for screening 
purposes. It was possibly due to the differences between HUVEC and HBMEC as studies 
have reported the heterogeneity of different endothelial cells (Swerlick et al., 1992; 
Salcedo et aI. , 2000; Man et al. , 2008), and the heterogeneity of microvascular endoth li al 
cells isolated from different anatomical sites (lnvemici et aI., 2005; Lu et a/.. 2007). 
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Hence, the optimized HUVEC nucleofection condition might not be suitable for HB::V1EC 
nucleofection, and the HBMEC nucleofection conditions would need extensiye 
optimization. 
As the cost for a nucleofection kit is high, but with low efficiency, alte~ative 
transfection reagents were explored. Plasmid DNA could be transfected into HBMEC by 
Lipofectamine™ LTX, and the transfection efficiency was improved by pre-complexing 
plasmid DNA with PLUS reagent before the addition of Lipofectamine™ reagent. The best 
transfection efficiency obtained from transfection performed with liposomal-based 
transfection reagents (Lipofectamine ™ L TX, and FuGENE® HD) was approximately 
30%. In addition to liposomal-based transfection reagents, cationic polymer (non-
liposomal) transfection reagents, including jetPRIME™, jetPEI™, and jetPEI™_HUVEC, 
were applied. Among these transfection reagents, HBMEC transfection efficiency was 
significantly increased to approximately 50% by altering plasmid DNA : jetPRIME™ 
ratios. As observed with HUVEC specific Amaxa Nucleofection kits, the HBMEC 
transfection efficiency achieved with HUVEC specific jetPEI, jetPEFM-HUVEC, was less 
satisfactory, probably due to the differences between HUVEC and HBMEC, as discussed 
above. Despite the significant improvement in the HBMEC transfection efficiency as 
observed from EGFP expression in pNI-EGFP transfection with jetPRIME™, the 
transfection efficiency was found to vary for different recombinant constructs used later in 
the study, presumably due to effects of exogenous protein expression in cells. 
V iral vectors offer another approach for introducing genetic materials into cells 
with generally high transduction efficiency. Most of these viral vectors enter into cells via 
a receptor-specific endocytic pathway, and some of these vectors, especially those 
originated from retroviruses, stably integrate the transferred gene into the genome of the 
transduced cells (Ramezani and Hawley, 2002; Lindemann and Schnittler, 2009). In 
general, viral vector transduction yields high transduction efficiency in most cell lines: 
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however, the transduction efficiency for endothelial cells vanes from 40 - 90% 
(Shichinohe et aI., 2001; Cefai et aI., 2005; Anliker et aI., 2010). Interestingly, Anliker ef 
al. (2010) constructed measles viral haemagglutinin-pseudotyped lentiviral vectors based 
on single-chain antibodies recognizing cell-surface antigens, which specifically targeted 
endothelial cells via CD 1 OS, a transmembrane glycoprotein predominantly expressed on 
endothelial cells (F onsatti and Maio, 2004). The CD lOS-targeted viral vector resulted in 
transduction efficiency of HUVEC of approximately 80%, while the transduction 
efficiency of human dermal microvascular endothelial cells (HDMEC) was 60.5% (Anliker 
et aI., 2010). This finding further demonstrated the differences of HUVEC from other 
sources of endothelial cells. Despite the endothelial cells variations, pseudotyped lentiviral 
vectors might be useful in improving HBMEC transfection efficiency. The major concern 
for this approach is the triggering of inflammatory responses after exposing the cells with 
viral vectors, which might affect the transduced cells responses to E. coli K 1 infection. 
Although common routine transfection methods are used for in vitro studies, 
researchers in the field of drug or gene delivery have strong interests in developing non-
viral-based nano-sized delivery vehicles for efficient delivery into vessels and blood-brain 
barrier endothelial cells (Dufes et aI., 2004; Zhang et aI., 2009; Georgieva et aI., 2011; Liu 
et aI., 2011). In the efforts of developing delivery vehicles, various transfection methods 
have been developed, such as a peptide based delivery system targeting caveolae-mediated 
endocytosis (Liu et aI., 2011), glucose-bearing delivery vesicle (Dufes et aI., 2004), and 
DNA intercalating conjugates with a short nuclear localization signal (NLS) peptide 
(Zhang et aI., 2009). However, the transfection efficiency of these alternative vectors 
remains unsatisfactory for clinical treatment. 
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5. E. coli Kl invasion of human brain microvascular endothelial cells via 
a caveolae-, flotillin 1-, and dynamin-independent pathway 
5.1 Introduction 
Phagocytosis IS a process that involves internalization of large particles into 
specialized cells such as phagocytic protozoa, and phagocytic leukocytes of the immune 
system. It functions to clear pathogens, such as bacteria or yeast, apoptotic cells, and cell 
debris (Conner. and Schmid, 2003), although some pathogens can piggyback on the 
phagocytic process and then create a propagatory intracellular niche. The process is an 
active and regulated process involving specific cell surface receptors and signalling 
cascades that regulate actin cytoskeleton rearrangement (Conner and Schmid, 2003; 
Kumari et al., 2010). 
As with phagocytic cells, non-phagocytic cells are able to take up fluid and small 
molecules via pinocytosis, such as clathrin-mediated endocytosis, caveolae-mediated 
endocytosis, and flotillin-mediated endocytosis, which are classified by the requirement of 
dynamin during vesicle scission at the plasma membrane (Conner and Schmid, 2003; 
Doherty and McMahon, 2009). Pathogenic bacteria have also been demonstrated to gain 
entry into non-phagocytic cells via these endocytic pathways, in addition to the classical 
classification of bacterial entry based on trigger and zipper mechanisms (Finlay and 
Cossart, 1997; Cossart and Sansonetti, 2004). It was found that endocytic coats and 
accessory proteins are recruited during bacterial invasion of non-phagocytic cells via 
zipper mechanism, but are not recruited to those bacteria, such as Salmonella erzterica 
Typhimurium, and Shigella, which trigger host entry by injecting bacterial effectors and 
lead to actin cytoskeleton rearrangement (Veiga et al., 2007). The requirement of dynamin 
and examples of pathogens that utilise specific endocytic pathways for cell entry are 
summarized in Table 1.1. 
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Dynamin is a 100 kDa GTPase, which is able to fonn helical tubes on lipid 
nanotubes in vitro (Sweitzer and Hinshaw, 1998: Stowell et al., 1999). and assemble at the 
neck of an endocytic vesicle for vesicle scission (Iversen et al., 2003). In mammalian cells, 
there are three closely related dynamin isofonns identified. Dynamin 1 (Dyn 1) is found 
specifically in neuronal tissue (Scaife and Margolis, 1990; Sontag et al., 1994). and there 
are eight splice variants identified (Cao et al., 1998); whereas dynamin 2 (Dyn2), which 
has four splice variants, is ubiquitously expressed (Nakata et al., 1993; Cook et al., 1994: 
Sontag et al., 1994; Cao et al., 1998). Dynamin 3 (Dyn3) is expressed predominantly in 
testes, brain, lung and heart, and has 13 splice variants (Nakata et al., 1993; Cao et al., 
1998). It was shown that each splice variant of dynamin isofonns is targeted to distinct 
cellular locations in Clone 9 cells, a nonnal rat hepatocyte cell line (Cao et al., 1998), and 
has different endocytic functions (Cao et al., 2007). Interestingly, the functions of Dyn 1 
and Dyn2 are indistinguishable in non-polarized epitheloid cell line, HeLa; however, in 
polarized epithelial cell lines, such as MDCK, both dynamins have distinct endocytic 
functions at the different membrane surfaces (Altschuler et al., 1998). The role of dynamin 
in endocytosis is often studied using either the chemical inhibitor Dynasore or 
overexpressing a mutant fonn of the dynamin protein. Overexpression of the K44A or 
S45N mutant, which demonstrates weak guanosine triphosphate (GTP) affinity in vitro and 
thus unable to release the endocytic vesicle from the plasma membrane, is sufficient to 
inhibit transferrin uptake via clathrin-mediated endocytosis as well as SV 40 uptake via 
caveolae-mediated endocytosis (Marks et al., 2001; Pelkmans et al., 2002; Ferguson and 
De Camilli, 2012). 
Caveolin-l IS a major protein In caveolae, and it has two isofonns, r:amely 
caveolin-l a (full length caveolin-l) and caveolin-l ~ (Parton and Simons, 2007: Parat, 
2009). Caveolin-l ~ is a product of alternate translation, and it lacks 31 amino acids found 
at the N-terminal of caveolin-la (Parat, 2009). It has also been proposed that caveolin-l ~ 
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is unable to form caveolae in the absence of caveolin-1a (Fujimoto et al., 2000). Caveolin-
1 is inserted into plasma membrane lipid bilayers in a wedge-like manner, with its N- and 
C-termini in the cytoplasm (Figure 1.6) (Parton, 2003). The protein is palmitoylated at the 
cysteine residue 133, 143, and 156 at the C termini (Dietzen et al., 1995), which has been 
shown to be essential for cholesterol binding and chaperone complex formation for 
cholesterol transportation to caveolae, but it is not required for caveolin-1 localization to 
caveolae (Dietzen et al., 1995; Uittenbogaard and Smart, 2000). The tyrosine residue 14 of 
caveolin-1 is phosphorylated by cellular Src tyrosine kinase (Li et al., 1996). Abrogation of 
caveolin-1 phosphorylation by mutating this tyrosine residue to phenylalanine (Cav1 
Y14F) might block the downstream effectors, and thus inhibits albumin uptake in rat lung 
microvascular endothelial cells (RLMEC) via caveolae-mediated endocytosis (Hu et aI., 
2006). Expression of Cav1 Y14F mutant in caveolin-1 knockout cells also inhibited raft 
internalization although caveolae was formed on the plasma membrane, suggesting that the 
non-phosphorylatable caveolin-1 mutant is still recruited to the plasma membrane, but 
defective in inteinalisation (del Pozo et aI., 2005). As such, Cay Y14F mutant provides a 
useful tool in studying caveolin-mediated endocytosis. 
In addition to clathrin-mediated endocytosis, which requires dynamin for vesicle 
scission from the plasma membrane, dynamin has also been implicated in caveolae-
mediated endocytosis, whereby overexpression of GDP-locked dynamin K44A mutant 
inhibits caveolar budding and cholera toxin B (a ligand used for studying caveolae-
mediated endocytosis) uptake in fibroblasts and endothelial cells (Oh et al., 1998; Shajahan 
et al., 2004; Yao et al., 2005). The tyrosine residue 231 and 596 of Dyn2 are required for 
caveolin-1 binding; however, only overexpression of non-phosphorylatable Dyn2 Y597F 
mutant in rat lung microvascular endothelial cells successfully inhibit albumin and cholera 
toxin B uptake to the level observed in cells overexpressing the Dyn2 K44A mutant 
(Shajahan et al., 2004). 
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There are a number of endocytic pathways that are independent of dynamin, 
including flotillin-mediated endocytosis (Glebov et aI., 2006), Arf6-mediated endocytosis 
(Donaldson et aI., 2009), and the CLIC/GEEC endocytosis pathway (Kumari et aI., 2008). 
These endocytic pathways are still not very well-studied and it is unclear how membrane 
scission on the plasma membrane occurs in these pathways in the absence of dynamin. 
E. coli K1 invasion of HBMEC has been proposed to be receptor-dependent, via 
the zipper mechanism, where actin cytoskeleton rearrangement is induced upon bacterial 
surface antigen attachment to a specific receptor on the host cell surface (Prasadarao et al. , 
1999). Numerous host cell receptors have been identified in parallel with the identification 
of bacterial virulence determinants required for host cell binding and invasion (Pras~darao, 
2002; Chung et aI., 2003; Khan et aI., 2007). Upon E. coli K1 binding to a cell receptor on 
HBMEC surface, a cascade of signalling molecules as detailed in 1.6.1, such as the signal 
transducer and activator of transcription 3 (stat3), focal adhesion kinase (F AK), 
phosphatidylinositol-3-kinase (PI3K), and protein kinase Ca (PKCa), Rho A, are activated 
and results in actin polymerization, which leads to bacterial invasion into HBMEC 
(Prasadarao et aI., 1999; Reddy et aI., 2000a; Reddy et aI., 2000b; Prasadarao, 2002; Khan 
et aI., 2003; Maruvada et aI., 2008). It has been shown that the bacterial invasion of 
HBMEC is c1athrin-independent (Prasadarao et al., 1999), but may be caveolae-mediated 
(Sukumaran et aI., 2002). These authors also showed association of intracellular E. coli K1 
with caveolin-1, and proposed that the caveolin-1 pathway was involved in bacterial 
transcytosis (Sukumaran et aI., 2002). The caveolae-mediated endocytosis pathway is 
thought to be dynamin-dependent in vitro and in vivo (Oh et aI., 1998; Pelkmans' et aI., 
2002; Yao et aI., 2005); however, the role of dynamin and the functional role of endocytic 
pathway during E. coli K1 invasion ofHBMEC is not clear. 
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S.2 Objectives and aims 
The aim of this chapter was to investigate the endocytic pathway used by E. coli Kl 
to invade HBMEC. The specific objectives are: 
• To study the role of dynamin for E. coli Kl invasion of HBMEC. 
• To study the requirement of caveolin-l for E. coli Kl invasion of HBMEC. 
• To study the requirement and the role of flotillin 1 for E. coli K1 invasion of 
HBMEC. 
5.3 Results 
5.3.1 E. coli K1 invasion of HBMEC is dynamin-independent 
The caveolae-mediated endocytic pathway has previously been implicated in E. 
coli K1 invasion of HBMEC (Sukumaran et aI., 2002). The authors also reported 
association of intracellular E. coli K1 with caveolin-1, hence, they proposed that caveolin-
1 was involved in the bacterial transcytosis. However, the authors did not investigate the 
involvement of dynamin, which has been found to be required in vesicle membrane fIssion 
in caveolae-mediated endocytosis both in vitro and in vivo (Oh et aI., 1998; Pelkmans et 
aI., 2002; Shajahan et aI., 2004; Yao et aI., 2005), during E. coli K1 invasion HBMEC. 
Both Dynl and Dyn2 have been implicated in caveolae-mediated endocytosis (Oh 
et aI., 1998;.Pelkmans et aI., 2002; Shajahan et aI., 2004; Yao et aI., 2005), but the 
majority of previous endothelial studies have focussed on Dyn2-dependent endocytic 
mechanisms as this isoform is ubiquitously expressed in mammalian tissues (Cook et aI., 
1994), whereas Dynl is more usually associated with neuronal tissue. Therefore, Dyn2 was 
initially selected to study its role during E. coli K1 invasion of HBMEC. Among the four 
Dyn2 splice variants (Cao et aI., 1998), Dyn2(aa) and Dyn2(ab) have been shown to 
interact directly with caveolin-l in vitro (Yao et aI., 2005), and overexpression of GDP-
locked Dyn2(aa)K44A (also termed dominant negative) mutant has been shown to inhibit 
137 
cholera toxin B internalization into rat fibroblasts and endothelium (Shajahan et al.. 200 .. +: 
Yao et aI., 2005). We hypothesized that overexpression of Dyn2(aa)K44A mutant would 
inhibit E. coli K1 invasion of HBMEC if the bacteria invaded HBMEC via a ca\'eolae-
mediated endocytic pathway. Dynasore, a cell-permeable inhibitor of Dyn1, Dyn2, and 
dynamin-related protein 1 (Drp 1) (Macia et al., 2006), was not applied as HBMEC used in 
this study are sensitive to a lot of chemical inhibitors (Kim, K.S., personal 
communication). 
To study the role of dynamin during the bacterial invasion quantitatively, HBMEC 
were transiently transfected with GFP-tagged Dyn2 chimaera, either wild type or dominant 
negative [Dyn2(aa)K44A GFP]. LDLR A18 GFP, which expressed GFP-tagged recycling-
deficient mutant of the low-density-lipoprotein receptor (LDLR) on the plasma membrane, 
was transfected into HBMEC as a transfection control. After 5 hours incubation of plasmid 
DNA-jetPRIMETM complex with HBMEC, media was removed and replenished with fresh 
media, and further incubated for approximately 16 hours. Cells were infected with K 1-
Cherry for 2 hours, incubated for 1 hour in media containing gentamicin to kill off 
extracellular bacteria and then imaged on the confocal microscope. Tiled z-stack confocal 
imaging was performed to acquire a large field and to minimise experimental bias, and 
GFP-expressing cells were manually scored for the presence of intracellular K I-Cherry 
(Figure 5.1A). The transfection efficiency of Dyn2(aa)WT, Dyn2(aa)K44A, and LDLR 
A18 GFP, was 19.5 ± 1.6%,19.1 ± 2.8%, and 11.7 ± 3.8%, respectively. Quantification of 
the infected GFP-expressing cells showed no inhibition in bacterial invasion in cells 
overexpressing Dyn2(aa)K44A GFP. In fact, there was a modest enhancement in E. coli 
K 1 internalization into these cells compared to cells expressing wild type Dyn2, though it 
was not statistically significant. 
As the endothelium specific dynamin isoform is unknown, the role of the neuronal 
specific Dyn 1 on E. coli Kl invasion was studied in similar manner (Figure 5.1 B). The 
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transfection efficiency of Dyn1WT, Dyn1K44A, and LDLR A18 GFP, was 41.4 ± 7.0%, 
20.9 ± 6.0%, and 38.3 ± 3.9%, respectively. As with Dyn2, the bacterial entry was not 
inhibited in cells that overexpressed dominant negative Dynl (DynlK44A-GFP) and again 
there was a trend to a slight increase in bacterial uptake in mutant over wild type Dyn 1 
expresslOn. 
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Figure 5.1. Overexpression of dominant negative dynamin 1 and 2 do not inhibit E. 
coli Kl invasion of HBMEC. (A) and (B) To study the requirement of dynamin during E. 
coli K1 invasion, HBMEC cells were transiently transfected with GFP tagged Dyn2 or 
Dyn1 chimaera: either wild type (WT), or dominant negative mutant (K44A). LDLR A 18 
GFP was transfection control. Cells were infected with KI-Cherry at MOl of 100 for 2 
hours, followed by 1 hours incubation in gentamicin containing media, and processed for 
microscopy. GFP chimaera-expressing cells were scored for the presence of intracellular 
K I-Cherry. Data shown are the mean ± SEM from three independent experiments; at least 
50 GFP-expressing cells were counted per sample. 
5.3.2 E. coli Kl invasion of HBMEC is caveolin-l-independent 
Caveolae-mediated endocytosis has been implicated to be dynamin-dependent (Oh 
et at., 1998; Pelkmans et at., 2002), however, the data above suggested that overexpression 
of dominant negative forms of both dynamin 1 and 2 did not inhibit E. coli Kl invasion of 
HBMEC. Hence, the requirement of caveolin-l during E. coli K 1 invasion of HBMEC was 
reassessed. To address the requirement of caveolin-l during E. coli K 1 invasion. HBMEC 
were infected with E. coli Kl, fixed at various time points post infection, and 
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immunostained for caveolin-l. Caveolin-I " staInIng re vealed bright punctate structure at 
the cell periphery and at the juxtanuclear position as " 'ell as 
V> in the C)1oplasm (Figure 
S.2A). After 30 minutes of infection, invading E. coli \vere found localized in 
compartments weakly stained for caveolin-l (Figure S.2A) . 
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Figure 5.2. Association of E. coli Kl with caveolin-l decreases over time of infection. 
(A) HBMEC were infected with K I-Cherry at MOl of 100 for 30 minutes, and fixed with 
2% formaldehyde, and immunostained for caveolin-1. Caveolin-I is shown in green. 
bacteria in red, nuclei in blue. The white arrow indicates bacterium local ising with 
caveolin-I ; wh ite arrow heads indicate bacteria that do not localise with caveo lin- I. A 
single confocal slice is shown. Scale bar: S 11m. (B) Quantification of the observed 
phenotype in (A) at various times p.i. Data shown are the mean ± SEM from h\ 0 
independent experiments; 2: 100 bacteria were counted per sample. 
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Quantification of the observed phenotype in Figure 5.2A showed that only about 
40/0 of the bacteria were closely associated with caveolin-l after 30 minutes infection and , 
the percentages reduced to about 1% and 0.5% at 2 and 20 hours post infection (p.i.). 
Therefore, association of E. coli Kl with caveolin-l seemed to be a rare event which 
occurred at the early time point when the bacteria were invading the cell. This would 
therefore suggest that caveolae-mediated uptake is not a major route of invasion for E. coli 
Kl into HBMEC. 
To further address the role of caveolin-l during E. coli Kl uptake, various GFP-
tagged caveolin-l mutant constructs were applied. Caveolin-l phosphorylation has been 
demonstrated to be required for albumin uptake via caveolae (Hu et aI., 2006), and 
overexpression of caveolin-l Y14F phosphorylation mutant, which is unable to be 
phosphorylated by Src family protein kinases (Labrecque et aI., 2004), in COS-l cells 
partially inhibits Campylobacter jejuni invasion (Watson and Galan, 2008). To study the 
effect of caveolin-l tyrosine phosphorylation on E. coli Kl invasion, GFP-tagged caveolin-
1 Y14A mutant (Caveolin-l Tyr14. N.B. this mutant is also non-phosphorylatable) was 
transiently overexpressed in HBMEC, and the cells were then infected with KI-Cherry. 
Quantification of the infected GFP-expressing cells showed no inhibition in the bacterial 
internalization as compared to cells overexpressing wild type caveolin-l (Caveolin-l WT-
GFP) (Figure 5.3). Similar results were seen by overexpressing the non-phosphorylatable 
isoform, caveolin-l~ (Caveolin-l~-GFP), which lacks the 31 amino acids of the N-terrninal 
of full length caveolin-l ( caveolin-l a) as a result of alternate initiation during translation. 
Caveolin-l is also post-translationally modified by palmitoylation at the three 
cysteine residues at the hydrophobic region at the C-terrninal. Whilst this is not required 
for the plasma membrane localization of caveolin-l, it is required for transport of newly 
synthesized cholesterol to the plasma membrane (Dietzen et at.. 1995; Uittenbogaard and 
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Smart, 2000~ Parat and Fox, 2001). Previous studies showed that depletion of cholesterol 
from HBMEC leads to reduction of E. coli K1 invasion (Sukumaran et a!., 2002; Chi et a!., 
2010). We hypothesized that the lack of cholesterol on the plasma membrane that results 
from overexpression of a caveolin-1 mutant that cannot be palmitoylated is able to block E. 
coli K1 invasion of HBMEC if the bacterial entry is cholesterol dependent. To test this 
hypothesis, HBMEC were transfected with a GFP-tagged caveolin-1 palmitoylation mutant 
construct, in which the 133, 143, and 156 cysteine residues were mutated to serine 
(Caveolin-1 palm-) (Parat et a!., 2003), infected with K1-Cherry, and imaged 3 hours p.i. 
(Figure 5.3). Quantification of the number of infected GFP-expressing cells revealed no 
inhibitory effect of the mutant on E. coli K1 internalization. These cumulative results 
strongly indicated that in our infection model, caveolae are not used as a route of invasion 
for E. coli K1 into HBMEC. 
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Figure 5.3. Overexpression of caveolin-lp isoform and caveolin-l mutants do not 
affect E. coli Kl invasion of HBMEC. To study the effect of different caveolin-l mutants 
and caveolin-l~ isoform on E. coli Kl invasion of HBMEC, HBMEC were transiently 
transfected with GFP-tagged caveolin-l chimaerae: either wild type (WT), caveolin-l~, 
palmitoylation mutant (palm-), or phosphorylation mutant (Tyr14) as indicated. Cells were 
infected with KI-Cherry at MOl of 100 and were imaged 3 hours p.i. Data shown are the 
mean ± SEM from two independent experiments; 2: 100 GFP cells were counted per sample 
and experiment. LDLR A18 was used as transfection control. The transfection efficiency 
of each construct was: LDLR A18 GFP = 34.24 ± 8.80/0; Caveolin-l WT-GFP = 41.8 ± 
13.9%; Caveolin-l~-GFP = 29.8 ± 10.3%; Caveolin-l palm- = 32.3 ± 12.1%; Caveolin-l 
Tyr14 = 43.2 ± 5.80/0. 
To investigate this further, an invasion assay was performed with mouse lung 
endothelial cells (MLEC) isolated from wild type (WT) and caveolin-l knockout (Cavl 
KlO) mice and cultured as described. MLEC were used instead of brain microvascular 
endothelial cells (BMEC) due to the technical difficulty to isolate a sufficient quantity of 
BMEC from mice, and the difficulty in culturing them beyond a single passage (Liebner, 
S., personal communication). The results from the invasion assay performed in RPMI-1640 
media showed that the number of recovered intracellular E. coli Kl per cell was 
approximately 40-fold higher than the number of recovered intracellular non-pathogenic E. 
coli K-12 per cell (Figure 5.4). This data indicated that MLEC could be used as an 
alternative in vitro model for studying E. coli K 1 pathogenesis. When the invasion assay 
was performed with MLEC Cavl KlO, E. coli Kl invasion of MLEC was not inhibited as 
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would be expected if caveolin were required for bacterial entry. However, the number of 
recovered intracellular E. coli K1 per cell was approximately 2-fold higher than the 
number of bacteria recovered from MLEC WT, although this observed increase in 
intracellular bacteria was not statistically significant, while there was no comparable 
increase in K 12 uptake into MLEC Cav 1 KJO cells. Overall, our data indicates that in our 
system E. coli K1 invasion of HBMEC is not dependent on caveolae-mediated 
endocytosis. 
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Figure 5.4. Caveolin-l knockout does not inhibit E. coli Kl invasion of MLEC. To 
confirm the requirement of caveolin-1 during E. coli K1 invasion of endothelial cells, 
MLEC purified from wild type and caveolin-1 knockout mice were infected with either E. 
coli K1 or K-12 at MOl of 100 for 2 hours, followed by 30 minutes incubation in 
gentamicin containing media. The results represent the mean number of bacteria per cell. 
Results are from one representative experiment of three independent repeats performed in 
triplicate and presented as mean of triplicates ± SEM. 
5.3.3 Flotillin 1 is recruited to invading and intracellular E. coli Kl 
All the evidence from this study suggested that E. coli K1 invasion of HBMEC is 
dynamin- and caveolae-independent. Therefore, other dynamin-independent endocytic 
pathways were explored. Cholesterol has been shown to be required for E. coli K 1 invasion 
of HBMEC by treating the cells with chemical inhibitors, such as filipin, methyl-~-
cyclodextrin, and nystatin (Sukumaran et aI., 2002: Chi et aI., 2010). We therefore 
investigated the potential role of flotillin 1, which is associated with cholesterol and lipid 
raft microdomains, and independent of dynamin, during E. coli K1 invasion. To address 
the involvement of flotillin 1 during E. coli K 1 uptake, HBMEC were infected \\'ith E. coli 
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Kl. Cells were fixed over a time course from 0.5 hours p.i. to oyernight and differential 
bacterial staining was performed to discriminate between extra- and intracellular bacteria. 
Flotillin 1 staining revealed bright punctate structures at the cell periphery and in the 
cytoplasm (Figure 5.5A). After 30 minutes infection, flotillin 1 could be found 
concentrated at bacterial attachment sites; 2 hours post-infection, strong co-localization of 
flotillin 1 with intracellular bacteria were observed (Figure 5.5A). In Figure 5.5B, 
quantification of E. coli Kl association with flotillin lover time showed that the 
association of flotillin 1 with extracellular bacteria was approximately 5%, and the 
percentage decreased to about 1 % by 2 hours. For the intracellular bacteria, the 
percentages of bacteria co-localized with flotillin 1 increased sharply from about 5% at 30 
minutes after infection to approximately 30% after 2 hours infection, and this association 
remained fairly constant at later time points. In comparison, caveolin-l associated E. coli 
Kl was 40/0 and 1 % at 30 minutes and 2 hours p.i., respectively (Figure 5.28). These 
results suggest that flotillin 1 might have a role during E. coli K 1 invasion of HBMEC. 
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Figure 5.5. Association of flotillin 1 with extra- and intracellular E. coli Kl over time 
of infection. (A) HBMEC were infected with E. coli K1 for the times indicated, fixed, and 
differential bacterial and flotillin 1 staining was performed as described in Chapter 2. 
Flotillin 1 is shown in green, extracellular bacteria in purple, intracellular bacteria in blue. 
A single confocal slice is shown. Flotillin 1 is associated with extracellular bacteria on the 
cell surface (white arrows), and concentrated around intracellular bacteria at the later time 
point (yellow arrows). Scale bars: 10 /lm. (B) Quantification of bacteria-flotillin 1 
association as in (A) at various time of infection. Data shown are the mean ± SEM from 
two independent experiments; 2:100 bacteria were counted per sample. 
5.3.4 E. coli Kl invasion of flotillin 1 knockout MLEC is enhanced 
To elucidate the role of flotillin 1 during E. coli K1 infection, an invasion assay 
was performed with flotillin 1 knockout MLEC (MLEC Flot1 KlO) (Figure 5.6A). At 150 
minutes p.i., in the absence of flotillin 1, the intracellular bacterial density per cell for both 
E. coli K1 and non-pathogenic E. coli K-12 was significantly higher than the recovered 
bacteria from MLEC WT. The mean number of intracellular E. coli K1 per cell recovered 
from MLEC Flot1 KlO was approximately 25-fold higher than the mean number of the 
intracellular bacteria per cell recovered from MLEC WT (p < 0.01). In MLEC WT, there 
was almost no E. coli K-12 recovered; however, in MLEC Flot1 KlO, the mean number of 
intracellular E. coli K-12 was about 0.02, which was about 60% increased compared to the 
mean number of E. coli K-12 recovered from MLEC WT (p < 0.0001). 
Despite being a plasma membrane protein, flotillin 1 has also been implicated as a 
late endosomal marker (Dermine et aI., 2001; Glebov et aI., 2006: Riento et al.. 2009). 
Therefore, the increase in recovered intracellular bacteria from MLEC Flot 1 KlO cells 
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could result either from enhanced bacterial entry into the cells o.c. d j:' • I 
, r lrom a electIve ate 
endosomal/lysosomal pathway due to flotillin I knockout, potentially preventing targeting 
of bacteria to lysosomal destruction. To address this question, both MLEC WT and MLEC 
Flotl KlO cells were infected with E. coli KI for 30 minutes, fixed, and differential 
bacterial staining was performed (Figure 5.6B). There were no intracellular bacteria found 
in MLEC WT after 30 minutes of infection. In contrast, approximately 8% of Flot 1 KlO 
cells were found to contain intracellular bacteria. This result suggested that the increased 
number of recovered intracellular bacteria from MLEC Flotl KlO lysates was due to 
enhanced bacterial entry. 
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Figure 5.6. Flotillin 1 knockout enhances E. coli Kl uptake into MLEC. (A) To study 
the role of flotillin I during E. coli KI invasion of endothelial cells, MLEC purified from 
wild type and flotillin I knockout mice were infected with either E. coli Kl or K-12 at 
MOl of 100 for 2 hours, followed by 30 minutes incubation in gentamicin containing 
media. The results represent the mean number of bacteria per cell. Results are from one 
representative experiment of three independent repeats performed in triplicate and 
presented as mean of triplicates ± SEM. (B) To confirm the enhanced recovered 
intracellular bacteria was due to increased bacterial invasion, wild type and flotillin 1 
knockout MLEC were infected with E. coli Kl for 30 minutes, fixed with formaldehyde, 
and differential bacterial staining was performed. Cells containing intracellular bacteria 
were counted. Data shown are the mean ± SEM from two independent experiments; ~40 
cells were counted per sample. 
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5.3.5 Flotillin as cellular regulatory barrier model 
Caveolin-l, flotillin 1, and flotillin 2 are lipid raft associated membrane proteins in 
mammalian cells. Previous studies have shown that knockdown or knockout of either 
protein leads to the alteration of expression levels of the other proteins in the target cells 
(Chintagari et ai., 2008; Vassilieva et ai., 2009; Ludwig et ai., 2010). To characterize the 
knockout MLEC used in this study, cells were stained for caveolin-l. flotillin 1. and 
flotillin 2 (Figure 5.7). The immunofluorescence micrographs showed that caveolin-l 
distribution in both MLEC Flot! KiO and MLEC WT was similar, where bright punctate 
structures were observed in the cytoplasm and cell periphery, although the protein 
expression might be lower in the flotillin 1 knockout cells than the wild type cells (Figure 
5.7 A. N.B. Contrast has been enhanced in these micrographs.). However, in MLEC Cav! 
KiO cells, for cells immunostained for flotillin 1, there was no punctate structure found in 
the cells (Figure 5.7B). Contrastingly, comparison of the flotillin 2 phenotype in the 
different MLEC cell lines revealed that in WT cells bright punctate structures were 
observed (Figure 5.7C). These were also present in MLEC Cavl KiO, but loss of the 
phenotype was observed in MLEC Flotl KiO. These observed phenotypes might suggest 
that the loss of flotillin 1 and 2 caused the plasma membrane of MLEC Flot 1 KiO to 
become more penetrable to bacteria. 
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Figure 5.7. Flotillin 1 and flotillin 2 distributions are altered in caveolin-l and flotillin 
1 knockout MLEC. (A) MLEC WT and MLEC Flot 1 KlO were stained with anti -
caveolin-1 (green). Bright punctate structures were observed in the cytoplasm and cell 
periphery of both cells. (B) MLEC WT and MLEC Cav1 KlO were stained with anti -
flotillin 1 (green). Bright punctate structures were observed in MLEC WT, but absent in 
MLEC Cavl KlO. (C) MLEC WT, MLEC Flotl KlO, and MLEC Cavl KlO were stained 
with anti-flotillin 2 (green). Bright punctate structures were observed in MLEC WT and 
MLEC Cav1 KlO, but absent in MLEC Flotl KlO. Scale bars: 5 11m . 
To test the hypothesis that flotillin may have a barrier function in preventing 
bacterial invasion, GFP-tagged flotillin 1, flotillin 2, caveolin-l , and LDLR A 18 were 
transfected into HBMEC, infected with KI-Cherry at MOl of 100 for 2 hours, followed by 
1 hour incubation in media containing gentamicin, and imaged with a confocal microscope. 
The number of GFP-expressing HBMEC with intracellular KI -Cherry was scored 
manually. As an experimental control, infection of untransfected HBMEC was included 
(Figure 5.8). The percentage of infected HBMEC overexpressing GFP-tagged fl otillin 
lSI 
after 3 hours infection was about 3-fold lower than the percentage of infected HBMEC 
overexpressing GFP-tagged caveolin-l and LDLR A18 at the similar infection time point. 
In HBMEC overexpressing GFP-tagged flotillin 2, no infected cells were found after 3 
hours infection. This preliminary observation suggests that overexpression of flotillin 1 or 
flotillin 2 has inhibitory effect on E. coli Kl invasion of HBMEC. 
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Figure 5.8. Overexpression of GFP tagged flotillin 1 and flotillin 2 affect E. coli Kl 
entry of HBMEC. To study the effect of flotillin 1 and flotillin 2 overexpression in 
HBMEC on E. coli Kl invasion, HBMEC were transiently transfected with a GFP-tagged 
constructs as indicated. Untransfected HBMEC was included as experimental control. 
Cells were infected with KI-Cherry at MOl of 100 for 2 hours, incubated in media 
containing 1 00 ~g/ml gentamicin for 1 hour, and imaged. Data shown are from one 
experiment. 
5.4 Discussion 
E. coli Kl invasion of HBMEC is dynamin- and caveolin-l independent 
Some bacteria, such as Salmonella Typhimurium, invade non-phagocytic cells by 
injecting bacterial effectors via T3SS, which leads to membrane ruffle formation and 
results in bacterial uptake (Gerlach et al., 2008). Some E. coli Kl clinical isolates were 
found to possess T3SS, and this T3SS was shown to be required for bacterial invasion of 
HBMEC and intracellular survival (Yao et al., 2006; Yao et al., 2009). The E. coli K 1 
strain used in this study, E44 strain, does not have T3SS, however, it harbours genes for 
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general secretory pathway (GSP), which are also present in uropathogenic E. coli strain 
CFT073 and other Gram negative bacteria (Welch et at., 2002; Yao et al., 2006). Studies 
performed with E44 proposed that the K1 bacterial invasion of HBMEC was via receptor-
mediated, clathrin-independent "zippering" mechanism (Prasadarao et at., 1999). Later, 
Sukumaran et al. (2002) reported that E. coli K1 hijacked the caveolae-mediated pathway 
for entry into HBMEC, and the authors also proposed that caveolin-1 was involved in 
bacterial transcytosis. 
Caveolae-mediated endocytosis has been implicated to be dynamin-dependent via a 
GTP-dependent fission process (Oh et at., 1998; Yao et al., 2005). Further evidence to 
support the requirement for dynamin in caveolae-mediated endocytosis has been 
demonstrated by the recruitment of Dyn2 during SV 40 internalization into a fibroblast cell 
line (Pelkmans et at., 2001; Pelkmans et at., 2002), and that phosphorylation of tyrosine 
231 and 597 of dynamin 2 is required for caveolin-1 binding, as shown by expression of 
non-Src-phosphorylatable Dyn2 Y597F mutant in microvessel endothelial cells, which 
abolished albumin and cholera toxin subunit B uptake (Shajahan et at., 2004). Therefore, 
we hypothesized that overexpression of GDP-bound Dyn2 K44A mutant, which has also 
been shown to abolish caveolae-mediated endocytosis in endothelium (Shajahan et at., 
2004), might block E. coli K1 invasion of HBMEC, if the bacteria utilized the caveolae-
mediated pathway for HBMEC entry. However, we did not find any inhibitory effect on 
the bacterial internalization in cells overexpressing GDP-bound Dyn2 (Figure 5.IA). 
Different isoforms and splice variants of dynamin exist in mammalian cells (Cao et at., 
1998; Hinshaw, 2000), and furthermore different dynamin isoforms regulate receptor-
mediated endocytosis at the different membrane surfaces in polarized MDCK cells 
(Altschuler et at., 1998). Since HBMEC are polarized cells, we repeated the experiments 
with GDP-bound Dyn1 (Figure 5.1B), but again E. coli K1 invasion was not inhibited. As 
observed by Watson and Galan (2008) in their study of Campylobacter jejuni invasion of 
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COS-1 cells, minor enhancement in E. coli K1 uptake in cells oyerexpressing GDP-bound 
dynamin was also observed in this study. These data suggest that dynamin is not required 
for E. coli K1 internalization into HBMEC. However, it should be noted that the 
functionality of the dominant negative mutants in our system has not been yalidated. 
Whilst the phenotype of the cells overexpressing the K44A mutants is similar to that 
previously published, it is possible that HBMEC dynamin-dependant endocytosis is still 
functioning. To ensure the observation with E. coli Kl was not due to non-functioning 
GDP-bound dynamin mutants in HBMEC, the inhibitive effect of the mutants on 
endocytosis should be confirmed by studying the uptake of transferrin, a ligand for 
clathrin-mediated endocytosis. A functional GDP-bound dynamin mutant is anticipated to 
inhibit transferrin uptake into HBMEC overexpressed the mutant. Furthermore, since 
dynamin isoforms seem to have redundant functions (Altschuler et al., 1998), there is a 
possibility that the other endogenous dynamin isoforms and splice variants might take over 
the role in cells overexpressing a specific GDP-Iocked dynamin isoform or splice variant. 
Although it appears that dynamin is not required for E. coli K1 uptake in our 
system, the observation does not completely eliminate the involvement of caveolae-
mediated endocytosis. Recently, it was reported that the uptake of cholera toxin B (CTB), 
which is a ligand commonly used for studying caveolae-mediated endocytosis, was not 
inhibited in Dyn2 knockout fibroblasts (Liu et al., 2008). Therefore, the absolute 
requirement for dynamin in caveolae-mediated endocytosis seems to be unclear and a role 
for caveolin that might be dynamin-independent was investigated further. 
Immunofluorescence staining of E. coli K1-infected HBMEC showed weak staining of the 
bacteria with caveolin-1 (Figure 5.2A), as compared to Sukumaran et al. (2002) \vho 
showed strong staining of the bacteria with caveolin-1. The observed discrepancy could be 
due to channel cross-talk in their results, because very high intensity of nonspecific 
background signals was shown in their micrographs, which they indicated as specific 
bacterial staining (using anti-Kl or anti-S-fimbriae antibody). Further, our findings showed 
that the association of the bacteria with caveolin-l was a rare event, with only 
approximately 40/0 of the bacterial population associated with caveolin-l after 30 minutes 
infection (Figure 5.2B), and the percentage of association further decreased to about 1 % at 
the end of 2 hours infection. 
Overexpression of tyrosine 14 mutant, caveolin-l YI4F, in COS-l cells has been 
shown previously to partially inhibit Campylobacter jejuni invasion (Watson and Galan, 
2008), however, in this study overexpression of caveolin-l Y14A in HBMEC had no 
inhibitory effect on E. coli Kl invasion. This result was further backed up by expressing 
the GFP-tagged caveolin-l p isoform, which is not phosphorylatable, in HBMEC. Instead 
of inhibiting E. coli Kl internalization into HBMEC, which might be expected if caveolin-
1 is required for uptake, a mild increase in the number of cells with intracellular bacteria 
was observed when overexpressing caveolin-l p. The functionality of caveolin-l Y 14A and 
caveolin-l p in HBMEC need to be validated by studying the uptake of lactosylceramide 
(LacCer), which was a specific ligand for caveolae-mediated endocytosis (Singh et al., 
2003) to substantiate these observations. 
To further support our data that caveolin-l is not required for E. coli K 1 infection, 
an invasion assay was performed with MLEC isolated from either wild type or caveolin-l 
knockout mice. The main reason for using lung endothelia was due to the technical 
difficulty to isolate of brain microvascular endothelium in sufficient quantity from mice 
and the difficulty to then culture the cells in vitro (Liebner, S., personal communication). 
Although bacterial invasion efficiency of MLEC is low, MLEC are still a valid in vitro 
model for studying E. coli Kl pathogenesis, as parallel infection with the non-pathogenic 
E. coli K-12 showed that these bacteria did not invade MLEC. Further, it was also shown 
previously that E. coli K 1 was able to invade other endothelial cells with lower invasion 
efficiency (Prasadarao et al., 1996a). Importantly, an invasion assay performed with 
caveolin-l knockout in MLEC did not inhibit E. coli Kl invasion (Figure 5.4). Although 
this evidence, in combination with our data using non-phosphorylatable caveolin-l mutant 
expression in HBMECs, suggests that E. coli Kl invasion is independent of caveolin-l. the 
possible effects of alterations in other signalling pathways or receptor expression on the 
plasma membrane caused by the removal of caveolin-l in the knockout cells cannot be 
disregarded (Barth et ai., 2007; Matthews et ai., 2008). Recently, Siddiqui et af. (2011) 
demonstrated the absence of caveolin-l led to destabilization of adherens junctions and 
activation of endothelial nitric oxide synthase (eNOS) in endothelial cells. The eNOS 
nitrated GTPase activating protein (GAP) p 190RhoGAP-A, resulting in impaired GAP and 
RhoA activation (Siddiqui et ai., 2011). Since RhoA was required for E. coli Kl invasion 
of HBMEC (Khan et al., 2002), the upregulation of RhoA in caveolin-1 knockout cells 
could facilitate the bacteria invasion of caveolin-l knockout MLEC. 
In addition to studying the role of caveolin-l during E. coli Kl invasion of 
HBMEC, we were also interested in studying the requirement of cholesterol for bacterial 
invasion of HBMEC. It was previously shown that E. coli Kl invasion of HBMEC was 
blocked by a number of cholesterol inhibitors (Sukumaran et af., 2002; Chi et af., 2010). 
Caveolin-l is irreversibly palmitoylated at the three cysteine residues in the hydrophobic 
region at the C-terminal (Figure 1.6) (Dietzen et af., 1995; Parat and Fox. 2001). Mutation 
of these cysteine residues affects caveolin-chaperone complex formation and abolishes 
transport of newly synthesized cholesterol to plasma membrane caveolae (Dietzen et af., 
1995; Smart et ai., 1996; Uittenbogaard and Smart, 2000; Fu et ai., 2004). We found no 
inhibitory effect of the caveolin-l palmitoylation mutant on E. coli Kl internalization of 
HBMEC. However, this observation is insufficient to rule out the role of cholesterol during 
E. coli Kl invasion of HBMEC, as caveolin-l knockout mice displayed normal mRl'!A and 
protein levels of cholesterol transport protein Niemann-Pick C I-like 1 (NPC 1 L 1) in 
intestinal mucosa, and did not show any defect in cholesterol transportation (Valasek et af.. 
2005). Therefore, overexpression of the caveolin-1 palmitoylation mutant might not have 
completely abolished the cellular cholesterol trafficking pathway, and cholesterol could be 
transported or acquired via alternative pathways. This could be more directly tested by 
depleting cholesterol with ~-trimethyl cyclodextrin, which is less toxic than filipin 
(Schneider, B., personal communication), or by cholesterol inhibiting agents, such as 
simvastatin, and lovastatin, if the cells can withstand these treatments. 
Loss of flotillin 1 enhanced E. coli Kl internalization 
Since cholesterol had been previously implicated in E. coli K1 invasion ofHBMEC 
(Sukumaran et a!., 2002; Chi et a!., 2010), we therefore looked at the requirement of 
flotillin, which is associated with lipid rafts (Glebov et a!., 2006), during the bacterial 
invasion of HBMEC. Although flotillin endocytosis is relatively rare (Doherty and 
McMahon, 2009; Riento et a!., 2009), it has been shown to endocytose a proportion of 
cholera toxin B, and this uptake is dynamin-independent (Glebov et a!., 2006). Other than 
the uptake of cholera toxin B, flotillin is required for uptake of plasma membrane 
components such as glycosyl-phosphatidylinositol (GPI)-linked proteins and 
glycosphingolipids (Glebov et a!., 2006; Frick et a!., 2007). Flotillin 1 has been shown to 
co-localize with lysosomal transmembrane glycoprotein, LAMP 1 (Dermine et a!., 2001), 
in addition to its localization on plasma membrane. It was suggested that the presence of 
flotillin 1 on the phagolysosomal membrane might be involved in actin accumulation and 
polymerization (Dermine et a!., 2001). No known pathogen is documented to invade 
eukaryotic cells via a flotillin-dependent pathway, although some bacteria have been found 
to associate with flotillin intracellularly (Li et a!., 2008a). For example, Campylobacter 
jejuni and Brucella abortus associate with flotillin 1 transiently (Arellano-Reynoso et aI., 
2005; Watson and Galan, 2008), while in Mycobacterium marinum infection of monocytes. 
flotillin 1 was found on the bacterial replication phagosomes which lack LAMP 1 
(Hagedorn and Soldati, 2007). 
Quantification of the population of E. coli K 1 associated with flotillin 1 reyealed 
that a small population of E. coli Kl (5%) associated with flotillin 1 after 30 minutes 
infection, but the bacterial population which associated with flotillin 1 increased to about 
30% after 2 hours infection (Figure 5.5A and B). The role of flotillin 1 on intracellular 
bacteria-containing vacuoles is unknown. In this study, the population of E. coli Kl 
associated with flotillin 1 remained stable at later time points. The low initial colocalisation 
with flotillin might suggest that E. coli Kl do not require flotillin for uptake, but that E. 
coli Kl might hijack a flotillin 1 pathway once inside the cell, and utilize the cytoskeletal 
machinery for intracellular transportation to the other membrane surface. 
To elucidate the role of flotillin 1 during E. coli Kl infection, the invasion assay 
was performed with MLEC isolated from flotillin 1 knockout mice. Instead of an inhibitory 
effect on the bacterial entry, we observed a 25-fold increase in E. coli Kl density 
recovered from the cell lysate of flotillin 1 knockout MLEC in comparison to wild type 
MLEC. This trend was also observed for infection performed with non-pathogenic E. coli 
K-12. The observed increase in intracellular bacteria could be due to either increased 
bacterial uptake, or a non-functioning lysosomal degradation pathway, due to the fact that 
flotillin 1 has been found on late endosomes (Dermine et aI., 2001). However, after 30 
minutes infection with E. coli Kl, which should be insufficient for the bacteria-containing 
vacuoles to mature to late endosomal stage and to fuse with lysosomes, there was no 
infected wild type MLEC, while 80/0 of the flotillin 1 knockout MLEC were infected. This 
observation strongly supported the hypothesis that the enhanced number of intracellular 
bacteria recovered from flotillin 1 knockout MLEC was due to increased bacterial uptake 
rather than an inhibition in lysosomally targeted bacterial lysis. There is a possibility that 
in these flotillin 1 knockout MLEC, the equilibrium of membrane protein popUlations are 
disrupted following the total absence of flotillin 1 in these cells, hence the bacterial 
internalization might be shunted to another endocytic pathway. Therefore, this result might 
need to be confirmed with flotillin 1 knockdown by flotillin 1 specific siRNA in HBMEC, 
where a small amount of flotillin 1 remains in the knockdown cells, and might maintain the 
equilibrium of the membrane protein populations. On the other hand the functionality of , . 
the lysosomal degradation pathway in MLEC FlotlKJO can be studied by comparing the 
number of recovered intracellular E. coli K-12, which have been shown to be unable to 
survive intracellularly (Figure 3.5), in FlotlKJO MLEC at early and extended time points 
of infection. A significant reduction in the number of recovered intracellular E. coli K -12 
from FlotlKJO MLEC at the extended time point of infection would be expected if the 
lysosomal pathway remains functional in the knockout cells. Alternatively, the 
functionality of the lysosomal degradation pathway can be studied by assessing the long-
lived protein degradation as described in (Razi et al., 2009). 
Flotillin as a regulatory cell barrier 
Although caveolae and flotillin form distinct microdomains, their cellular 
expressions and protein stability are interdependent (Solis et al., 2007; Chintagari et aL 
2008; Vassilieva et al., 2009; Ludwig et al., 2010). In conjunction with previous published 
data on caveolin-l, flotillin 1, and flotillin 2 expression levels in protein knockdown or 
knockout cells, as well as our immunofluorescence observations on the protein 
distributions, we propose that both flotillin 1 and flotillin 2 distributions on the plasma 
membrane might have a role as a regulatory cellular barrier. This is evidenced by the loss 
of flotillin 2 punctate structures in flotillin 1 knockout MLEC, \vhich showed enhanced 
bacterial internalization for both E. coli strains; whereas in caveolin-l knockout tvlLEC, 
only flotillin 1 distribution was affected, and a mild increase which was not statistically 
significant in E. coli Kl uptake into the knockout MLEC \Vas obser.ed. It is also possible 
that the inhibitory effect on E. coli Kl uptake into caveolin-l knockout MLEC is cancelled 
by the loss of flotillin 1, but some flotillin 2 is still expressed on the surface of these cells. 
Hence, the increase in bacterial internalization was not as great as in flotillin 1 knockout 
MLEC. 
Previously, Hoffmann et a!. (2010) observed increased membrane fluidity in 
caveolin-l knockout fibroblasts, which was corroborated by strong increased mobility of 
GFP-GPI in these knockout cells based on FRAP experiment. The increased GFP-GPI 
mobility correlated with enhanced Staphylococcus aureus uptake in caveolin-l knockout 
fibroblasts (Hoffmann et a!., 2010). Since membrane fluidity is known to be influenced by 
cholesterol (SpeCtor and Y orek, 1985), the absence of both flotillin isoforms on the plasma 
membrane might affect the cholesterol content of the plasma membrane. which made the 
membrane more easily penetrable by the bacteria. 
It is known that some plasma membrane rafts interact with cytoskeletal structures 
(Maxfield, 2002; Meiri, 2005; Langhorst et a!., 2007; Sverdlov et a!., 2009; Ludwig et a!., 
2010), and this interaction has been hijacked by certain pathogens, such as SV40, for 
invading non-phagocytic mammalian cells (Pelkmans et aI., 2001; Pelkmans et a!., 2002). 
Rather than facilitating pathogen entry by raft-cytoskeleton interactions, it was found that 
tyrosine-phosphorylated caveolin-l induced cytoskeleton rearrangements at Neisseria 
gonorrhoeae attachment sites and blocked the bacterial internalization into a human cervix 
carcinoma cell line, ME-180 (Boettcher et al., 2010). We speculate that the enhanced E. 
coli Kl into flotillin 1 knockout MLEC could also link to an impact on cytoskeletal 
structures, as flotillin 2 has been shown to interact with F-actin via its stomatin, prohibitin, 
flotillin, and HflKlC (SPFH) domain, and the protein lateral mobility is modulated by the 
actin cytoskeleton (Langhorst et al., 2007; Langhorst et aI., 2008a). This model is also 
supported by our data where bacterial internalization was inhibited in HBMEC 
overexpressing-GFP-tagged flotillin 1 and flotillin 2 (Figure 5.8). Therefore, we propose 
that flotillin might act as cellular regulatory barrier either by regulating plasma membrane 
cholesterol or by modulating plasma membrane-cytoskeleton interactions and, hence, 
protect eukaryotic cells from pathogen invasion. 
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6. Intracellular E. coli Kl interacts with various organellar markers, 
revealing the potential bacterial transcytosis pathway in HBMEC 
6.1 Introduction 
After entry into host cells, bacteria successfully escape the direct attack from the 
host immunity, but the intracellular environment is also unfriendly to the bacteria. Indeed, 
intracellular bacteria face "intracellular immunity" from the host cell degradation 
mechanism, and the bacteria have to obtain nutrients and biosynthetic precursors, as well 
as evade detection by the host's immune system (Bhavsar et aI., 2007; Ham et aI., 2011). 
In order to survive intracellularly, pathogenic bacteria have evolved diverse 
strategies to modulate host cellular machinery to make a cosy and protected intracellular 
niche for survival and replication (Brumell and Scidmore, 2007; Ham et aI., 2011). To 
escape from lysosomal degradation, some bacteria, such as Listeria monocytogenes 
(Tweten, 2005; Henry et aI., 2006), Mycobacterium marinum (Stamm et aI., 2003; 
Hagedorn and Soldati, 2007), Burkholderia pseudomallei (Sitthidet et aI., 2011), and 
Shigella flexneri (Sansonetti et aI., 1986), trigger rupture of the phagosome and escape into 
the cytosol. Listeria is the best-studied pathogen to employ this strategy, whereby the 
bacterium secretes listeriolysin 0 for delaying endosomal maturation and for the formation 
of transmembrane pores on the vacuolar membrane (Tweten, 2005), thereby escaping from 
the late endosome-like compartment into the cytosol (Henry et aI., 2006). The expression 
of GTP-Iocked Rab5 (Rab5Q79L) mutant showed co-localization of the bacteria with 
Rab5Q79L, but did not block the bacterial escape into the cytosol (Henry et al., 2006). In 
the cytosol, these bacteria replicate and acquire host actin for cell-cell spreading in vitro 
(Hagedorn and Soldati, 2007). 
On the other hand, those invasive bacteria that reside and replicate in membrane-
bound vesicles must delay or block endosomal maturation to avoid fusion with lysosomcs 
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by modifying the endosomal membrane (Gruenberg and van der Goot, 2006). To preyent 
lysosomal fusion, pathogenic Brucella secretes cyclic p-1.2-glucan (CPG) that is 
structurally similar to cyclodextrins and disrupts lipid rafts (Arellano-Reynoso ef aI., 
2005). Brucella-containing vacuoles eventually fuse with the endoplasmic reticulum (ER) 
after transient acquisition oflate endocytic markers (Celli ef al.. 2003; Starr ef aI., 2008). 
For Salmonella enterica serovar Typhimurium, once inside the cells, the bacterium 
secretes bacterial virulence effectors into the cytosol via T3SS. and the Salmonella-
containing vacuoles (SCV) undergo standard endosomal maturation to late endosomes, 
without interacting with mannose-6-phosphate-containing late endosomes or lysosomes 
(Meresse et at., 1999; Steele-Mortimer et at., 1999). In macrophage cell line, SpiC, one of 
the bacterial effectors encodes within SPI-2 pathogenicity island, is thought to prevent 
fusion of SCV with lysosomes (Uchiya et at., 1999). In fact, it was shown that before SCV 
mature to late endosomal stage, various regulators of endocytic recycling, including Arf6, 
Rab4, syntaxin 13, and Rab11, are transiently associated with SCV. These recycling 
regulators are not only required for recycling cell surface protein from SCV, but they are 
also essential for acquisition of lysosomal glycoproteins to SCV (Smith et aI., 2005). SCV 
also recruit Rab7-interacting lysosomal protein (RILP) to allow migration to the 
perinuclear region, where the bacterial vacuoles are associated with Golgi (Salcedo and 
Holden, 2003; Guignot et at., 2004). 
The obligate intracellular bacteria Chlamydia speCIes have evolved an umque 
strategy for the bacterial intracellular survival and replication. Chlamydiae replicate in a 
specialized compartment that is not acidified and does not fuse with lysosomes (Heinzen ef 
at., 1996), but the bacterium-containing compartment is enriched with host lipids, such as 
sphingomyelin and cholesterol, which are acquired via golgi-dependent transportation, and 
the acquisition is a bacterially driven process (Carabeo ef at., 2003). Additionally. 
screening with a panel of GFP-tagged Rab GTPases constructs revealyed that the 
1£1 
chlamydial compartment is also decorated with various Rab GTPases, such as Rab 11, 
Rab4, Rabl, Rab6, and Rab14 (Rzomp et al., 2003). The functional roles of most of these 
GTPases on the chlamydial compartment are not clear, but the association of Rab 11 a with 
the compartment has been shown to regulate the development of the bacterial elementary 
bodies (an infectious form of the bacteria) by affecting Golgi fragmentation via the golgin-
84 dependent pathway (Lipinski et a!., 2009). Recently, it was demonstrated that the 
bacterium secretes a serine protease, chlamydial protease-like activity factor (CPAF), 
which regulates the membrane integrity of the bacterial compartment, prevents 
superinfection by degrading early Chlamydia effectors, Tarp, during infection of a pre-
infected cell, as well as interfering with the caspase-l apoptotic pathway of infected cells 
(Jorgensen et a!., 2011). 
Although the majority of invasive bacteria surVIve intracellularly by avoiding 
fusion with lysosomes, Coxiella burnetii, the etiologic agent that causes Q fever, evolved a 
radically opposite strategy. Coxiella-containing vacuole (CCV) fuses with the 
autophagosome before the vacuole fuses with lysosome and its vacuole is decorated with 
lysosomal glycoproteins, vacuolar H+-ATPase, Rab7, cathepsin D, and other lysosomal 
hydrolytic enzymes (Beron et a!., 2002; Brumell and Scidmore, 2007; Romano et a!., 
2007; Voth and Heinzen, 2007). The acidic environment is required for stimulating the 
intracellular bacteria to become metabolically active, and also to activate the bacterial type 
4 secretion system in order to evade the host innate immune signalling pathways (Newton 
and Roy, 2011). 
In order to establish a successful infection, pathogenic bacteria not only survive 
intracellularly, but they need to disseminate systemically. However, the host's body is 
structured with various barriers of sheets of epithelial and endothelial cells. Therefore, to 
disseminate to other anatomical sites, the bacteria need to traverse through these polarized 
barrier cells. 
To date, most knowledge on transcytosis pathways in polarized epithelial cells has 
been contributed by studies of immunoglobulins, and macromolecules. such as albumin, 
and insulin (Ghitescu and Bendayan, 1992; Predescu and Palade, 1993; Apodaca, 2001: 
Minshall et aI., 2003; Ducharme et aI., 2007; Tzaban et aI., 2009). However. it is unknown 
if similar membrane trafficking pathways exist in flat endothelial cells. Several pathogens 
are known to traverse polarized epithelial or endothelial cells but bacterial transcvtotic , . 
pathways are poorly understood (Nikitas et aI., 2011), and the majority of previous studies 
mainly focused on the requirement for micro filaments, motor proteins, and microtubules 
(Bomsel, 1997; Bras and Ketley, 1999; Eyngor et aI., 2007; Hu et al.. 2008: Wang et al.. 
2008). Recently, uropathogenic E. coli (UPEC) traslocation across renal medullary 
collecting duct (MCD) was demonstrated to depend on lipid rafts via a Toll-like receptor 4 
(TLR4)-dependent process. The authors correlated the decrease in bacterial translocation 
across cholesterol-depleted MCD with the downregulation of proinflammatory mediator 
expression (Chassin et aI., 2008). 
A previous study has shown that the majority of E. coli K 1 acquire the early 
endosomal marker, transferrin receptor (TfR) , after 30 minutes of infection (Kim et aI., 
2003). The association with TfR gradually decreased at later time points of infection, while 
the population of bacteria associated with late endosomal marker, LAMP 1, increased over 
time of infection (Kim et aI., 2003). E. coli Kl has been shown to survive intracellularly 
in a late endosomal-like compartment devoid of lysosomal enzymes (Kim et aI., 2003). 
The bacterium is able to traverse an HBMEC monolayer in vitro without affecting the 
monolayer's integrity (Stins et aI., 2001), but to date the transcytosis pathway has not been 
identified. 
6.2 Objectives and aims 
The aim of this chapter was to identify the intracellular fate of E. coli Kl and a 
potential transcytosis pathway in HBMEC. The specific objectives are as below: 
• 
• 
To screen the interactions of E. coli Kl with various cellular compartments by 
transfecting HBMEC with various GFP-tagged chimaerae. 
To study the identified pathway(s) for E. coli Kl traversal ofHBMEC cells . 
6.3 Results 
6.3.1 E. coli Kl containing compartment is not arrested at early endosomal stage 
A pervious study showed that E. coli Kl did not replicate intracellularly III 
HBMEC (Prasadarao et at., 1999), but data from our intracellular survival assay showed 
that E. coli Kl could survive and replicate in HBMEC up to 7 hours p.i. (Figure 3.2). 
Therefore, we were interested to study the host proteins that were present on the bacterial 
containing compartments. We first analyzed the E. coli Kl compartmentation in HBMEC 
by infecting HBMEC transiently overexpressing GFP-tagged Rab5 chimaerae with K 1-
Cherry for 2 hours, followed by 1 hour incubation in media containing gentamicin. and 
processed for live-cell imaging. Wild type Rab5 (Rab5WT) was found diffuse in the 
cytoplasm with vesicular structures observed at the perinuclear region and some at the 
cytoplasm (Figure 6.1 A). KI-Cherry were found in areas that exclude cytosolic Rab5WT 
expression and had no membrane accumulation of Rab5 around them. This observation 
demonstrated that E. coli K 1 did not arrest endosomal maturation at early endosomal stage, 
evidenced by the absence of Rab5 accumulation on the E. coli Kl containing vacuoles 
(ECV) 3 hours pj. in HBMEC transiently overexpressing GFP-tagged Rab5WT. We also 
looked for co-localization ofGFP-Rab5 with KI-Cherry at an early time point (30 minutes 
p.i.) in fixed cells; however, no co-localization of Rab5 with KI-Cherry observed (data not 
shown). One possibility is that the interaction of Rab5 and ECV is rapid and transient. or 
Rab5 is not involved in the ECV development. We further investigated the interaction of 
KI-Cherry with early endosome by infecting HBMEC with E. coli Kl for 30 minutes, 
fixed, and stained for early endosomal antigen 1 (EEA1) (Figure 6.10), which is an 
effector of Rab5 (Galperin and Sorkin, 2003). EEAl staining showed bright punctate 
structures in the cell cytoplasm and some weak signal of EEA 1 around the bacteria was 
observed, which might suggest that ECV did fuse with early endosomes during its 
maturation, but once again this interaction might be too rapid and transient to be detectable 
ill our assay. 
To overcome the possibility that any interactions of E. coli Kl were too short to be 
detected, we investigated if Rab5 mutant chimaerae might have an effect on the protein 
localization with ECV. Rab5Q79L and Rab5S34N are GTP- and GOP-locked Rab5 
mutants, respectively, which the GTPase activity of these mutants has been well-
characterized (Stenmark et al., 1994). The defects in these mutants prevent normal vesicle 
fusion and maturation, as such if E. coli Kl did interact with Rab5-associated vesicles, 
normal vesicle progress would be stalled, and an accumulation of Rab5 and E. coli K 1 
expected. In HBMEC overexpressed Rab5Q79L, large vesicular structures were observed 
in the cytoplasm, and KI-Cherry was located in an enlarged vacuole (Figure 6.1B). 
Whereas in HBMEC overexpressed Rab5S34N, diffuse punctate signal was observed 
(Figure 6.1 C), and KI-Cherry was localized in the cytoplasm without any protein 
accumulation around them. 
As overexpression of GOP-locked Rab5 (Rab5S34N) was shown to inhibit 
Coxiella burnetii entry of CHO cells (Romano et al., 2007), to ensure that E. coli K 1 
internalization into HBMEC overexpressing GFP-tagged Rab5S34N was not affected, 
HBMEC overexpressing GFP-Rab5 chimaerae were infected with KI-Cherry at MOl of 
100 for 2 hours, followed by incubation in media containing gentamicin for 1 or 5 hours, 
and processed for live-cell imaging. The number of GFP-expressing cells with intracellular 
1/.., 
KI-Cherry was quantified. We did not find any evidence of the inhibition of E. coli Kl 
invasion in HBMEC overexpressing GDP-Iocked Rab5 (Rab5S34N) 3 and 7 hours p.i. 
(Figure 6.1E) as would be expected if Rab5-associated vesicles were involved in the 
intracellular survival of E. coli Kl. Therefore, our results suggested that ECV interact 
transiently with early endosomal markers, and the interaction was only observed in cells 
overexpressing Rab5Q79L mutant. On the other hand, E. coli Kl inyasion of HBMEC was 
not affected in HBMEC overexpressing Rab5 chimaera. 
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Figure 6.1. The E. coli Kl-containing vacuole is not arrested ,at an early endosomal 
stage. (A) - (C) Representative confocal micrographs of HBMEC cells transiently 
expressing GFP-Rab5WT (A), GFP-Rab5Q79L (B), and GFP-Rab5S34N (C) that \\'er~ 
infected with mCherry-expressing E. coli Kl (KI-Cherry) (red) at MOl of 100 for 2 hours, 
followed by 1 hour incubation in media containing gentamicin, and were imaged with a 
confocal microscope as described in Chapter 2. The white arrows indicate intracellular K 1-
Cherry. (D) Representative confocal micrograph of HBMEC infected with E. coli Kl (red) 
at 30 minutes p.i., fixed and immunostained for EEAl and visualized by FluoProbes®-
488-conjugated secondary antibodies (green). Nuclei were stained with DAPI (blue). A 
single confocal slice is shown. The white arrows indicate bacterium localising with EEA 1, 
and the white arrow heads indicate bacterium that does not localise with EEAl. Scale bars: 
5 11m. (E) To investigate overexpression of GFP-tagged Rab5 on KI-Cherry invasion. 
HBMEC were transfected with GFP-tagged Rab5 chimaerae, infected with KI-Cherry as 
above, followed by 1 or 5 hours incubation in media containing gentamicin, and imaged as 
in (A) - (C). pNI-EGFP was included as the experimental control. GFP-expressing 
HBMEC with intracellular E. coli Kl were scored by confocal microscopy at 3 and 7 hours 
p.i. Data are mean ± SEM from two independent experiments. 
6.3.2 E. coli Kl does not utilize endosomal recycling pathway 
Rab 11 is one of the Rab GTPases that regulates endosomal recycling at the 
juxtanuclear recycling endosome. To determine whether E. coli Kl utilizes the Rabl1a 
recycling pathway, HBMEC were transiently transfected with GFP-tagged Rabl1 
chimaera, either Rabl1a wild type (RabllaWT) (Figure 6.2A), or GTP-Iocked ~ablla 
(RabllaQ70L) (Figure 6.2B), or GDP-Iocked Rablla (Rabl1aS25N) (Figure 6.2C), 
infected with KI-Cherry as described above, followed by incubation in media containing 
gentamicin for 1 or 18 hours, and imaged. Both GDP- and GTP-Iocked Rablla mutants 
were applied in case ECV association with Rab 11 a was transient. Bright punctate 
structures were observed in the cytoplasm and juxtanuclear position of HBMEC 
overexpressing Rab 11 a WT; while only bright punctate structures were observed in the 
cytoplasm of HBMEC overexpressing Rab 11 aQ70L. In HBMEC overexpressing 
RabllaS25N, the GFP signal was dispersed in the cytoplasm, no punctate structure was 
observed. At 3 and 20 hours p.i., none of the Rablla chimaera localized specifically with 
intracellular KI-Cherry. No localization of intracellular KI-Cherry with GFP-RabllaWT. 
and GFP-Rabl1aQ70L suggests that Rablla is not involved in regulation of the pathway 
hijacked by intracellular E. coli Kl during the bacterial infection ofHBMEC. 
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Figure 6.2. E. coli Kl-containing vacuoles do not acquire Rablla during endosomal 
maturation. (A) - (C) Representative confocal micrographs of HBMEC cells transiently 
expressing GFP-RabllaWT (A), GFP-RablIaQ79L (B), and GFP-RabllaS25 (C) that 
were infected with K I-Cherry (red) at MOl of 100 for 2 hours, followed by incubation in 
media containing gentamicin for I or 18 hours, and imaged with a confocal microscope as 
described in Chapter 2. The white arrows indicate intracellular K I-Cherry. Scale bars: 5 
flm. 
6.3.3 E. coli Kl localizes in a late endosomai/lysosomal compartment 
Kim et al. (2003) also showed that the K I capsule prevented the ECY that acquired 
characteristics of late endosome (positive for Rab7 and LAMP 1) from fusion with 
Iysosomes 2 hours p.i. , evidenced by the absence of cathepsin 0 co-locali zation with ECY. 
We further investigated the role of Rab7 on ECY development by infecting HBMEC 
transiently overexpressing wild type Rab7 (Rab7WT) with K I-Cherry as described for 2 
hours, and imaged live with a confocal microscope. Two mutant forms of Rab7 GTP-
locked Rab7 (Rab7Q67L), or GDP-Iocked Rab7 (Rab7T22N), were also used in case any 
association with Rab7 was transient. Vesicular and punctate structures were observed in 
the cytoplasm and juxtanuclear position of HBMEC expressing Rab7 WT (Figure 6.3 ). 
and K I-Cherry was localized in a membrane bound compartment decorated 'vvith Rab7 in 
the cell cytoplasm. It was observed that all the intracellular K I-Cherry ere localized in 
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Rab7WT compartments (data not shown). In HBMEC overexpressing Rab7Q67L (Figure 
6.3B), large vesicular structures were observed and KI-Cherry were localized in the 
mutant protein decorated compartments. In contrast to HBMEC overexpressing Rab7\VT 
and Rab7Q67L, diffuse punctate signals were seen in the cytoplasm of HBMEC 
overexpressing Rab7T22N (Figure 6.3C). In these Rab7T22N-expressing HBMEC, clumps 
of K I-Cherry were found localised in areas devoid of cytoplasmic Rab 7T22N. 
To ensure that the bacterial invasion was not affected by the overexpression of 
these Rab7 chimaerae in HBMEC, HBMEC expressing GFP-Rab7 chimaerae were 
infected with KI-Cherry as described in section 6.3.1 and processed for imaging (Figure 
6.3D). The number of KI-Cherry infected GFP-Rab7 chimaerae expressing HBMEC were 
counted. The preliminary data showed that the number of infected Rab7Q67L-expressing 
HBMEC was lower than the number of infected HBMEC overexpressing either Rab7WT 
or Rab7T22N; however, the number of infected Rab7Q67L-expressing HBMEC increased 
sharply to about 10%, which was higher than that of other infected Rab7 chimaerae-
expressing HBMEC. This data is inconclusive and the experiment needs to be repeated. 
We further asked if ECV-Rab7 association is transient or stable. To address this 
question, time-lapse imaging of HBMEC transiently overexpressing GFP-tagged wild type 
Rab7 with KI-Cherry was performed 2 hours p.i. (Figure 6.3E). KI-Cherry was found to 
remain in Rab7 -enriched compartments for prolonged periods of time (here shown 
approximately 6 hours). Intriguingly, cross-sectional view of the last time point revealed 
that the bacteria in the Rab7 compartments were localized at the basolateral membrane 
surface; while at 2 hours p.i., cross-sectional view revealed that the bacteria were very 
close to the apical surface of the cell (Figure 6.3F). 
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Figure 6.3. Localization of intracellular E. coli Kl in Rab7 compartments. (A) - (C) 
Representative confocal micrographs of HB MEC ce lls transient ly expressing GFP-
Rab7WT (A), GFP-Rab7Q67L (B), and GFP-Rab7T22N (C) that were then infected with 
K I-Cherry (red) at MOl of 100 for 2 hours. Transfected, infected HBMEC cel ls were 
imaged at 2 hours p.i. with a confocal microscope as described in Chapter 2. The white 
arrows indicate intracellular KI-Cherry. (D) To investi gate overexpression of GFP-tagged 
Rab7 chimaerae on K I-Cherry invasion, HBMEC overexpressing GFP-tagged Rab7 
chimaerae were infected with K I-Cherry at MOl of 100 for 2 hours. followed by 
incubation in media containing gentamicin fo r I or 5 hours, and imaged as in (A) - (C) . 
pN I-EGFP was included as the experimental contro l. GFP-express ing HBMEC v ith 
intracellular E. coli K I were scored by confoca l microscopy at 3 and 7 hours p.i. Data are 
from one experiment. (E) Representative frames of time-lapse imaging of K I-Cherry 
infected GFP-Rab7WT-expressing HBMEC 2 hours p. i. The elapsed time (hours: minutes) 
is indicated at the lower left hand comer of each panel. The white arrow ind icate 
intracellular K I-Cherry co-loca lized with Rab7. Scale bars: 5 ~m . The white dotted line 
indicate the position of cross-sectional view in (F). (F) The micrographs sho\\ the cro -
sectional view of infected ce lls at 2:00 and 5:45 timepoints. Scale bar: 5 ~m . 
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In agreement with Kim et al. (2003), our live-ce ll imaging results also re\ealed 
localization of the bacteria in LAMPI-pos iti ve compartments at 3 and 20 hours p.i. (Figure 
6.4A and B). We also observed that the intrace llular K I-Cherry in LAMP 1 compartments 
appeared intact and brightly fluorescent 20 hours p.i. (F igure 6.4B). Intriguingly. e\eral 
the bacteria were located in these LAMPI compartments 20 hours p. i .. wh il e indi idua l 
bacillus was observed in LAMPI compartments 3 hours p.i . Thi s observation might 
suggest intracellular bacterial replication in LAMPI compartment at later time po int. 
which was supported by increased number of recovered intrace llular E. coli K 1 7 hour p.l. 
(Figure 3.5) 
A 
B 
F ' 64 E coli Kl-containing vacuoles acquire the lysosomal membrane Igure " , . EC II 
glycoprotein, LAMPL (A) and (B) Representative confocal mIcrographs of HBM ce s 
transiently expressing LAMPI -GFP tha~ we.re infe~ted wit.h .KI-Cherry. C:ed). at ~O[ of 
100, followed by 1 or 18 hours incubatIOn m me~la contaInmg gent~mlc In , lIn a~ed. at 3 
(A), and 20 hours p.i. (B) with a confocal mIcroscope. The whIte arrows indIcate 
intracellular K I-Cherry. Scale bars: 5 ~m. 
We further investigated the interaction of Rab9 chimaerae with E. coli K 1. GFP-
Rab9 chimaera, either wild type Rab9 (Rab9WT), or GTP-Iocked Rab9 (Rab9Q66L). or 
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GDP-locked Rab9 (Rab9S2lN), was transfected into HBMEC, and the transfected cells 
were infected with Kl-Cherry as described (Figure 6.5). The cells were imaged with a 
confocal microscope 3 and 20 hours p.i. Both GDP- and GTP-Iocked mutants were also 
used in case any association with Rab9 was transient. In HBMEC overexpressing 
Rab9WT, vesicular structures were concentrated at the juxtanuclear position as well as in 
the cytoplasm (Figure 6.5A), whereas in HBMEC overexpressing Rab9Q66L fluorescent 
signal was diffuse in the cytoplasm with some large vacuolar structures observed (Figure 
6.5B). In HBMEC overexpressing Rab9S21N, fluorescent signal was diffuse in cytoplasm. 
but some enlarged vacuolar structures were observed, with some of these structures 
appeared at juxtanuclear position (Figure 6.5C). We found that intracellular K I-Cherry 
were localized in Rab9WT and Rab9Q66L-enriched compartments at 3 and 20 hours p.i. in 
HBMEC transiently overexpressing respective GFP-tagged Rab9 chimaerae (Figure 6.5A 
and B respectively), but not with Rab9S21N (Figure 6.5C). Interestingly, similar with the 
observation with bacteria localized in LAMPI compartment, several KI-Cherry was found 
in an individual Rab9WT compartment at 20 hours p.i., which might suggest bacterial 
replication. 
From these results we conclude that ECY development might involve early 
endosomal markers, in which the interaction might be rapid and transient. ECY was not 
directed to recycling endosomes which involved Rab 11, but the vacuole matured to late 
endosome-like compartment with Rab7, Rab9, and LAMPI detected on the vacuole. 
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Figure 6.5. E. coli Kl-containing vacuoles acquire Rab9 during endosomal 
maturation. (A) - (C) Representative confocal micrographs of HBMEC cells transiently 
expressing GFP-Rab9WT (A), GFP-Rab9Q66L (B), and GFP-Rab9S21 N (C) that were 
infected with K I-Cherry (red) at MOl of 100 for 2 hours, fo llowed by incubation in media 
containing gentamicin for 1 or 18 hours, and imaged at 3, and 20 hours p.i. with a confocal 
microscope as described in Chapter 2. The white arrows indicate intracellular K I-Cherry. 
Scale bars: 5 11m. 
6.4 Discussion 
The E. coli K 1 invasion pathway of HBMEC has been studied extensively for the 
past two decades (Prasadarao et af. , 1993; Huang et af. , 1995; Prasadarao et af. , 1996a; 
Prasadarao et af. , 1996b; Reddy et af. , 2000a; Reddy et al., 2000b; Khan et af. , 2003 ; 
Prasadarao et af., 2003; Maruvada et af. , 2008; Liu et af. , 2010) ; however, the trafficking 
pathways involved in bacterial intracellular survival are poorly understood. The classical 
degradative endocytic pathway to the lysosome is prevented by the presence of the K 1 
capsule, which is essential for the bacterial intracellular survival by preventing lysosomal 
fusion with the ECY (Hoffman et af. , 1999; Kim et af. , 2003). 
In this study, we showed that E. coli K 1 does not arrest endosomal maturation at 
early endosomal stage and that overexpression of various GFP-tagged Rab5 chimaerae 
does not affect the bacterial invasion of HBMEC. Intracellular E. coli K I does not loca l ize 
to the Rablla recycling compartment, but the bacteria were found to loca li ze in late 
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endosomal compartments, which are positive for Rab7, Rab9, and LAMPL Time-lapse 
imaging revealed that the intracellular bacteria were associated with Rab7 2 hours p.i. and 
remain associated throughout the imaging time point. 
Numerous pathogenic bacteria, such as Campylobacter jejuni. Coxiella burnetii, 
and Salmonella enterica serovar Typhimurium, localize in late endosomal-like 
compartments, but the bacteria-containing vacuoles do not fuse with lysosomes (Meresse 
et aI., 1999; Beron et aI., 2002; Watson and Galan, 2008). Although cathepsin D has 
previously been shown to be absent from ECV (Kim et aI., 2003), we were unable to 
repeat this finding and to demonstrate the absence of cathepsin D from the 
Rab7/LAMP l/Rab9-associated ECV at later time points of infection, due to reagent 
compatibility (data not shown). However, intracellular mCherry-expressing E. coli K 1 
remained intact and brightly fluorescent 20 hours p.i. (Figure 6.4B, 6.5A - C), which might 
indicate the bacteria were viable (Hagedorn and Soldati, 2007). in vitro study has also 
demonstrated that fluorescent protein fails to retain in bactericidal compound-killed 
Mycobacterium tuberculosis, while the protein is stably maintained in bacteriostatic 
compound-treated bacteria (Carroll et aI., 2010). Recently, the application of a 
fluorescence dilution bacterial reporter system found that a large population of Salmonella 
Typhimurium does not replicate upon entry into macrophages, but enters a dormant stage, 
in which the bacteria are unculturable on laboratory medium, but some are able to respond 
to an extracellular chemical inducer, and equally there is no evidence of their being killed 
intracellularly (Helaine et al., 2010). The Salmonella findings open up a critical question of 
the viability and dormancy of intracellular E. coli Kl in various identified cellular 
compartments in this study, especially at late time points of infection. One of the results 
from this study showed that E. coli Kl could survive intracellularly 7 hours p.i. (Figure 
3.2), but a very low number of viable bacteria were recovered 20 hours p. i. (data not 
shown), which was possibly due to bacterial dormancy, or bacterial killing, or the majority 
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of the bacteria having egressed from the infected cells at late time point and by gentamicin 
in the media. 
In the previous chapter, 2':300/0 intracellular bacteria were found to be associated 
with flotillin 1, while comparison to more traditional endocytic markers in this chapter 
additionally found that the intracellular bacteria were localized in late endosomal 
compartments that are positive for Rab7 (Figure 6.3A and E), Rab9 (Figure 6.5A), and 
LAMP 1 (Figure 6.4A and B). With these observations, we questioned the correlation 
between flotillin 1 and these late endosomal markers on ECV. Flotillin 1 is considered as a 
late endosomal marker and co-localizes with LAMPI (Derrnine et al., 2001), but live 
intracellular Mycobacterium marinum (M marinum) are found to replicate in flotillin 1 
compartments that are devoid of LAMP 1 in human peripheral monocytes (Hagedorn and 
Soldati, 2007). Therefore, it is important to characterize if those flotillin I-associated ECV 
exist as an independent compartment or associate with LAMP 1, and which of these 
compartments provides a safe niche for the bacteria. These experiments are ongoing. 
Furthermore, to elucidate the specific endosomal stage at which flotillin 1 is recruited to 
ECV, the presence of flotillin 1 on ECV in cells overexpressing the dominant negative Rab 
proteins should be studied. 
During this study, it was also hoped to identify a potential transcytosis pathway that 
E. coli KI hijack for crossing HBMEC, however, our data is so far insufficient to address 
this question. HBMEC are rich with caveolae, which is rationale to speculate the caveolae 
as the major endocytic and also transcytotic pathway for the cells (Minshall et al., 2003). 
However, this study showed that only approximately 4% of E. coli K 1 was associated with 
caveolin-l at the early infection time point, and this further reduced to less than 1 % ~t later 
time points of infection. Therefore, it is very unlikely that E. coli K 1 traverses to the 
basolateral surface via a caveolae-mediated pathway. Based on the current data, we 
speculated that E. coli Kl could potentially harness late/lysosomal, flotillin I-dependent 
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pathway for traversing HBMEC (Figure 6.6, model 2), which has been proposed for 
exosome egress (Lakkaraju and Rodriguez-Boulan, 2008; Thery et al., 2009). Further. the 
cellular markers present on ECY are typically identified on exosomes (Chertova et al., 
2006; Simons and Raposo, 2009; Chen et al., 2011). Alternatively, ECY associated with 
flotillin 1 (independent of LE markers) might be the route by which the bacterial 
population traverses and exocytoses from HBMEC (model 1) (Figure 6.6). The presence of 
flotillin 1 on ECY could have a role in the recruitment of actin and other motor proteins 
onto the endosome (Dermine et al., 2001), as flotillin binds F -actin \'ia its stomatin, 
prohibitin, flotillin, and HflK/C (SPFH) domain (Langhorst et al., 2007). In addition to 
actin and motor proteins recruitment to ECY, the actin binding ability of flotillin could be 
. 
required for vesicles docking onto the target membrane, and for exocytosis (Nightingale et 
aI., 2011). Overall, other potential transcytotic markers, such as Rab25 and Rab 1 a, will be 
investigated in future experiments. Once a potential transcytotic marker is identified on 
ECY, the endosomal stage which the marker is recruited can be identified with the 
application of the available Rab dominant negative mutant constructs. 
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Figure 6.6. Potential E. coli Kl transcytotic pathway in HBMEC. E. coli K I enters 
HBMEC via an actin-dependent process with unknown endocytic pathway. After 
internalization, the ECY transiently acqui res di fferent markers of the class ical endocyt ic 
pathway. We speculated that E. coli Kl might traverse HBMEC via either fl otillin I 
(model 1) or late endosomes (LE) with fl otillin 1 (model 2) pathway. EE, early endosome: 
LE, late endosome. 
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7. General discussion and conclusion 
E. coli is one of the bacteria predominantly isolated from neonatal bacterial 
meningitis cases (Osrin et al., 2004; May et al., 2005; Wu et aI., 2009; Talbert et aI., 2010; 
Gaschignard et aI., 2011), with high mortality rate observed in some countries (May et al., 
2005; Wu et aI., 2009). The majority of the E. coli strains isolated from neonatal 
meningitis cases possess K1 capsule (Robbins et al., 1974; Sarff et aI., 1975), which is 
structurally homologous to, and immuno-cross-reactive with, the a-2,8-linked polysialic 
acid (polySia) glycan highly expressed on the developing brain and kidney of newborn 
mammals (Finne ~t aI., 1983a; Roth et aI., 1987; Harvey et aI., 2001). 
For this study, an immortalized HBMEC line, which was generated by transfecting 
primary HBMEC isolated from patients aged 4 - 7 -year-old with SV 40 large T antigen 
(Stins et aI., 2001), representing the BBB, was applied to study E. coli K 1 pathogenesis in 
vitro. Early in the study, we tried E. coli K1 infection on mouse brain endothelioma cell 
lines (bEndS), an in vitro BBB model commonly applied for T cell migration studies 
(Steiner et aI., 2011), but this resulted in no intracellular bacteria recovered from infected 
bEndS lysates (data not shown). With the HBMEC model, E. coli K 1 invasion efficiency 
was approximately 0.1 % of the initial bacterial inoculums (Figure 3.2), which agreed with 
the published E. coli Kl invasion efficiency by Prasadarao et al. (1996). In fact, this level 
of bacterial invasion efficiency is low, and the bacterial invasion is FCS-dependent, which 
is a major experimental hindrance for studies that involve cholesterol depletion. The low 
bacterial invasion efficiency leads to some degree of experimental difficulty, especially in 
the studies of the bacterial entry pathways. Despite various optimization steps that were 
performed, such as determination of the optimum MOl, bacteria-HBMEC incubation time, 
total volume of experimental media used during infection, and centrifugation of the 
bacteria to the cell surface for synchronizing the infection. only minor improyements were 
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achieved. The observed low bacterial invasion could be an outcome of age-related 
differences in the HBMEC used, as indirectly evidenced bv an earlier study that 
. . 
demonstrated the age-related susceptibility of an infant rat model in developing 
Haemophilus influenza type b-associated meningitis (Moxon et af., 1977). and a similar 
observation was made with E. coli Kl infection in vivo (Zelmer, A., personal 
communication)(Mushtaq et af., 2005). The difference in neonate- and adult-derived 
mouse brain microvascular endothelial cells (BMEC) was also demonstrated by different 
level of protease secretion following glutamate induction, though both endothelial cells 
exhibited similar phenotypes (Legros et af., 2009). Therefore. we hypothesize that E. coli 
Kl would invade neonate-derived HBMEC more efficiently than HBMEC derived from 
patients aged 4 - 7 years of age such as the HBMEC used in this study. Owing. to the 
involvement of complicated ethical issues in obtaining and utilizing human tissues either 
from live or dead patients lately (Carmichael, 2011; Marchant, 2011), neonate BMEC 
could be obtained from other species such as bovine and porcine, as no difference was 
reported in E. coli Kl invasion efficiency of BMEC derived from other species (Prasadarao 
et af., 1996a). 
An additional difficulty in this invasion model is that HBMEC. like other 
endothelial cells, are also resistance to plasmid DNA transfection, either by lipid- or 
polymer-based transfectants, or by electroporation (Kovala et af., 2000; Segura et af., 
2001; Kang et af., 2009; Anliker et af., 2010). In this study, various transfection reagents 
were tried, but the transfection efficiency usually ranged between 10 - 30% (Figure 4.2). 
Transfection efficiency of about 50% was achieved by altering the amount of pNI-EGFP 
plasmid DNA and jetPRIME™ used per transfection reaction (Figure 4.3). however. with 
other recombinant constructs this ranged between 20 - 45%. The current transfection 
efficiency could probably be further improved with gene-specific lentiviral vectors, which 
were psudotyped with mutated truncated measles viral haemagglutinin, and displayed a 
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single-chain variable fragment (scFv) specific to CD 1 05, an endothelial cell specific 
marker (Anliker et aI., 2010). However, it has been documented that the application of 
lentiviral vector for transducing monocyte-derived dendritic cells resulted with decrease 
CD 1 d presentation (Garg et aI., 2011). Therefore, there is a possibility that transduced cells 
might respond differently to infection. 
Confocal microscopy imaging was one of the experimental techniques heavily 
applied in this study. To enable visualization of the bacteria under a confocal microscope, 
fluorescent E. coli Kl were required, either by surface-labelling with fluorescent dye. or by 
immunostaining with specific antibody, or by cytoplasmic expression of fluorescent 
protein. There is a limited choice of E. coli Kl-specific antibodies, and bacterial surface-
labelling with FITC dye led to unexpected imaging channel cross-talk, as well as a 
decrease in bacterial invasion of HBMEC. Therefore, in Chapter 3, we described the 
making of fluorescent bacteria that retain bacterial virulence by transforming the bacteria 
with various bacterial expression vectors expressing fluorescent protein. All the 
transformed bacteria fluoresced under a confocal microscope, but the majority of them 
demonstrated impairment in bacterial invasion of HBMEC, except E. coli K 1 transformed 
with pFPV25.1, which has been widely applied in Salmonella (Cheminay et aI., 2005; 
Radtke et aI., 2007; Gerlach et aI., 2008), and pathogenic E. coli studies (Radtke et aI., 
2007; Marches et aI., 2008). Surprisingly, the invasiveness of transformed E. coli K 1 
bearing pFPV -mCherry construct, in which the gfpmut3a gene of pFPV25.1 was replaced 
with mammalian codon-optimised mCherry cDNA, was closely similar to the 
untransformed bacteria (Figure 3.19). Even so, our results show that the presence of 
plasmid DNA and expression of fluorescent proteins could affect bacterial virulence. and 
the possibility that the fluorescent protein gene or the plasmid DNA copy number might 
also affect bacterial virulence gene expression must be kept in consideration when 
interpreting results (Clark et al., 2009; Valdivia, R., personal communication). The 
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mCherry-expressing E. coli K1 not only served as a useful tool for this study, retaining 
virulence in the assays here, but also might be a valuable tool for future preliminary in "i\'O 
live animal imaging, in which the application of the longer excitation wavelength needed 
for mCherry also enables better deep tissue penetration and is less prone to tissue 
autofluorescence. 
E. coli K1 entry has been proposed to be receptor-dependent and VIa ZIpper 
mechanism (Prasadarao et a!., 1999), which was further supported by the absence of T3SS 
in the RS218 clinical strain or the E44 strain used in all studies by Kim' s group for the past 
two decades (Yao et a!., 2006). The molecular events that lead to actin polymerization at 
the bacterial adhesion site have been very well-studied (Prasadarao et a!., 1999; Reddy et 
a!., 2000a; Reddy et a!., 2000b; Prasadarao, 2002; Khan et a!., 2003; Maruvada et al., 
2008). The endocytic pathway manipulated by the bacteria for HBMEC entry was reported 
to be clathrin-independent (Prasadarao et at., 1999), and caveolae-dependent (Sukumaran 
et a!., 2002). Based on the current knowledge of caveolae-mediated entry. dynamin is 
required for caveolar fission in vitro and in vivo (Oh et al., 1998; Pelkmans et al., 2002; 
Yao et a!., 2005), and dynamin might also have a role in actin cytoskeleton recruitment 
(Lee and De Camilli, 2002). However, previous studies have not investigated the role of 
dynamin during E. coli K1 internalization. Given the proposed entry site of caveolae, we 
hypothesized that overexpression of GDP-Iocked dynamin would inhibit the bacterial 
uptake into HBMEC. To our surprise, we found no inhibitory effect on the E. coli K1 entry 
in HBMEC overexpressing GDP-Iocked dynamin 1 or 2 (Figure 5.1A and B). Although 
these constructs have been widely used in previous studies (Cao et al., 1998; Watson and 
Galan, 2008; Rahn et a!., 2011) the uptake of a known specific ligand, such as transferrin 
(clathrin-mediated endocytosis), into HBMEC overexpressing GDP-Iocked dynamin need 
to be assessed to ensure this observation was not due to non-functioning GDP-locked 
dynamin mutants. Dynamin inhibitors, such as dynasore (Macia et al., 2006), could be 
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applied for blocking dynamin isoforms in cells and studied their effects on E. coli K 1 
invasion of HBMEC. Since dynasore is a broad spectrum inhibitor, the application of this 
inhibitor for studying E. coli Kl invasion of HBMEC would rule out the possibility that 
other endogenous dynamin isoforms and splice variants take over roles in cells 
overexpressing a GDP-Iocked dynamin isoform. 
To confirm the findings by Sukumaran et al. (2002), we revisited the role of 
caveolin-l during E. coli Kl infection of HBMEC, and found that only about 4% of the 
bacteria were localized in compartments weakly stained for caveolin-l at 30 minutes p.i., 
i.e., at a timepoint where we would expect to see bacteria undergoing invasion, and that 
population of bacteria further reduced to approximately 1 % at later timepoints indicating 
no obvious association with caveolin-l during uptake or with the intracellular ECV (Figure 
5.2A and B). Furthermore, the application of caveolin-l mutants had no effect on E. coli 
Kl internalization. Importantly, E. coli Kl invasion of caveolin-l knockout MLEC was not 
inhibited. However, this observation is insufficient to completely rule out the b~cterial 
invasion via non-caveolae-mediated endocytic pathway, as Siddiqui et al. (2011) 
demonstrated the absence of caveolin-l led to destabilization of adherens junctions, 
activation of endothelial nitric oxide synthase (eNOS) in endothelial cells, which impaired 
GTPase activating protein (GAP) p190RhoGAP-A by nitrating tyrosine residue 1105, and 
led to RhoA activation (Siddiqui et al., 2011). RhoA was shown to be required for E. coli 
K 1 invasion of HBMEC (Khan et al., 2002), therefore, the inhibitory effect of bacterial 
invasion in caveolin-l knockout MLEC might be cancelled by RhoA. To further elucidate 
the role of caveolin-l during E. coli Kl invasion, caveolin-l Y14A mutant, which is non-
phosphorylatable and its expression in cells inhibited caveolae-mediated endocytosis (del 
Pozo et al., 2005; Hu et al., 2006), could be transfected into caveolin-l knockout MLEC. 
and infect with the bacteria. It is hypothesized that the bacterial invasion of ca\"eolin-l 
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Y14A expressing caveolin-l knockout MLEC would be inhibited if caveolae-mediated 
endocytosis is exploited by E. coli Kl for cell invasion. 
At this stage of the study, our findings are contradictory to the Sukumaran et af. 
(2002) findings, where they reported inhibition in E. coli Kl invasion in HBMEC 
overexpressing dominant negative caveolin-l (caveolin-l with two amino acids mutation at 
the scaffolding domain for phosphor-PKCa interaction), and strong staining of the 
invading and intracellular bacteria with caveolin-l. As discussed above, further 
experiments are needed to further substantiate our findings; however, there are also several 
ambiguities in their findings. First, in the panel of micrographs that was indicated as 
bacteria-specific staining, very strong non-specific background was observed, and appears 
to show staining of the entire cell periphery. This strongly suggests that the caveolin-l 
signal on the bacteria that they observed could be signal resulting from channel crosstalk 
with bacterial staining. Secondly, the authors stated that the presented micrographs were 
from 30 minutes pj. (MOl unknown, but it was stated that 1 x 107 E. coli Kl were used for 
infection), and a high number of bacteria was observed in the panels that they claimed to 
be intracellular. We have never seen such a high number of intracellular bacteria at 30 
minutes pj., a maximum single bacterium per cell is more frequently observed in our 
hands at the similar time point. We only see clumps of intracellular bacteria at much later 
timepoints (see below). Thirdly, filipin was applied to deplete cholesterol from HBMEC 
plasma membrane in their study, and a dose-dependent reduction in recovered intracellular 
E. coli Kl was reported. We tried to repeat this experiment, but 30 minutes incubation with 
1 or 4 /lg/ml of filipin in FCS-free media resulted in massive cell detachment from the 
well, probably due to the sensitivity of HBMEC to some chemical inhibitors (Ki~, K.S., 
personal communication). 
Since no link was found between E. coli K 1 invasion and dynamin- and caveolin-l-
mediated endocytic uptake, which endocytic pathway that the bacteria manipulated for 
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invading HBMEC was explored. We chose to focus on the flotillin-mediated pathway. 
which forms distinct lipid raft microdomains on the plasma membrane and the pathway is 
dynamin-independent. Both flotillin 1 and flotillin 2 co-localize and co-assemble into 
microdomains distinct from caveolae microdomains (Frick et a!., 2007). It has been shown 
that knockout of flotillin 1 causes concomitant reduction in flotillin 2 expression (Ludwig 
et a!., 2010), and this study showed that in flotillin 1 knockout MLEC. flotillin 2 
distribution was disrupted as evidenced by the absence of flotillin 2 punctate staining. We 
observed weak flotillin 1 signal accumulated beneath approximately 5% of extracellular 
bacterial population and 50/0 of the intracellular bacterial population were associated with 
flotillin 1 at 30 minutes pj. (Figure 5.5A and B). The intracellular bacteria that associated 
with flotillin 1 increased to about 30% at 2 hour pj. However, in flotillin 1 knockout 
MLEC, instead of blocking the bacterial internalization as would be expected if flotillin 1 
were required for uptake, both E. coli K1 and non-pathogenic E. coli K-12 intracellular 
density was significantly enhanced at 150 minutes p.i. (Figure 5.6A). The enhanced 
bacterial density was caused by enhanced bacterial invasion into flotillin 1 knockout 
MLEC, and not because of non-functioning lysosomal pathway (Figure 5.6B). These 
results show that E. coli Kl does not require the flotillin I-mediated pathway for invading 
HBMEC and the bacterial invasion should also be flotillin 2 independent since both , 
flotillin 1 and flotillin 2 co-assemble to form microdomains and their expression are 
interdependent. 
The data in this study suggest that E. coli K 1 endocytosis is dynamin-independant, 
and the precise endocytic pathway utilized is still unclear. There are three major dynamin-
independent endocytic pathways, namely the Arf-6-regulated pathway. the Cdc42-
regulated pathway, and macropinocytosis (Mayor and Pagano, 2007; Kumari and Mayor. 
2008; Mercer and Helenius, 2009; Howes et a!., 2010; Kumari et a!., 2010). Arf6 and 
Cdc42 dominant active and dominant negative constructs have been sourced and will be 
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tested in HBMEC to study their effects on E. coli Kl invasion. To date. there is no singular 
cellular target to study macropinocytosis, a number of different cellular markers together 
are needed to imply the activity of the macropinocytic pathway. It is interesting to note that 
current experimental criteria to implicate macropinocytosis specifically exclude a 
dependency on the Rho GTPase RhoA (Mercer and Helenius, 2009). Activation of RhoA 
during E. coli K 1 invasion of HBMEC has been published previously (Khan ef al., 2002; 
Khan et at., 2003). Furthermore, overexpression of dominant negative RhoA T 19N mutant 
reduces E. coli invasion; while overexpression of the dominant positive fonn (RhoA 
G14V) increased invasion (Khan et at., 2002). Rho A has also been proposed as a clathrin-
independant but dynamin-dependent endocytic pathway for interleukin 2 (lL2) receptor 
(Lamaze et at., 2001), which is contradictory with the dynamin-independent findings in 
this study. Since RhoA is one of the key signalling molecules involved in the regulation 
and dynamics of the actin cytoskeleton, the activation of RhoA seen in E. coli K 1 infection 
of HBMEC may be a bystander effect due to the actin rearrangement triggered during 
infection. Indeed, a dependency of E. coli Kl invasion on RhoA has not been shown. 
Enhanced intracellular bacterial density was observed in flotillin 1 knockout 
MLEC, which we believed was a result of enhanced bacterial uptake. evidenced by higher 
number of infected flotillin 1 knockout cells than the number of infected wild type cells 
after 30 minutes infection (Figure 5.6B). We hypothesize that the cholesterol content of the 
plasma membrane might have been depleted in the flotillin 1 knockout cells; hence, the 
membrane fluidity might be enhanced, and could lead to facilitated penetration by the 
bacteria. Alternatively, flotillin 1 might have a role in regulating cellular cytoskeletal 
structures (Langhorst et at., 2008a), that might form a cellular barrier at the bacterial 
attachment sites, or the absent of flotillin 1 disrupt the cytoskeletal signalling pathway as 
observed in caveolin-l knockout endothelial cells (Siddiqui ef al., 2011). This cellular 
barrier hypothesis might explain one of our preliminary data, wherein HB\ 1 Fe 
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overexpressing either GFP-tagged flotillin 1 or flotillin 2 showed a lower rate of infection 
than HBMEC overexpressing other GFP-tagged recombinant constructs at 3 hours p.i. 
(Figure 5.8). 
The general role of flotillin 1 in vivo is not known. Flotillin 1 knockout mice do 
survive, although a defect in neutrophil and monocyte recruitment in response to 
chemoattractant has been observed (Ludwig et a!., 2010). In addition to have a key role in 
host defense system, the data from this study as well as the results from others suggest that 
flotillin 1 might actively maintain integral barrier against external environment at the 
cellular and systemic level (Li et a!., 2008b). Therefore, future study should look into the 
susceptibility of flotillin 1 knockout animals to infections (particularly enteric and 
neurotropic pathogens), as well as autoimmune and allergy diseases, such as Crohn's 
disease and Asthma. 
Another part of this project was to study the E. coli Kl intracellular survival by 
screening the organellar markers on the bacterial compartments. We found that the post 
invasion ECV had the characteristics of late endosomes. Intriguingly, at 20 hours p.i., we 
observed clumps of intact and fluorescent intracellular bacteria localized in these late 
endosomal compartments, which we believe to result from intracellular bacterial 
replication, also evidenced from our survival assay data (Figure 3.2). There was no 
evidence of E. coli Kl clumping in culture based on live microscopy examination (data not 
shown). Again, this finding is contradictory with previous publication which claimed that 
E. coli Kl did not replicate intracellularly based on transmission electron micrographs, as 
TEM micrograph only shows small regions of interest, there is potential bias in figure 
selection (Prasadarao et a!., 1999; Sukumaran and Prasadarao, 2002). This study also 
found 35% of intracellular bacteria were localized in flotillin 1 compartments at late time 
points of infection, to understand the distribution of flotillin 1 and late endosomal markers 
(Rab7 and LAMP 1) on the ECV is a high priority. More detailed analysis of the host cell 
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factors present on the ECV could be achieved by performing a proteome analysis with 
mass spectrometry of purified ECV as described in (Urwyler et al., 2009). 
A previous study showed that the inhibition of lysosomal fusion is achie\'ed by the 
presence of the Kl capsule on the bacteria (Kim et al., 2003), but the lysosomal inhibition 
strategy that involves the Kl capsule is unknown. Therefore, other bacterial factors may 
involve in inhibiting ECV fusion with lysosomes. The bacteria might secrete bacterial 
virulence factors into the cytosol of infected HBMEC via the bacterial GSP system, which 
might be the alternative secretion system in the absence of T3SS (Yao et al., 2006), and 
interfere with host factors (such as GTPases, vATPases, components of homotypic fusion 
and vacuole protein sorting (HOPS) complex, N-ethylmaleimide sensitive factor (NSF). 
etc.) required for late endosome-lysosome fusion. Further, the bacteria were shown to 
contain icmF and icmH in one of the bacterial pathogenicity islands (Xie et al., 200Q). The 
Legionella homologues of these proteins encode a type IV secretion system required for 
Legionella species' intracellular survival by avoiding trafficking to lysosomes in human 
macrophages (VanRheenen et al., 2004). To study if the icmF, icmH, and other potential 
bacterial secretory proteins are translocated into the cytosol of infected HBMEC, split-GFP 
teachnology could be applied, whereby the bacterial proteins are tagged with the 13-
amino-acid 11 th strand of the GFP ~-barrel (GFPIl), and the non-fluorescent 
complementary fragment of the first ten strands of GFP (GFPI-IO) is expressed in 
HBMEC (Van Engelenburg and Palmer, 2010). Fluorescent signal is resulted if the 
GFP II-tagged bacterial protein is translocated into the cytosol and complemented with 
GFP 1-1 0 in HBMEC. After the identification of secreted bacterial proteins, gene specific 
knockout bacterial mutants could be constructed for screening of bacterial factors that are 
required for inhibiting lysosomal fusion to ECV. 
The ability of E. coli KI to traverse HBMEC cultured on a Transwell® insert 
without disrupting the monolayer's integrity was described a decade ago (Stins et at.. 
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200 I), but the cellular pathway has never been studied. Sukumaran et al. (2002) proposed 
the bacteria utilized caveolin-I for HBMEC traversal based on their observation of co-
localization between the intracellular bacteria and caveolin-I. Howe\'er, there are some 
ambiguities with their findings as discussed previously, and we only found about 1 % of 
bacteria weakly associated with caveolin-I at later time points of infection. Therefore, we 
believe that caveolin-I is unlikely to form the basis of the bacterial transcytosis pathway, 
unless the I % population of E. coli KI weakly associated with caveolin-l is sufficient for 
the bacteria to egress from HBMEC at the basolateral membrane. Based on our findings in 
Chapter 6, we speculated that E. coli K I might egress from HBMEC via late/lysosomal 
[N.B. Lysosomal membrane proteins, such as LAMPI, are actively interacting with plasma 
membrane, and are involved in membrane repairing (Divangahi et al., 2009).], or a flotillin 
I-dependent pathway. The role of flotillin I on the intracellular vacuoles might have a role 
in recruiting motor proteins for intracellular transportation, for docking of the vacuoles to 
the target membrane surface, or for releasing the cargo. The low transfection efficiency of 
HBMEC is the major experimental obstacle for studying bacterial transcytosis pathway. 
An alternative experimental approach would be the application of tannic acid, which only 
fixes the membrane surface in contact, at the basolateral compartment of Transwell® filter 
insert to arrest the bacteria at the basolateral membrane surface (Polishchuk et al., 2004), 
and the infected HBMEC on the Transwell® filter insert is fixed and immunostained for 
organellar markers. 
Although HBMEC has been widely applied for studying the E coli K 1 
pathogenesis (Huang et al., 1995; Reddy et al., 2000a; Stins et al., 2001; Kim et al., 2003; 
Khan et al., 2007), the precise bacterial entry site in vivo remains controversial. The 
current model is based on findings by Kim et al. (1992), where, in a newborn (5-day-old) 
rat model, the authors found the bacteria present in the perivascular area of the 
subarachnoid space, but not in the choroid plexus, where the BCSFB is found (sec section 
19.+ 
1.4). The group further showed that the bacteria invaded isolated brain microvascular 
endothelium more efficiently than endothelial cells isolated from other anatomical sites in 
vitro (Prasadarao et at., 1996a). More than a decade later, Zelmer et al. (2008) found 
evidence to support the alternative BCSFB entry site in their newborn (2-day-old) rat 
model. The observed discrepancy by both groups is complex and multifactorial, where one 
of the factors could be the age of the animals used, or the different route of bacterial 
administration in these studies. The precise bacterial entry site in the animal could be 
elucidated by the application of multiphoton microscopy for deep tissue live animal 
imaging (Melican and Richter-Dahlfors, 2009; Melican et al., 201l), in conjunction with 
innovative thin-skull microsurgery procedure (Marker ef al., 2010). The main challenge for 
this experimental approach is to keep the fragile, hypothermia-prone newborn animal alive 
and physiologically stable during the surgery procedure as well as during imaging. Live 
animal deep tissue imaging is also important to confirm previous in vitro findings that have 
arisen from the HBMEC model, as differences in Listeria monocytogenes infection cycle 
both in vitro and in vivo has been demonstrated recently (Nikitas et al., 2011). Further, an 
infection is more heterogeneous than merely E. coli K1-HBMEC interactions in culture 
medium, and would also depend upon a complex interaction between the pathogen and 
capillary endothelium as well as various tissues, including microglial cells, astrocytes, 
immune cells, inflammatory factors, etc. It has also been shown that approximately 40% of 
plasma membrane proteins failed to express on the plasma membrane of purified 
endothelial cells maintained in vitro (Durr et al., 2004), which might affect the results 
obtained in vitro and in vivo. All the future in vivo imaging works can be achieved .by the 
mCherry-expressing E. coli Kl constructed in this study. 
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Conclusion 
The purpose of this study was to investigate the interactions of E. coli K 1 with 
HBMEC in order to elucidate the pathway by which the bacteria cross the BBB into the 
CNS. To this end, an mCherry-expressing E. coli Kl that retains the bacterial invashoeness 
of HBMEC was constructed. Our data suggest E. coli Kl invade HBMEC via a cayeolae-, 
dynamin-, and flotillin-independent pathway. Once inside the cells, E. coli Kl were found 
to localize in late endosome-like compartment. We speculate that the bacteria may cross 
BBB via late/lysosomal pathway. Interestingly, when MLEC knockout cells were used to 
model bacterial infection, the absence of flotillin 1 was found to enhance bacterial invasion 
compared to wild type. We further suggest flotillin has an essential role in maintaining the 
cell wall as a barrier to the external environment. In addition, flotillin appears to be an 
important component in maintaining mucosal membrane integrity, having significant 
impacts in diseases such as Crohn's disease and asthma (Li et af., 2008b). Thus, the results 
in this study not only have an impact in the understanding of how E. coli K 1 traverse the 
BBB, but are also of interest in relation to the role of flotillin in maintaining cellular barrier 
integrity. 
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